OBO_ID (LABEL):	CHEBI_27300 (vitamin D)

IGNORANCE CATEGORY:	difficult_task

ARTICLE	ARTICLE DATE	SENTENCE NUM	SENTENCE	IGNORANCE CATEGORIES	NUM IGNORANCE CATEGORIES	OBO ID (LABEL)
PMC1533075	6/1998	S9-PMC1533075	['mothers also took individual Micronutrient supplements (e.g., Vitamin C tablets), but most mothers who took these also took multivitamins, making it IMPOSSIBLE to determine POTENTIAL independent EFFECTS of these Micronutrients.']	[('DIFFICULT_TASK', 149), ('INCOMPLETE_EVIDENCE', 173), ('SUPERFICIAL_RELATIONSHIP', 195)]	3	[('CHEBI_33962', 'mu4-sulfido-quadro-tetracopper(6+)', 29, 'micronutrient'), ('CHEBI_27300', 'vitamin D', 62, 'vitamin C'), ('PR_000004900', 'complement C3', 70, 'C'), ('CHEBI_33839', 'macromolecule', 212, 'micronutrients')]
PMC2582131	11/2008	S125-PMC2582131	['intervention studies[14],[40]–[44]assessing the EFFECT of Vitamin D and Calcium supplements on Glucose Metabolism among non-Pregnant Individuals have yielded MIXED results, which is AT LEAST PARTLY DUE TO VARIATIONS in the dose of supplementation and the duration of follow up.']	[('SUPERFICIAL_RELATIONSHIP', 48), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 158), ('PROBABLE_UNDERSTANDING', 182), ('INCOMPLETE_EVIDENCE', 191), ('PROBLEM_COMPLICATION', 198), ('DIFFICULT_TASK', 205)]	6	[('CHEBI_27300', 'vitamin D', 58, 'vitamin D'), ('CHEBI_22313', 'alkaline earth metal atom', 72, 'calcium'), ('CHEBI_17234', 'glucose', 95, 'glucose'), ('GO_0006006', 'glucose metabolic process', 95, 'glucose metabolism'), ('GO_0007565', 'female pregnancy', 124, 'pregnant'), ('NCBITaxon_1', 'root', 133, 'individuals')]
PMC2582131	11/2008	S126-PMC2582131	['optimizing the effective dose of Vitamin D supplement continues to be a CHALLENGE.']	[('DIFFICULT_TASK', 72)]	1	[('CHEBI_27300', 'vitamin D', 33, 'vitamin D')]
PMC2821652	2/2010	S75-PMC2821652	['THEREFORE, we were faced with the CHALLENGE of establishing novel criteria for Vitamin D supplement adherence by Serum 25(Oh)D levels; HOW we arrived at this definition is described below.']	[('PROBABLE_UNDERSTANDING', 0), ('DIFFICULT_TASK', 34), ('EXPLICIT_QUESTION', 135)]	3	[('CHEBI_27300', 'vitamin D', 79, 'vitamin D'), ('UBERON_0001977', 'blood serum', 113, 'serum'), ('CHEBI_71657', 'versiconol acetate', 119, '25(OH)D'), ('PR_000003010', 'moesin isoform 1', 121, '(OH ... D')]
PMC3257641	3/2010	S132-PMC3257641	['this is a DIFFICULT BUT IMPORTANT AREA to research [101,102,103,104], with Animal work indicting transient Prenatal Vitamin D deficiency is ASSOCIATED with subtle alterations in Learning and Memory functions in Adult Rats [105].']	[('DIFFICULT_TASK', 10), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 20), ('IMPORTANT_CONSIDERATION', 24), ('FUTURE_WORK', 34), ('SUPERFICIAL_RELATIONSHIP', 140)]	5	[('NCBITaxon_33208', 'Metazoa', 75, 'animal'), ('GO_0007565', 'female pregnancy', 107, 'prenatal'), ('CHEBI_27300', 'vitamin D', 116, 'vitamin D'), ('GO_0007612', 'learning', 178, 'learning'), ('GO_0007613', 'memory', 191, 'memory'), ('UBERON_0007023', 'adult organism', 211, 'adult'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 217, 'rats')]
BMJ_2010_Apr_29_340_c1640	4/2010	S18-BMJ_2010_Apr_29_340_c1640	['this EVIDENCE comes from both case-control and cohort studies and INDICATES that age of operation for such a PROTECTIVE EFFECT MIGHT include both childhood and early Adulthood.67891011\nexposure to ultraviolet radiation in early Life has NOT YET been formally examined but MIGHT be LINKED to excess risk of multiple sclerosis at Birth through seasonal deficiency in maternal Vitamin D concentrations.12A study of half siblings with multiple sclerosis has ALSO SHOWN that risk CAN be maternally MEDIATED.13pregnancy is a vulnerable time for Vitamin d deficiency BECAUSE of increased physiological needs and reduced maternal outdoor activity.14experimental data on Animal Fetal Development INDICATE that Cerebral White Matter is responsive to Vitamin D and that Oligodendrocytes in the Brain and Spinal Cord have Vitamin D Receptors.1516furthermore, maternal Vitamin D depletion alters Neurogenesis in the developing Rat Brain,17with subsequent altered Gene Expression in Adult Life.18a RECENT Genetic STUDY in Humans has FURTHER IMPLICATED Vitamin D as a strong environmental CANDIDATE by SHOWING direct functional INTERACTION with the major locus that determines susceptibility to multiple sclerosis.19ALTHOUGH Human EVIDENCE pertaining to fetal development HAS BEEN DIFFICULT to obtain, the body of RELATED EVIDENCE to date has led SOME to RECOMMEND Antenatal supplementation with Vitamin D to prevent multiple sclerosis.14\nAS an indicator of POSSIBLE Perinatal environmental exposures, such as ultraviolet radiation, individual studies in the northern hemisphere have examined month of Birth and risk of multiple sclerosis with VARIED results.2021222324a large RECENT pooled analysis of Births in the northern hemisphere, HOWEVER, SHOWED an excess of multiple sclerosis among People Born in may and a relative deficit among those Born in november; these results were stronger in familial cases and SUGGESTED INTERACTIONS between Genes and environment that are RELATED to climate and that MIGHT act during Gestation or shortly after Birth.12we EXAMINED month of Birth and risk of multiple sclerosis in australia.']	[('INCOMPLETE_EVIDENCE', 5), ('INCOMPLETE_EVIDENCE', 66), ('SUPERFICIAL_RELATIONSHIP', 109), ('SUPERFICIAL_RELATIONSHIP', 120), ('INCOMPLETE_EVIDENCE', 127), ('FULL_UNKNOWN', 237), ('INCOMPLETE_EVIDENCE', 272), ('SUPERFICIAL_RELATIONSHIP', 281), ('INCOMPLETE_EVIDENCE', 399), ('INCOMPLETE_EVIDENCE', 454), ('INCOMPLETE_EVIDENCE', 475), ('SUPERFICIAL_RELATIONSHIP', 493), ('PROBABLE_UNDERSTANDING', 560), ('INCOMPLETE_EVIDENCE', 687), ('INCOMPLETE_EVIDENCE', 984), ('INCOMPLETE_EVIDENCE', 1019), ('SUPERFICIAL_RELATIONSHIP', 1027), ('INCOMPLETE_EVIDENCE', 1074), ('INCOMPLETE_EVIDENCE', 1087), ('SUPERFICIAL_RELATIONSHIP', 1113), ('ANOMALY_CURIOUS_FINDING', 1199), ('ANOMALY_CURIOUS_FINDING', 1199), ('INCOMPLETE_EVIDENCE', 1216), ('INCOMPLETE_EVIDENCE', 1257), ('DIFFICULT_TASK', 1266), ('INCOMPLETE_EVIDENCE', 1299), ('SUPERFICIAL_RELATIONSHIP', 1299), ('INCOMPLETE_EVIDENCE', 1332), ('FUTURE_WORK', 1340), ('PROBABLE_UNDERSTANDING', 1424), ('INCOMPLETE_EVIDENCE', 1443), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 1629), ('INCOMPLETE_EVIDENCE', 1662), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 1723), ('INCOMPLETE_EVIDENCE', 1732), ('INCOMPLETE_EVIDENCE', 1899), ('SUPERFICIAL_RELATIONSHIP', 1909), ('SUPERFICIAL_RELATIONSHIP', 1961), ('INCOMPLETE_EVIDENCE', 1989), ('QUESTION_ANSWERED_BY_THIS_WORK', 2044)]	40	[('UBERON_0000113', 'post-juvenile adult stage', 166, 'adulthood'), ('UBERON_0000104', 'life cycle', 228, 'life'), ('GO_0007567', 'parturition', 328, 'birth'), ('CHEBI_27300', 'vitamin D', 374, 'vitamin D'), ('CHEBI_33229', 'vitamin (role)', 539, 'vitamin'), ('NCBITaxon_33208', 'Metazoa', 662, 'animal'), ('GO_0002065', 'columnar/cuboidal epithelial cell differentiation', 669, 'fetal development'), ('UBERON_0002437', 'cerebral hemisphere white matter', 701, 'cerebral white matter'), ('CHEBI_27300', 'vitamin D', 740, 'vitamin D'), ('CL_0000128', 'oligodendrocyte', 759, 'oligodendrocytes'), ('UBERON_0000955', 'brain', 783, 'brain'), ('UBERON_0002240', 'spinal cord', 793, 'spinal cord'), ('CHEBI_27300', 'vitamin D', 810, 'vitamin D'), ('PR_000001708', 'sphingosine 1-phosphate receptor 3', 810, 'vitamin D receptors'), ('CHEBI_27300', 'vitamin D', 856, 'vitamin D'), ('GO_0022008', 'neurogenesis', 883, 'neurogenesis'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 914, 'rat'), ('UBERON_0000955', 'brain', 918, 'brain'), ('GO_0010467', 'gene expression', 950, 'gene expression'), ('SO_0000704', 'gene', 950, 'gene'), ('UBERON_0000113', 'post-juvenile adult stage', 969, 'adult life'), ('SO_0000704', 'gene', 991, 'genetic'), ('NCBITaxon_9606', 'Homo sapiens', 1008, 'humans'), ('CHEBI_27300', 'vitamin D', 1038, 'vitamin D'), ('NCBITaxon_9606', 'Homo sapiens', 1210, 'human'), ('GO_0007567', 'parturition', 1350, 'antenatal'), ('CHEBI_27300', 'vitamin D', 1381, 'vitamin D'), ('GO_0036268', 'swimming', 1452, 'perinatal'), ('UBERON_0012101', 'perinatal stage', 1452, 'perinatal'), ('GO_0007567', 'parturition', 1587, 'birth'), ('GO_0007567', 'parturition', 1688, 'births'), ('NCBITaxon_10088', 'Mus <genus>', 1777, 'people'), ('GO_0007567', 'parturition', 1784, 'born'), ('GO_0007567', 'parturition', 1831, 'born'), ('SO_0000704', 'gene', 1930, 'genes'), ('GO_0007565', 'female pregnancy', 2006, 'gestation'), ('GO_0007567', 'parturition', 2033, 'birth'), ('GO_0007567', 'parturition', 2062, 'birth')]
PMC2889879	5/2010	S142-PMC2889879	['the absorption of dietary Vitamin D is GENERALLY high at all stages of Life [34], BUT Serum levels also depend on the endogenous Production Of Vitamin D due to sun exposure which is subject to seasonal VARIATIONS.']	[('PROBABLE_UNDERSTANDING', 39), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 82), ('DIFFICULT_TASK', 202)]	3	[('CHEBI_27300', 'vitamin D', 26, 'vitamin D'), ('UBERON_0000104', 'life cycle', 71, 'life'), ('UBERON_0001977', 'blood serum', 86, 'serum'), ('GO_0018240', 'protein S-linked glycosylation via cysteine', 129, 'production of vitamin D'), ('CHEBI_27300', 'vitamin D', 143, 'vitamin D')]
PMC2889879	5/2010	S143-PMC2889879	['THUS, the CORRELATION between Vitamin D intake and Serum levels MAY VARY.']	[('PROBABLE_UNDERSTANDING', 0), ('SUPERFICIAL_RELATIONSHIP', 10), ('INCOMPLETE_EVIDENCE', 64), ('DIFFICULT_TASK', 68)]	4	[('CHEBI_27300', 'vitamin D', 30, 'vitamin D'), ('UBERON_0001977', 'blood serum', 51, 'serum')]
PMC3032617	5/2010	S30-PMC3032617	['SEVERAL randomized placebo controlled STUDIES have ATTEMPTED to repeat pauling’s experience with INCONSISTENT and variable results which to date can not provide a definite conclusion around the real extent of overall health BENEFIT brought in by Vitamin C high daily intake [16-18].']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 38), ('DIFFICULT_TASK', 51), ('INCOMPLETE_EVIDENCE', 51), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 97), ('IMPORTANT_CONSIDERATION', 224)]	6	[('CHEBI_27300', 'vitamin D', 246, 'vitamin C')]
PMC3032617	5/2010	S60-PMC3032617	['we HYPOTHESIZED to record at least 30% of women not hospitalized during Pregnancy in the control group in consideration of the fact they were supplemented regularly throughout their Pregnancy with Ferrous, Folic Acid and b-Complex for anemia prevention, also followed-up every month, ON THE OTHER SIDE at least a 50% of women not hospitalized in the group of women supplemented with Vitamin C in a 1:1 randomized ratio.']	[('INCOMPLETE_EVIDENCE', 3), ('DIFFICULT_TASK', 223), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 284)]	3	[('GO_0007565', 'female pregnancy', 72, 'pregnancy'), ('GO_0007565', 'female pregnancy', 182, 'pregnancy'), ('CHEBI_15378', 'hydron', 197, 'ferrous'), ('CHEBI_30751', 'formic acid', 206, 'folic acid'), ('CHEBI_34652', 'compactin diol lactone', 223, 'complex'), ('GO_0032991', 'protein-containing complex', 223, 'complex'), ('CHEBI_27300', 'vitamin D', 383, 'vitamin C')]
PMC3075531	7/2010	S10-PMC3075531	['introduction\nmultiple sclerosis (ms) is a chronic PROBABLY with Autoimmune basis and UNCERTAIN etiology characterized by Demyelinative and inflammatory physiopathology causing Axonal damages.12this disease AFFECTS females more than males with ordinary 10 years Relapsing-remitting course and secondary progressive phase.2on histological basis, T Helper Cells type 1 (th1) is the MOST RESPONSIBLE cause for pathologies SEEN in ms.1–3there are multiple RISK FACTORS for ms in a COMPLEX RELATIONSHIP with each other from Genetic ones to environmental FACTORS BUT exact mechanism leading to ms has REMAINED UNCLEAR yet.45from GUESSED environmental RISK FACTORS for ms, past infection with Ebv, smoking and low Serum level of Vitamin D are more favorable.67the MOST IMPORTANT Vitamin in calcium and Phosphor Homeostasis is Vitamin D. this Vitamin has PROPOSED POTENTIAL power for Modulating Immune System.48this is achieved via enhancing the Phagocytic function of Monocytes9And decreasing the secretion of Il-6, Il-12, Tnf-Α and Pge2 by Monocytes.10also, immature or semi mature Apc’S cannot mature in presence of 1,25 (Oh)2D.8MANY STUDIES SHOWED a ROLE of paracrine function and Nerve Growth Factor Synthesis Of Vitamin D in Cns and also, SHOWED that deficiency of this Vitamin in Pregnancy Period CAN cause Neural System disorder in Animal cases.811–14then, Vitamin D has a near RELATION with ms and the results of DIFFERENT studies can be summarized as follows: first, the EFFECT of latitude via exposure to sun light and Serum level of Vitamin D on ms prevalence, that increases with distance from equator, with ONLY one EXCEPTION in norway.23815second, vander et al.']	[('PROBABLE_UNDERSTANDING', 50), ('FULL_UNKNOWN', 85), ('SUPERFICIAL_RELATIONSHIP', 206), ('PROBABLE_UNDERSTANDING', 379), ('PROBABLE_UNDERSTANDING', 384), ('INCOMPLETE_EVIDENCE', 418), ('SUPERFICIAL_RELATIONSHIP', 451), ('DIFFICULT_TASK', 476), ('SUPERFICIAL_RELATIONSHIP', 484), ('SUPERFICIAL_RELATIONSHIP', 548), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 556), ('INCOMPLETE_EVIDENCE', 594), ('FULL_UNKNOWN', 603), ('INCOMPLETE_EVIDENCE', 622), ('SUPERFICIAL_RELATIONSHIP', 644), ('PROBABLE_UNDERSTANDING', 756), ('IMPORTANT_CONSIDERATION', 761), ('INCOMPLETE_EVIDENCE', 846), ('INCOMPLETE_EVIDENCE', 855), ('INCOMPLETE_EVIDENCE', 1123), ('INCOMPLETE_EVIDENCE', 1136), ('SUPERFICIAL_RELATIONSHIP', 1145), ('INCOMPLETE_EVIDENCE', 1236), ('INCOMPLETE_EVIDENCE', 1295), ('SUPERFICIAL_RELATIONSHIP', 1377), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 1413), ('SUPERFICIAL_RELATIONSHIP', 1472), ('ANOMALY_CURIOUS_FINDING', 1612), ('ANOMALY_CURIOUS_FINDING', 1621)]	29	[('UBERON_0001442', 'skeleton of manus', 64, 'autoimmune'), ('GO_0006188', 'IMP biosynthetic process', 121, 'demyelinative'), ('GO_0030424', 'axon', 176, 'axonal'), ('GO_0065007', 'biological regulation', 261, 'relapsing'), ('CL_0000545', 'T-helper 1 cell', 344, 'T helper cells'), ('SO_0000704', 'gene', 518, 'genetic'), ('NCBITaxon_10088', 'Mus <genus>', 685, 'EBV'), ('UBERON_0001977', 'blood serum', 706, 'serum'), ('CHEBI_27300', 'vitamin D', 721, 'vitamin D'), ('CHEBI_33229', 'vitamin (role)', 771, 'vitamin'), ('CHEBI_30215', 'muonide', 794, 'phosphor'), ('GO_0042592', 'homeostatic process', 803, 'homeostasis'), ('CHEBI_27300', 'vitamin D', 818, 'vitamin D'), ('CHEBI_33229', 'vitamin (role)', 834, 'vitamin'), ('GO_0065007', 'biological regulation', 875, 'modulating'), ('UBERON_0002405', 'immune system', 886, 'immune system'), ('GO_0006909', 'phagocytosis', 937, 'phagocytic'), ('CL_0002198', 'oncocyte', 960, 'monocytes9and'), ('PR_000001470', 'interleukin-28B', 1002, 'IL-6'), ('PR_000001470', 'interleukin-28B', 1008, 'IL-12'), ('PR_000000134', 'tumor necrosis factor alpha', 1015, 'TNF-α'), ('PR_000012560', 'peroxisomal membrane protein PEX14', 1025, 'PGE2'), ('CL_0000576', 'monocyte', 1033, 'monocytes'), ('PR_000004122', 'adenomatous polyposis coli protein', 1075, 'APC'), ('PR_000011000', 'N-alpha-acetyltransferase 60', 1079, 's'), ('CHEBI_82784', 'PVP38-Ag NP', 1110, '1,25 (OH)2D'), ('UBERON_0001021', 'nerve', 1176, 'nerve'), ('GO_0040007', 'growth', 1182, 'growth factor'), ('GO_0030474', 'spindle pole body duplication', 1196, 'synthesis of vitamin D'), ('CHEBI_27300', 'vitamin D', 1209, 'vitamin D'), ('UBERON_0001017', 'central nervous system', 1222, 'CNS'), ('CHEBI_33229', 'vitamin (role)', 1267, 'vitamin'), ('GO_0007565', 'female pregnancy', 1278, 'pregnancy'), ('UBERON_0018298', 'stylocone', 1278, 'pregnancy period'), ('UBERON_0023879', 'neural system', 1305, 'neural system'), ('NCBITaxon_33208', 'Metazoa', 1331, 'animal'), ('CHEBI_27300', 'vitamin D', 1356, 'vitamin D'), ('UBERON_0001977', 'blood serum', 1521, 'serum'), ('CHEBI_27300', 'vitamin D', 1536, 'vitamin D')]
PMC3075531	7/2010	S59-PMC3075531	['one option WOULD BE a national or multinational study based on randomization of school districts or other suitable units in regions of low sunlight intensity, PERHAPS including multiple outcomes that MIGHT be AFFECTED by Vitamin D, such as diabetes, obesity, Respiratory infections, and asthma.4546ALTERNATIVELY, high-risk first-degree relatives of individu-als with ms COULD BE targeted in a smaller trial,47ALTHOUGH randomization and compliance COULD BE more CHALLENGING.']	[('FUTURE_WORK', 11), ('INCOMPLETE_EVIDENCE', 159), ('INCOMPLETE_EVIDENCE', 200), ('SUPERFICIAL_RELATIONSHIP', 209), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 298), ('FUTURE_WORK', 370), ('ANOMALY_CURIOUS_FINDING', 409), ('FUTURE_WORK', 447), ('DIFFICULT_TASK', 461)]	9	[('CHEBI_27300', 'vitamin D', 221, 'vitamin D'), ('UBERON_0001004', 'respiratory system', 259, 'respiratory')]
PMC2963768	10/2010	S106-PMC2963768	['HOWEVER, these age-DEPENDENT DIFFERENCES MAY HAVE BEEN CONFOUNDED by seasonal timing of Gestation—a younger age IMPLIED that the third trimester COINCIDED with the expected seasonal nadir of Vitamin D Synthesis, when maternal Vitamin D stores MIGHT be relatively depleted and, THUS, when transfer of Vitamin D Metabolites to the foetus MAY have been minimized.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('SUPERFICIAL_RELATIONSHIP', 19), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 29), ('INCOMPLETE_EVIDENCE', 41), ('INCOMPLETE_EVIDENCE', 45), ('DIFFICULT_TASK', 55), ('SUPERFICIAL_RELATIONSHIP', 112), ('SUPERFICIAL_RELATIONSHIP', 145), ('INCOMPLETE_EVIDENCE', 243), ('PROBABLE_UNDERSTANDING', 277), ('INCOMPLETE_EVIDENCE', 336)]	11	[('GO_0007565', 'female pregnancy', 88, 'gestation'), ('CHEBI_27300', 'vitamin D', 191, 'vitamin D'), ('GO_0042368', 'vitamin D biosynthetic process', 191, 'vitamin D synthesis'), ('CHEBI_27300', 'vitamin D', 226, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 300, 'vitamin D'), ('CHEBI_25212', 'metabolite', 310, 'metabolites')]
PMC2996405	11/2010	S9-PMC2996405	['in an ATTEMPT to try to EXPLAIN this POSSIBLE LINK between latitude and schizophrenia, we INVESTIGATED their ASSOCIATIONS with Vitamin D. we FOUND in a set of vitamin d related Genes a significant enrichment of both lrgs and of Genes INVOLVED in schizophrenia.']	[('DIFFICULT_TASK', 6), ('QUESTION_ANSWERED_BY_THIS_WORK', 6), ('PROBABLE_UNDERSTANDING', 24), ('INCOMPLETE_EVIDENCE', 37), ('SUPERFICIAL_RELATIONSHIP', 46), ('QUESTION_ANSWERED_BY_THIS_WORK', 90), ('SUPERFICIAL_RELATIONSHIP', 109), ('INCOMPLETE_EVIDENCE', 141), ('SUPERFICIAL_RELATIONSHIP', 234)]	9	[('CHEBI_27300', 'vitamin D', 127, 'vitamin D'), ('SO_0000704', 'gene', 177, 'genes'), ('SO_0000704', 'gene', 228, 'genes')]
PMC2996405	11/2010	S59-PMC2996405	['in an ATTEMPT to try to EXPLAIN this POSSIBLE LINK between latitude and schizophrenia, we INVESTIGATED their ASSOCIATION with Vitamin D, which had been PREVIOUSLY ASSOCIATED, separately, to both of them.']	[('DIFFICULT_TASK', 6), ('QUESTION_ANSWERED_BY_THIS_WORK', 6), ('PROBABLE_UNDERSTANDING', 24), ('INCOMPLETE_EVIDENCE', 37), ('SUPERFICIAL_RELATIONSHIP', 46), ('QUESTION_ANSWERED_BY_THIS_WORK', 90), ('SUPERFICIAL_RELATIONSHIP', 109), ('INCOMPLETE_EVIDENCE', 152), ('SUPERFICIAL_RELATIONSHIP', 163)]	9	[('CHEBI_27300', 'vitamin D', 126, 'vitamin D')]
PMC2798111	12/2010	S113-PMC2798111	['while a group of infants that received placebo would allow for more refined statistical analyses, it is deemed UNETHICAL by the investigators and the irb not to supplement the infants with what is now the standard of care for Vitamin D supplementation of infants and children in both the u.s. and canada (see aap statement 2008 [5] and canadian paediatric society statement 2007 [33]).']	[('DIFFICULT_TASK', 111)]	1	[('CHEBI_27300', 'vitamin D', 226, 'vitamin D')]
PMC3004407	12/2010	S24-PMC3004407	["it was HYPOTHESIZED that DESPITE south carolina's lower latitude and abundance of sunlight, given modern-day lifestyles that OFTEN PRECLUDE sunlight exposure, the majority of the women presenting for obstetrical care at this community health center network would have Vitamin D insufficiency and a significant number would have outright Vitamin D deficiency."]	[('INCOMPLETE_EVIDENCE', 7), ('ANOMALY_CURIOUS_FINDING', 25), ('PROBABLE_UNDERSTANDING', 125), ('DIFFICULT_TASK', 131)]	4	[('CHEBI_27300', 'vitamin D', 268, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 337, 'vitamin D')]
PMC3039633	2/2011	S75-PMC3039633	['[30]302 children (australia)1,3(at 4 yrs)stanford-binet intelligence scale strengths and difficulties questionnaireiron vs. placebo20 weeks Gestation to Birth∅ 1,317/21\n1 = Cognitive Development\n2 = Motor Development\n3 = Behavioral Development\n4 = Visual Development\n5 = auditory development\n∅ = no effect of Nutrient(s) on development\n+ = positive EFFECT of Nutrient(s) on development\n- = negative EFFECT of Nutrient(s) on development\nmvm = multivitamin-Mineral\nHchp = high calorie, high protein\nlclp = low calorie, low protein\nmvm-a = multivitamin-Mineral without Vitamin a\nmvm+a = multivitamin-Mineral with Vitamin A\nld = lower dosage\ngiven the heterogeneity of methods and outcome measures in the studies reviewed, it was NOT FEASIBLE to compare effect sizes or to perform a meta-analysis.']	[('SUPERFICIAL_RELATIONSHIP', 349), ('SUPERFICIAL_RELATIONSHIP', 399), ('DIFFICULT_TASK', 726)]	3	[('GO_0007565', 'female pregnancy', 140, 'gestation'), ('GO_0007567', 'parturition', 153, 'birth'), ('GO_0007567', 'parturition', 158, '∅'), ('GO_0050787', 'detoxification of mercury ion', 173, 'cognitive development'), ('GO_0009653', 'anatomical structure morphogenesis', 199, 'motor development'), ('GO_0007420', 'brain development', 221, 'behavioral development'), ('GO_0007506', 'gonadal mesoderm development', 248, 'visual development'), ('CHEBI_33284', 'nutrient', 309, 'nutrient'), ('CHEBI_33284', 'nutrient', 359, 'nutrient'), ('CHEBI_33284', 'nutrient', 409, 'nutrient'), ('CHEBI_46662', 'mineral', 455, 'mineral'), ('CHEBI_17883', 'hydrogen chloride', 463, 'HCHP'), ('CHEBI_46662', 'mineral', 550, 'mineral'), ('CHEBI_33229', 'vitamin (role)', 566, 'vitamin'), ('CHEBI_46662', 'mineral', 597, 'mineral'), ('CHEBI_27300', 'vitamin D', 610, 'vitamin A'), ('PR_000004370', 'asialoglycoprotein receptor 2', 618, 'A')]
PMC3061267	2/2011	S50-PMC3061267	['LATER trials within less Vitamin A deficient populations in bangladesh [23] and ghana [24] FAILED TO FIND any IMPACT.']	[('INCOMPLETE_EVIDENCE', 0), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 91), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 91), ('DIFFICULT_TASK', 91), ('SUPERFICIAL_RELATIONSHIP', 110)]	5	[('CHEBI_27300', 'vitamin D', 25, 'vitamin A')]
PMC3103150	3/2011	S16-PMC3103150	['this IMPLIES that babies Born to mothers with Vitamin D deficiency are very LIKELY to develop Vitamin D deficiency UNLESS supplemented from outside or adequately exposed to sunlight which is OFTEN NOT PRACTICAL during early Infancy.']	[('PROBABLE_UNDERSTANDING', 5), ('PROBABLE_UNDERSTANDING', 76), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 115), ('PROBABLE_UNDERSTANDING', 191), ('DIFFICULT_TASK', 197)]	5	[('GO_0007567', 'parturition', 25, 'born'), ('CHEBI_27300', 'vitamin D', 46, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 94, 'vitamin D'), ('UBERON_0000023', 'wing', 224, 'infancy')]
PMC3103150	3/2011	S124-PMC3103150	['HOWEVER, for any given infant, it is DIFFICULT to determine reliably the amount of sunlight exposure sufficient to maintain normal Vitamin D status, as it is influenced by many factors such as clothing, skin pigmentation, sunscreen use, weather conditions, latitude, air pollution, time of the day and time of the year31.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('DIFFICULT_TASK', 37)]	2	[('CHEBI_27300', 'vitamin D', 131, 'vitamin D')]
PMC3099599	5/2011	S4-PMC3099599	['subdural hematoma MAY also be the result of common Birth trauma, COMPLICATED by Prenatal Vitamin D deficiency, which also CONTRIBUTES to the appearance of Long Bone fractures commonly ASSOCIATED with child abuse.']	[('INCOMPLETE_EVIDENCE', 18), ('DIFFICULT_TASK', 65), ('SUPERFICIAL_RELATIONSHIP', 122), ('SUPERFICIAL_RELATIONSHIP', 184)]	4	[('GO_0007567', 'parturition', 51, 'birth'), ('GO_0007565', 'female pregnancy', 80, 'prenatal'), ('CHEBI_27300', 'vitamin D', 89, 'vitamin D'), ('UBERON_0002495', 'long bone', 155, 'long bone')]
PMC3271033	1/2012	S79-PMC3271033	['Prenatal Vitamin Supplement composition VARIED by brand; however, most brands included 200 iu Vitamin D per pill.']	[('DIFFICULT_TASK', 40)]	1	[('GO_0007565', 'female pregnancy', 0, 'Prenatal'), ('CHEBI_63635', 'valganciclovir', 9, 'vitamin supplement'), ('CHEBI_27300', 'vitamin D', 94, 'vitamin D')]
PMC3271033	1/2012	S127-PMC3271033	['regardless, Serum calcium in the Cord Blood and in the first days of Life is LIKELY Controlled by a VARIETY of FACTORS, of which Vitamin D is ONLY one FACTOR.']	[('PROBABLE_UNDERSTANDING', 77), ('DIFFICULT_TASK', 100), ('SUPERFICIAL_RELATIONSHIP', 111), ('INCOMPLETE_EVIDENCE', 142), ('SUPERFICIAL_RELATIONSHIP', 151)]	5	[('UBERON_0001977', 'blood serum', 12, 'serum'), ('UBERON_0002240', 'spinal cord', 33, 'cord'), ('UBERON_0000178', 'blood', 38, 'blood'), ('UBERON_0000104', 'life cycle', 69, 'life'), ('GO_0065007', 'biological regulation', 84, 'controlled'), ('CHEBI_27300', 'vitamin D', 129, 'vitamin D')]
PMC3271033	1/2012	S148-PMC3271033	['the EFFECTS of maternal Vitamin D deficiency are COMPLEX and MAY EXTEND beyond bone health EFFECTS in infants.']	[('SUPERFICIAL_RELATIONSHIP', 4), ('DIFFICULT_TASK', 49), ('INCOMPLETE_EVIDENCE', 61), ('SUPERFICIAL_RELATIONSHIP', 65), ('SUPERFICIAL_RELATIONSHIP', 91)]	5	[('CHEBI_27300', 'vitamin D', 24, 'vitamin D')]
PMC3296991	2/2012	S102-PMC3296991	['because Vitamin D inadequacy during Gestation and its IMPACTS on offspring bone integrity are of PUBLIC HEALTH CONCERN, FURTHER STUDIES ARE WARRANTED to investigate the COMPLEX mechanisms LINKING in utero Vitamin D status to fetal Bone Development.']	[('SUPERFICIAL_RELATIONSHIP', 54), ('IMPORTANT_CONSIDERATION', 97), ('FUTURE_WORK', 120), ('FUTURE_WORK', 128), ('DIFFICULT_TASK', 169), ('SUPERFICIAL_RELATIONSHIP', 188)]	6	[('CHEBI_27300', 'vitamin D', 8, 'vitamin D'), ('GO_0007565', 'female pregnancy', 36, 'gestation'), ('CHEBI_27300', 'vitamin D', 205, 'vitamin D'), ('GO_0048539', 'bone marrow development', 231, 'bone development')]
PMC3385441	2/2012	S269-PMC3385441	['caption (table-wrap): table 3\n\nchallenges to developing comprehensive fish Consumption ADVICE.viewpoint and challengesexamplestoxicological hazards: fish contaminants (e.g., mehg, Pcbs, Pesticides)multiple co-occurring contaminantssynergistic adverse EFFECTS on Neurodevelopment with Joint mehg and pcb exposureadvisories for single contaminantfarmed salmon low in mehg but can be high in pcbstoxicant levels vary within and across speciestilefish Mehg: high in gulf of mexico but low in atlanticvariable susceptibility to toxicitiesprenatal exposure: increased susceptibility to Mehg neurotoxicityconfounding by nutritional BENEFITSUNDERESTIMATION of hazard from mehg if CONFOUNDED by n‑3 lcpufasnutritional BENEFITS: fish Nutrients (e.g., n‑3 lcpufas, Vitamin D, Iodine, Selenium)multiple co-occurring nutrientsfor Neurodevelopment, fish intake more CONSISTENTLY beneficial than n‑3 lcpufa supplementsanutrient levels vary within and across specieshealth benefits associated with high n‑3 lcpufa fishaconfounding by contaminant riskunderestimation of benefit from n‑3 lcpufas if CONFOUNDED by Mehgincreased fish intake (for most populations) RECOMMENDED by nutrition GUIDELINESAVAILABLE fish insufficient to meet demand EVEN without greater intakeenvironmental sustainability: overfishing, habitat destruction, aquaculturemodern harvesting can deplete fish stocks, other aquatic wildlife, and habitatsfishing trawls plough the Seafloor, removing most, if not all, aquatic Life and structures in their pathwild fish stocks insufficient to meet projected GLOBAL demandapproximately 90% of large predatory fish stocks (e.g., bluefin Tuna, atlantic salmon) are already depletedaquaculture CAN adversely AFFECT wild fish and ecosystems; CONTAMINANTSFARMED salmon can escape and outcompete wild fish and MAY have higher Pcb levelseconomic INFLUENCES: consumer choice, industry stakeholders, fisheries managementeconomic ASSUMPTION of improved consumer welfare with more information not necessarily TRUE for fish choiceu.s.']	[('FUTURE_WORK', 87), ('SUPERFICIAL_RELATIONSHIP', 251), ('IMPORTANT_CONSIDERATION', 625), ('DIFFICULT_TASK', 672), ('IMPORTANT_CONSIDERATION', 709), ('PROBABLE_UNDERSTANDING', 852), ('DIFFICULT_TASK', 1081), ('FUTURE_WORK', 1144), ('PROBABLE_UNDERSTANDING', 1169), ('ANOMALY_CURIOUS_FINDING', 1222), ('IMPORTANT_CONSIDERATION', 1555), ('INCOMPLETE_EVIDENCE', 1687), ('SUPERFICIAL_RELATIONSHIP', 1701), ('IMPORTANT_CONSIDERATION', 1734), ('INCOMPLETE_EVIDENCE', 1800), ('SUPERFICIAL_RELATIONSHIP', 1835), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 1916), ('PROBABLE_UNDERSTANDING', 1994)]	18	[('GO_0007631', 'feeding behavior', 75, 'consumption'), ('CHEBI_26199', 'polyprenol', 180, 'PCBs'), ('CHEBI_35392', 'glucarate(1-)', 186, 'pesticides'), ('GO_0007399', 'nervous system development', 262, 'neurodevelopment'), ('UBERON_0004905', 'articulation', 284, 'joint'), ('CHEBI_82056', 'Mebenil', 448, 'MeHg'), ('CHEBI_82056', 'Mebenil', 580, 'MeHg'), ('CHEBI_33284', 'nutrient', 724, 'nutrients'), ('CHEBI_27300', 'vitamin D', 754, 'vitamin D'), ('CHEBI_24859', 'iodine atom', 765, 'iodine'), ('CHEBI_27568', 'selenium atom', 773, 'selenium'), ('GO_0007399', 'nervous system development', 817, 'neurodevelopment'), ('CHEBI_82492', 'N-Methylolacrylamide', 1095, 'MeHgIncreased'), ('UBERON_0001273', 'ilium', 1429, 'seafloor'), ('UBERON_0000104', 'life cycle', 1474, 'life'), ('NCBITaxon_10088', 'Mus <genus>', 1632, 'tuna'), ('CHEBI_8102', 'phenylmethanesulfonyl fluoride', 1816, 'PCB')]
PMC3347028	3/2012	S146-PMC3347028	['such readily observable fetal and neonatal Skeletal EFFECTS of profound Vitamin D deficiency are easily understood in terms of cause and effect, BUT the more subtle EFFECTS of deficiency on the developing Immune System, for example, and subsequent infection risk or Immune dysfunction are more DIFFICULT to understand [19,84,97,98,99].']	[('SUPERFICIAL_RELATIONSHIP', 52), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 145), ('SUPERFICIAL_RELATIONSHIP', 165), ('DIFFICULT_TASK', 294)]	4	[('UBERON_0004288', 'skeleton', 43, 'skeletal'), ('CHEBI_27300', 'vitamin D', 72, 'vitamin D'), ('UBERON_0002405', 'immune system', 205, 'immune system'), ('UBERON_0002405', 'immune system', 266, 'immune')]
PMC3347007	4/2012	S21-PMC3347007	['the definition of optimal Vitamin D status and optimal intake level of Vitamin D HAVE BEEN subject to much DEBATE, and RECOMMENDATIONS VARY between countries.']	[('INCOMPLETE_EVIDENCE', 81), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 107), ('FUTURE_WORK', 119), ('DIFFICULT_TASK', 135)]	4	[('CHEBI_27300', 'vitamin D', 26, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 71, 'vitamin D')]
PMC3347007	4/2012	S137-PMC3347007	['the most common doses of Vitamin D in supplements were 10 µg and 5 µg, INDICATING that the available supplements in denmark all have doses of 5 and 10 µg Vitamin D. low dose supplements make it DIFFICULT for the women to obtain the RECOMMENDED dose of Vitamin D. all Vitamin D supplements aimed at Pregnant women SHOULD THEREFORE contain 10 µg.']	[('INCOMPLETE_EVIDENCE', 71), ('DIFFICULT_TASK', 194), ('FUTURE_WORK', 232), ('FUTURE_WORK', 313), ('PROBABLE_UNDERSTANDING', 320)]	5	[('CHEBI_27300', 'vitamin D', 25, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 154, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 252, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 267, 'vitamin D'), ('GO_0007565', 'female pregnancy', 298, 'pregnant')]
PMC3348565	4/2012	S114-PMC3348565	['genotyping, which was NOT PRACTICAL in our study setting, MIGHT have aided the INTERPRETATION of our findings, AS SHOWN in a Vitamin D supplementation trial for tuberculosis.20\nwe accounted for nutritional factors through a diet questionnaire, weight at recruitment, and growth comparison at the end of our study—any nutritional deficiencies WOULD HAVE BEEN equally balanced between the two groups.']	[('DIFFICULT_TASK', 22), ('INCOMPLETE_EVIDENCE', 58), ('INCOMPLETE_EVIDENCE', 79), ('INCOMPLETE_EVIDENCE', 111), ('FUTURE_PREDICTION', 342), ('INCOMPLETE_EVIDENCE', 348)]	6	[('CHEBI_27300', 'vitamin D', 125, 'vitamin D')]
PMC3348565	4/2012	S127-PMC3348565	['AS IN our studies, these INCONSISTENT findings POINT to the existence of COMPLICATED pathways for the function of Vitamin D in disease processes, or simply that the correct effective dose of Vitamin D supplementation NEEDS to be BETTER defined.']	[('INCOMPLETE_EVIDENCE', 0), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 25), ('INCOMPLETE_EVIDENCE', 47), ('DIFFICULT_TASK', 73), ('FUTURE_WORK', 217), ('INCOMPLETE_EVIDENCE', 229)]	6	[('CHEBI_27300', 'vitamin D', 114, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 191, 'vitamin D')]
PMC3348565	4/2012	S141-PMC3348565	['in populations with similar characteristics, quarterly population level supplementation of Vitamin D to infants and young children IS NOT a policy OPTION for reducing THE BURDEN of pneumonia in children.']	[('DIFFICULT_TASK', 131), ('IMPORTANT_CONSIDERATION', 167)]	2	[('CHEBI_27300', 'vitamin D', 91, 'vitamin D')]
PMC3356951	4/2012	S43-PMC3356951	['[39]\npatients with one of the fat malabsorption syndromes and bariatric patients are OFTEN UNABLE TO absorb the fat-soluble Vitamin D, and patients with nephritic syndrome lose 25(Oh)D bound to the Vitamin D-binding protein in the Urine.']	[('PROBABLE_UNDERSTANDING', 85), ('DIFFICULT_TASK', 91)]	2	[('CHEBI_27300', 'vitamin D', 124, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 177, '25(OH)D'), ('CHEBI_27300', 'vitamin D', 198, 'vitamin D'), ('UBERON_0001088', 'urine', 231, 'urine')]
PMC3356951	4/2012	S52-PMC3356951	['groups AT RISK of Vitamin-D inadequacy\nobtaining sufficient Vitamin D from natural Food sources alone is DIFFICULT.']	[('IMPORTANT_CONSIDERATION', 7), ('DIFFICULT_TASK', 105)]	2	[('CHEBI_83326', 'tedizolid phosphate', 18, 'vitamin-D'), ('CHEBI_27300', 'vitamin D', 60, 'vitamin D'), ('CHEBI_33290', 'food', 83, 'food')]
PMC3427192	4/2012	S55-PMC3427192	['furthermore, in those subjects with current asthma, lower 25(Oh)D concentrations were ASSOCIATED with increased odds of asthma exacerbations and healthcare utilization in the preceding year.81OTHER STUDIES have also NOTED ASSOCIATIONS between decreased Serum 25(Oh)D concentrations and decreased Lung function, increased Airway hyperresponsiveness to Methacholine, and blunted Glucocorticoid responsiveness.80,82,84HOWEVER, in a RECENT case-control STUDY of obese subjects with and without asthma, no associations between Vitamin D status and asthma prevalence were NOTED.83the cross-sectional nature of these studies SHOULD again BE EMPHASIZED SINCE causation CANNOT BE determined DUE TO potential CONFOUNDING of the study results.']	[('SUPERFICIAL_RELATIONSHIP', 86), ('INCOMPLETE_EVIDENCE', 190), ('ANOMALY_CURIOUS_FINDING', 216), ('SUPERFICIAL_RELATIONSHIP', 222), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 413), ('INCOMPLETE_EVIDENCE', 429), ('ANOMALY_CURIOUS_FINDING', 566), ('FUTURE_WORK', 618), ('ANOMALY_CURIOUS_FINDING', 631), ('IMPORTANT_CONSIDERATION', 634), ('PROBLEM_COMPLICATION', 645), ('DIFFICULT_TASK', 661), ('PROBLEM_COMPLICATION', 682), ('PROBLEM_COMPLICATION', 699)]	14	[('CHEBI_71657', 'versiconol acetate', 58, '25(OH)D'), ('UBERON_0001977', 'blood serum', 253, 'serum'), ('CHEBI_71657', 'versiconol acetate', 259, '25(OH)D'), ('PR_000009880', 'Lon protease, mitochondrial', 259, '25 ... OH ... D'), ('UBERON_0002048', 'lung', 296, 'lung'), ('UBERON_0001005', 'respiratory airway', 321, 'airway'), ('CHEBI_6805', 'methacycline', 351, 'methacholine'), ('CHEBI_24261', 'glucocorticoid', 377, 'glucocorticoid'), ('CHEBI_27300', 'vitamin D', 522, 'vitamin D')]
PMC3407995	7/2012	S85-PMC3407995	['HOWEVER, a recent global review of Vitamin D status HAS SHOWN that its Intake is OFTEN TOO low TO sustain healthy circulating 25(Oh)D in countries without mandatory staple Food fortification and is EVEN too low in countries that do fortify due to low Milk Consumption, vegetarianism, non-supplement use and low fish Intake [46].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 52), ('PROBABLE_UNDERSTANDING', 81), ('DIFFICULT_TASK', 87), ('ANOMALY_CURIOUS_FINDING', 198)]	5	[('CHEBI_27300', 'vitamin D', 35, 'vitamin D'), ('GO_0007631', 'feeding behavior', 71, 'intake'), ('CHEBI_71657', 'versiconol acetate', 126, '25(OH)D'), ('PR_000008838', 'serine protease HTRA1', 126, '25(OH ... D'), ('CHEBI_33290', 'food', 172, 'food'), ('UBERON_0001913', 'milk', 251, 'milk'), ('GO_0007631', 'feeding behavior', 256, 'consumption'), ('GO_0007631', 'feeding behavior', 316, 'intake')]
PMC3407995	7/2012	S303-PMC3407995	['HOWEVER, one SHOULD CONSIDER the COMPLEX nature of Vitamin D EFFECTS SINCE EITHER deficiency OR excess MAY BE harmful [53].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('FUTURE_WORK', 13), ('FUTURE_WORK', 20), ('DIFFICULT_TASK', 33), ('SUPERFICIAL_RELATIONSHIP', 61), ('PROBABLE_UNDERSTANDING', 69), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 75), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 93), ('INCOMPLETE_EVIDENCE', 103)]	9	[('CHEBI_27300', 'vitamin D', 51, 'vitamin D')]
PMC3427250	8/2012	S18-PMC3427250	['HOWEVER there is so far NO CONCLUSIVE EVIDENCE about the causality of these RELATIONSHIPS, as NO randomised controlled TRIALS of Vitamin D supplementation with an appropriate assessment of a VARIETY of health outcomes have been carried out to date[21].']	[('ANOMALY_CURIOUS_FINDING', 0), ('INCOMPLETE_EVIDENCE', 24), ('SUPERFICIAL_RELATIONSHIP', 76), ('FULL_UNKNOWN', 94), ('DIFFICULT_TASK', 191)]	5	[('CHEBI_27300', 'vitamin D', 129, 'vitamin D')]
PMC3471827	10/2012	S116-PMC3471827	['the Mammalian maternal Vitamin E REQUIREMENTS occur prior to the developmental stage in which ttp is REQUIRED in the Zebrafish, creating a BARRIER to the study of ttp in Placental MODELS.']	[('IMPORTANT_CONSIDERATION', 33), ('IMPORTANT_CONSIDERATION', 101), ('DIFFICULT_TASK', 139), ('INCOMPLETE_EVIDENCE', 180)]	4	[('NCBITaxon_40674', 'Mammalia', 4, 'mammalian'), ('CHEBI_27300', 'vitamin D', 23, 'vitamin E'), ('NCBITaxon_7955', 'Danio rerio', 117, 'zebrafish'), ('UBERON_0001987', 'placenta', 170, 'placental')]
PMC3501517	11/2012	S194-PMC3501517	['these data SUGGEST that SOME PROTECTIVE BENEFIT MAY BE derived from Vitamin D supplementation in the setting of radiation-induced Lung injury; HOWEVER, the POTENTIAL physiological relevance of these differences is DIFFICULT to ascertain given the absence of systematic sampling or the LACK OF DATA on the magnitude of the differences.']	[('INCOMPLETE_EVIDENCE', 11), ('INCOMPLETE_EVIDENCE', 24), ('SUPERFICIAL_RELATIONSHIP', 29), ('IMPORTANT_CONSIDERATION', 40), ('INCOMPLETE_EVIDENCE', 48), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 143), ('INCOMPLETE_EVIDENCE', 156), ('DIFFICULT_TASK', 214), ('INCOMPLETE_EVIDENCE', 285)]	9	[('CHEBI_27300', 'vitamin D', 68, 'vitamin D'), ('UBERON_0002048', 'lung', 130, 'lung')]
PMC3552819	12/2012	S218-PMC3552819	['these erratic PATTERNS COULD NOT EASILY BE EXPLAINED on THE BASIS OF KNOWN Vitamin D pharmacokinetics, but were MOST LIKELY ATTRIBUTABLE TO small-sample ARTIFACTS, biological variability in the absorption and Metabolism Of Vitamin D, and inherent imprecision in the laboratory assessment of [25(Oh)D].']	[('SUPERFICIAL_RELATIONSHIP', 14), ('DIFFICULT_TASK', 23), ('INCOMPLETE_EVIDENCE', 29), ('PROBABLE_UNDERSTANDING', 43), ('INCOMPLETE_EVIDENCE', 56), ('INCOMPLETE_EVIDENCE', 69), ('PROBABLE_UNDERSTANDING', 112), ('PROBABLE_UNDERSTANDING', 124), ('QUESTION_ANSWERED_BY_THIS_WORK', 137), ('PROBLEM_COMPLICATION', 153)]	10	[('CHEBI_27300', 'vitamin D', 75, 'vitamin D'), ('GO_0019458', 'methionine catabolic process via 2-oxobutanoate', 209, 'metabolism of vitamin D'), ('CHEBI_27300', 'vitamin D', 223, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 292, '25(OH)D')]
PMC3659910	1/2013	S24-PMC3659910	['modern day cosmetology and our urbanization has eclipsed the sunlight and it is IMPOSSIBLE is to fulfill daily Intake via diet AS a large amount of Vitamin D NEEDS to be Consumed.']	[('DIFFICULT_TASK', 80), ('PROBABLE_UNDERSTANDING', 127), ('IMPORTANT_CONSIDERATION', 158)]	3	[('GO_0007631', 'feeding behavior', 111, 'intake'), ('CHEBI_27300', 'vitamin D', 148, 'vitamin D'), ('GO_0007631', 'feeding behavior', 170, 'consumed')]
PMC3659910	1/2013	S64-PMC3659910	["although Liver and cod Liver oil contain Vitamin D, they are not recommended in Pregnancy as they also contain too much Vitamin A.\nVitamin D is a unique Nutrient BECAUSE its REQUIREMENT can be met by both endogenous production from sunlight as well as exogenous dietary sources, which COMPLICATES determining the body's daily nutritional REQUIREMENTS."]	[('PROBABLE_UNDERSTANDING', 162), ('IMPORTANT_CONSIDERATION', 174), ('DIFFICULT_TASK', 285), ('IMPORTANT_CONSIDERATION', 338)]	4	[('UBERON_0002107', 'liver', 9, 'liver'), ('UBERON_0002107', 'liver', 23, 'liver'), ('CHEBI_27300', 'vitamin D', 41, 'vitamin D'), ('GO_0007565', 'female pregnancy', 80, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 120, 'vitamin A'), ('CHEBI_28384', 'vitamin K', 131, 'Vitamin D'), ('CHEBI_33284', 'nutrient', 153, 'nutrient')]
PMC3659910	1/2013	S158-PMC3659910	['the BASIS for these RECOMMENDATIONS was made BEFORE IT WAS POSSIBLE to measure the circulating concentration of 25-Hydroxyvitamin D [25(Oh) D], the INDICATOR of nutritional Vitamin D status.']	[('PROBABLE_UNDERSTANDING', 4), ('FUTURE_WORK', 20), ('DIFFICULT_TASK', 45), ('SUPERFICIAL_RELATIONSHIP', 148)]	4	[('CHEBI_62218', '23,24-dihydrocucurbitacin D', 112, '25-hydroxyvitamin D'), ('CHEBI_71657', 'versiconol acetate', 133, '25(OH) D'), ('CHEBI_27300', 'vitamin D', 173, 'vitamin D')]
PMC3659910	1/2013	S161-PMC3659910	['[44] ALTHOUGH 1,25(Oh) 2D is the active circulating form of Vitamin D, measuring this level is NOT HELPFUL BECAUSE it is quickly and tightly Regulated by the Kidney.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 5), ('DIFFICULT_TASK', 95), ('PROBLEM_COMPLICATION', 107)]	3	[('CHEBI_37983', 'sulfur-35 atom', 14, '1'), ('CHEBI_66212', "5,7,3',4'-tetrahydroxy-2'-(3,3-dimethylallyl)isoflavone", 16, '25(OH) 2D'), ('CHEBI_27300', 'vitamin D', 60, 'vitamin D'), ('PR_000006444', 'diacylglycerol kinase delta', 68, 'D'), ('GO_0065007', 'biological regulation', 141, 'regulated'), ('UBERON_0002113', 'kidney', 158, 'kidney')]
PMC3629265	4/2013	S66-PMC3629265	['in an ATTEMPT to address the CONCERNING frequency of Vitamin D deficiency in aboriginal infants, the canadian paediatric society advocates for an increase to 800 iu/day in northern native communities during the winter months (23).']	[('DIFFICULT_TASK', 6), ('IMPORTANT_CONSIDERATION', 29)]	2	[('CHEBI_27300', 'vitamin D', 53, 'vitamin D')]
PMC3641012	4/2013	S30-PMC3641012	['individuals were not eligible if they had any of the following exclusion criteria: use of any dietary supplement containing more than 400\xa0iu/day (10 mcg/day) of Vitamin D within the month prior to enrolment, or refusal to stop taking supplemental Vitamin D at any dose after enrollment; current use of anti-convulsant or Anti-Mycobacterial (tuberculosis) Medications; severe anemia (hemoglobin\u2009<\u200970\xa0g/l); systolic Blood pressure\u2009≥140\xa0mm hg or diastolic Blood pressure\u2009≥90\xa0mm hg; positive Urine dipstick for proteinuria or glycosuria; COMPLICATED medical or obstetric history; or, reported prior history of Delivery of an infant with a major congenital anomaly, Birth asphyxia, or Perinatal death.']	[('DIFFICULT_TASK', 534)]	1	[('CHEBI_27300', 'vitamin D', 161, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 247, 'vitamin D'), ('CHEBI_59132', 'antigen', 321, 'anti'), ('CHEBI_52217', 'pharmaceutical', 326, 'mycobacterial'), ('CHEBI_25441', 'mycothiols', 355, 'medications'), ('UBERON_0000178', 'blood', 414, 'blood'), ('UBERON_0000178', 'blood', 453, 'blood'), ('UBERON_0001088', 'urine', 488, 'urine'), ('GO_0007567', 'parturition', 606, 'delivery'), ('GO_0007567', 'parturition', 661, 'birth'), ('GO_0036268', 'swimming', 680, 'perinatal'), ('UBERON_0012101', 'perinatal stage', 680, 'perinatal')]
PMC3641012	4/2013	S161-PMC3641012	['given the substantial inter-Individual VARIABILITY in the response to Vitamin D supplementation (figure\xa03), we EXPLORED the ROLE of the following POTENTIAL MODIFIERS of the magnitude of the change in 25(Oh)D (δ25(Oh)D) from baseline to Delivery (selected a priori ): maternal weight at baseline, maternal age, Gestational age, maternal body mass index at baseline (bmi), gravidity, parity, baseline Pth status, season and baseline Vitamin D status.']	[('DIFFICULT_TASK', 39), ('QUESTION_ANSWERED_BY_THIS_WORK', 111), ('SUPERFICIAL_RELATIONSHIP', 124), ('INCOMPLETE_EVIDENCE', 146), ('SUPERFICIAL_RELATIONSHIP', 156)]	5	[('NCBITaxon_1', 'root', 28, 'individual'), ('CHEBI_27300', 'vitamin D', 70, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 200, '25(OH)D'), ('PR_000006444', 'diacylglycerol kinase delta', 206, 'D'), ('CHEBI_33010', 'chromide(1-)', 212, '(OH)D'), ('GO_0007567', 'parturition', 236, 'delivery'), ('GO_0007565', 'female pregnancy', 310, 'gestational'), ('CHEBI_8102', 'phenylmethanesulfonyl fluoride', 399, 'PTH'), ('CHEBI_27300', 'vitamin D', 431, 'vitamin D')]
PMC3821254	4/2013	S80-PMC3821254	['WHETHER a single ingredient of drakshavaleha such as Vitamin C, Vitamin P, Folic Acid, Minerals, etc., was EFFECTIVE in the current research OR the result was a collective outcome is such DIFFICULT to conclude at this level.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('SUPERFICIAL_RELATIONSHIP', 107), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 141), ('DIFFICULT_TASK', 188)]	4	[('CHEBI_27300', 'vitamin D', 53, 'vitamin C'), ('CHEBI_27300', 'vitamin D', 64, 'vitamin P'), ('CHEBI_30751', 'formic acid', 75, 'folic acid'), ('CHEBI_46751', 'quinolizidine', 87, 'minerals')]
PMC3705146	5/2013	S160-PMC3705146	['furthermore, a RECENT report DEMONSTRATES an equivalently strong season-of-Birth EFFECT in multiple sclerosis with peaks in april and may and in PARALLEL with schizophrenia (torrey et al.,1997; davies et al.,2003), deficits in births of future multiple sclerosis patients during october and november (dobson et al.,2013), a FINDING the authors ATTRIBUTE to VARIATIONS in sunlight during Gestation and to the resulting variations in Vitamin D availability.']	[('INCOMPLETE_EVIDENCE', 15), ('INCOMPLETE_EVIDENCE', 29), ('SUPERFICIAL_RELATIONSHIP', 81), ('SUPERFICIAL_RELATIONSHIP', 145), ('INCOMPLETE_EVIDENCE', 324), ('SUPERFICIAL_RELATIONSHIP', 344), ('DIFFICULT_TASK', 357)]	7	[('GO_0007567', 'parturition', 75, 'birth'), ('GO_0007565', 'female pregnancy', 387, 'gestation'), ('CHEBI_27300', 'vitamin D', 432, 'vitamin D')]
PMC3705146	5/2013	S226-PMC3705146	['HOWEVER, mcgrath and colleagues have ALSO SHOWN that the RELATIONSHIP between Vitamin D in Gestation and subsequent schizophrenia MAY BE COMPLEX, in that those with low maternal vitamin d are at INCREASED RISK of bearing offspring who become schizophrenic as are those with overly high Vitamin D (mcgrath et al.,2010a).']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 37), ('SUPERFICIAL_RELATIONSHIP', 57), ('INCOMPLETE_EVIDENCE', 130), ('DIFFICULT_TASK', 137), ('IMPORTANT_CONSIDERATION', 195)]	6	[('CHEBI_27300', 'vitamin D', 78, 'vitamin D'), ('GO_0007565', 'female pregnancy', 91, 'gestation'), ('CHEBI_27300', 'vitamin D', 286, 'vitamin D')]
PMC3717170	5/2013	S76-PMC3717170	['it WAS THOUGHT for decades that Human Milk was minimally sufficient in Vitamin D;17yet, PRELIMINARY results of the RECENTLY COMPLETED nichd Vitamin D supplementation trial during Lactation SHOW that when a mother is Vitamin D replete, with an Intake of 6400 iu Vitamin D3/day, Breast Milk is replete and a breastfeeding infant has excellent Vitamin D status without infant supplementation that is COMPARABLE to combined maternal and infant supplementation of 400 iu Vitamin D3/day.18the IMPLICATIONS of SAFELY achieving vitamin d SUFFICIENCY for both mother and breastfeeding infant solely through maternal supplementation is just BEGINNING TO BE UNDERSTOOD and will LIKELY CHALLENGE researchers for decades to come.']	[('INCOMPLETE_EVIDENCE', 3), ('INCOMPLETE_EVIDENCE', 7), ('INCOMPLETE_EVIDENCE', 88), ('INCOMPLETE_EVIDENCE', 115), ('INCOMPLETE_EVIDENCE', 189), ('INCOMPLETE_EVIDENCE', 397), ('IMPORTANT_CONSIDERATION', 487), ('IMPORTANT_CONSIDERATION', 503), ('IMPORTANT_CONSIDERATION', 530), ('INCOMPLETE_EVIDENCE', 631), ('PROBABLE_UNDERSTANDING', 667), ('DIFFICULT_TASK', 674)]	12	[('NCBITaxon_9606', 'Homo sapiens', 32, 'human'), ('UBERON_0001913', 'milk', 38, 'milk'), ('CHEBI_27300', 'vitamin D', 71, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 140, 'vitamin D'), ('GO_0007595', 'lactation', 179, 'lactation'), ('CHEBI_27300', 'vitamin D', 216, 'vitamin D'), ('GO_0007631', 'feeding behavior', 243, 'intake'), ('CHEBI_33279', 'vitamin D5', 261, 'vitamin D3'), ('PR_000017299', 'VIP peptides', 261, 'vitamin D3'), ('UBERON_0000310', 'breast', 277, 'breast'), ('UBERON_0001913', 'milk', 284, 'milk'), ('CHEBI_27300', 'vitamin D', 341, 'vitamin D'), ('CHEBI_33279', 'vitamin D5', 466, 'vitamin D3'), ('PR_000017299', 'VIP peptides', 466, 'vitamin D3')]
PMC3717170	5/2013	S178-PMC3717170	['INTERESTINGLY, a RECENT STUDY FOUND that vdrs are highly concentrated in the Cristae of the Mitochondria Inner Membrane.51the ROLE of Vitamin D in Homeostatic Signaling is COMPLEX and pervasive.']	[('ANOMALY_CURIOUS_FINDING', 0), ('INCOMPLETE_EVIDENCE', 17), ('INCOMPLETE_EVIDENCE', 30), ('SUPERFICIAL_RELATIONSHIP', 126), ('DIFFICULT_TASK', 172)]	5	[('UBERON_0004721', 'crista ampullaris', 77, 'cristae'), ('GO_0005743', 'mitochondrial inner membrane', 92, 'mitochondria inner membrane'), ('CHEBI_27300', 'vitamin D', 134, 'vitamin D'), ('GO_0038128', 'ERBB2 signaling pathway', 147, 'homeostatic signaling')]
PMC3691177	6/2013	S14-PMC3691177	['dietary intake of Vitamin D makes a relatively small CONTRIBUTION to overall Vitamin D status, and APPARENT EFFECTS of Vitamin D intake MAY BE CONFOUNDED by OTHER CORRELATED nutrients.']	[('SUPERFICIAL_RELATIONSHIP', 53), ('INCOMPLETE_EVIDENCE', 99), ('SUPERFICIAL_RELATIONSHIP', 108), ('INCOMPLETE_EVIDENCE', 136), ('DIFFICULT_TASK', 143), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 157), ('SUPERFICIAL_RELATIONSHIP', 163)]	7	[('CHEBI_27300', 'vitamin D', 18, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 77, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 119, 'vitamin D')]
PMC3691177	6/2013	S117-PMC3691177	['the 95% confidence interval for our primary outcome measure was 0.49 to 1.50, so we are UNABLE TO confidently exclude EFFECTS of Prenatal vitamin D supplementation on RISK of wheezing, or on the development of atopy especially in mothers treated with daily Vitamin D. third, we DID NOT assess Vitamin D receptor polymorphisms or OTHER POTENTIALLY IMPORTANT genotypic variations.']	[('DIFFICULT_TASK', 88), ('SUPERFICIAL_RELATIONSHIP', 118), ('IMPORTANT_CONSIDERATION', 167), ('INCOMPLETE_EVIDENCE', 278), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 329), ('INCOMPLETE_EVIDENCE', 335), ('IMPORTANT_CONSIDERATION', 347)]	7	[('GO_0007565', 'female pregnancy', 129, 'prenatal'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 146, 'D'), ('CHEBI_27300', 'vitamin D', 257, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 293, 'vitamin D')]
PMC3691177	6/2013	S133-PMC3691177	['we are UNABLE TO confidently exclude a SIMILAR RELATIONSHIP in more Vitamin D sufficient populations[8].']	[('DIFFICULT_TASK', 7), ('SUPERFICIAL_RELATIONSHIP', 39), ('SUPERFICIAL_RELATIONSHIP', 47)]	3	[('CHEBI_27300', 'vitamin D', 68, 'vitamin D')]
PMC3702245	6/2013	S17-PMC3702245	['the institute of medicine in the us in its RECENT report RECOMMENDS that a Serum 25(Oh)D concentration of 50 nmol/l (20 ng/ml) is adequate for calcium absorption and bone health in Adults, including Pregnant women, in the us and canada.7HOWEVER, new clinical guidelines from the endocrine society RECOMMEND maintaining a Serum 25(Oh)D concentration >75 nmol/l (30 ng/ml) in order to maximize calcium absorption and bone health, and for POTENTIAL Extraskeletal benefits noted in observational studies.8many RECENT STUDIES13,15–17,48–57that evaluated Vitamin D nutrition during Pregnancy in different geographic locations REPORTED wide VARIATION in Vitamin D status depending on latitude, season, sunlight exposure behavior, and Vitamin D intake (table 1).']	[('INCOMPLETE_EVIDENCE', 43), ('FUTURE_WORK', 57), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 236), ('FUTURE_WORK', 297), ('INCOMPLETE_EVIDENCE', 436), ('INCOMPLETE_EVIDENCE', 506), ('INCOMPLETE_EVIDENCE', 620), ('DIFFICULT_TASK', 634)]	8	[('UBERON_0001977', 'blood serum', 75, 'serum'), ('CHEBI_71657', 'versiconol acetate', 81, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 81, '25(OH)D'), ('UBERON_0007023', 'adult organism', 181, 'adults'), ('GO_0007565', 'female pregnancy', 199, 'pregnant'), ('UBERON_0001977', 'blood serum', 321, 'serum'), ('CHEBI_71657', 'versiconol acetate', 327, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 327, '25(OH)D'), ('UBERON_0001431', 'distal carpal bone 2', 446, 'extraskeletal'), ('CHEBI_27300', 'vitamin D', 549, 'vitamin D'), ('GO_0007565', 'female pregnancy', 576, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 647, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 727, 'vitamin D')]
PMC3702339	6/2013	S152-PMC3702339	['association between Vitamin A status and various POTENTIAL risk factors among Pregnant women in rural sidama, southern ethiopia, february 2011variableserum Retinol µmol/l (mean ±sd)vad+vad-crude or (95% ci)adjusted or (95% ci)**staple diet\xa0\xa0enset-based0.81±0.411802711.28 (0.93-1.77)-\xa0\xa0Cereal-based0.88±0.42851641r-dietary diversity in the previous day\xa0\xa0low (dds ≤3)0.75±0.411191242.55 (1.63-4.00)*1.94 (1.17-3.19)*\xa0\xa0optimal (dds of 4 or 5)0.87±0.411082101.37 (0.88-2.12)1.10 (0.70-1.72)\xa0\xa0high (dds ≥6)0.91±0.43381011r1rconsumed Foods from Animal source in the previous day\xa0\xa0no0.81±0.422163031.92 (1.33-2.78)*1.51 (1.04-2.13)*\xa0\xa0yes0.91±0.39491321r1rsevere acute malnutrition\xa0\xa0no (muac ≥220 mm)0.87±0.421783301r1r\xa0\xa0yes (muac <220 mm)0.75±0.39871051.54 (1.10-2.15)*1.26 (0.88-1.81)zinc deficiency status\xa0\xa0non-deficient0.92±0.41912381r1r\xa0\xa0deficient0.76±0.401741972.31 (1.68-3.17)*1.80 (1.28-2.53)*parity\xa0\xa000.89±0.4034821r1r\xa0\xa01-20.85±0.411021741.41 (0.86-2.26)1.14 (0.69-1.87)\xa0\xa03-40.84±0.42911401.57 (0.97-2.53)1.35 (0.81-2.26)\xa0\xa0≥50.72±0.4038392.35 (1.29-4.28)*1.92 (1.02-3.64)*walking distance from nearby Health facility\xa0\xa00-30 minutes0.83±0.412293691r-\xa0\xa0longer than 30 minutes0.89±0.4436660.88 (0.57-1.36)-number of anc follow-ups\xa0\xa000.87±0.411212431r1r\xa0\xa01-20.80±0.431341731.56 (1.14-2.13)*1.42 (0.97-2.02)\xa0\xa0≥30.86±0.4110191.06 (0.48-2.34)0.70 (0.30-1.64)received Nutrition education during Pregnancy\xa0\xa0yes0.80±0.41701051r-\xa0\xa0no0.85±0.421953300.89 (0.62-1.26)-\n*statistically significant association at 0.05 level of significance;\n**adjusted for all significant variables in the table plus Gestational age and crp level; ci=confidence interval; r=reference value; sd=standard deviation\n\nlinear regression modelling\nin the linear regression model, ABOUT 26.2% of the VARIABILITY in Serum Retinol level (μmol/l) was explained by 8 independent variables (table 2).']	[('INCOMPLETE_EVIDENCE', 49), ('INCOMPLETE_EVIDENCE', 1742), ('DIFFICULT_TASK', 1761)]	3	[('CHEBI_27300', 'vitamin D', 20, 'vitamin A'), ('GO_0007565', 'female pregnancy', 78, 'pregnant'), ('CHEBI_26536', 'retinoic acid', 156, 'retinol'), ('CHEBI_27989', 'cis-dodec-3-enoyl-CoA', 286, 'Cereal'), ('CHEBI_33290', 'food', 529, 'foods'), ('NCBITaxon_33208', 'Metazoa', 540, 'animal'), ('UBERON_0000025', 'tube', 1103, 'health'), ('CHEBI_35222', 'inhibitor', 1361, 'nutrition'), ('GO_0007565', 'female pregnancy', 1388, 'pregnancy'), ('GO_0007565', 'female pregnancy', 1585, 'gestational'), ('UBERON_0001977', 'blood serum', 1776, 'serum'), ('CHEBI_26536', 'retinoic acid', 1782, 'retinol')]
PMC3695234	7/2013	S74-PMC3695234	['AS OUR STUDY is LIMITED by its retrospective cross-sectional design, we COULD NOT analyze the RELATIONSHIP between sun exposure and Vitamin D concentration.']	[('PROBABLE_UNDERSTANDING', 0), ('QUESTION_ANSWERED_BY_THIS_WORK', 3), ('INCOMPLETE_EVIDENCE', 16), ('DIFFICULT_TASK', 72), ('ANOMALY_CURIOUS_FINDING', 78), ('SUPERFICIAL_RELATIONSHIP', 94)]	6	[('CHEBI_27300', 'vitamin D', 132, 'vitamin D')]
PMC3713405	7/2013	S139-PMC3713405	['this Complex binds to Vitamin D response elements (vdre) in the Promoters of a number of Genes; to Regulate their transcription (christakos et al., 2003).']	[('DIFFICULT_TASK', 5)]	1	[('GO_0032991', 'protein-containing complex', 5, 'complex'), ('CHEBI_27300', 'vitamin D', 22, 'vitamin D'), ('SO_0000167', 'promoter', 64, 'promoters'), ('SO_0000704', 'gene', 89, 'genes'), ('GO_0065007', 'biological regulation', 99, 'regulate')]
PMC3798907	8/2013	S0-PMC3798907	['COMPLEX EFFECTS of Vitamin E and vitamin c supplementation on in vitro neonatal Mononuclear Cell responses to allergens\n\nabstract\nlow maternal dietary Vitamin E (but not Vitamin C) Intake during Pregnancy HAS BEEN ASSOCIATED with increased in vitro Cord Blood Mononuclear Cell (Cbmc) proliferative responses, childhood wheezing and asthma.']	[('DIFFICULT_TASK', 0), ('SUPERFICIAL_RELATIONSHIP', 8), ('INCOMPLETE_EVIDENCE', 205), ('SUPERFICIAL_RELATIONSHIP', 214)]	4	[('CHEBI_28384', 'vitamin K', 19, 'Vitamin E'), ('CL_0000842', 'mononuclear cell', 80, 'Mononuclear Cell'), ('GO_0030061', 'mitochondrial crista', 80, 'Mononuclear'), ('CHEBI_27300', 'vitamin D', 151, 'vitamin E'), ('CHEBI_27300', 'vitamin D', 170, 'vitamin C'), ('GO_0007631', 'feeding behavior', 181, 'intake'), ('GO_0007565', 'female pregnancy', 195, 'pregnancy'), ('CL_0002153', 'corneocyte', 249, 'cord'), ('UBERON_0002240', 'spinal cord', 249, 'cord'), ('CL_0000081', 'blood cell', 254, 'blood'), ('UBERON_0000178', 'blood', 254, 'blood'), ('CL_0000842', 'mononuclear cell', 260, 'mononuclear cell'), ('GO_0031097', 'medial cortex', 260, 'mononuclear'), ('CL_0002062', 'type I pneumocyte', 278, 'CBMC')]
PMC3798907	8/2013	S7-PMC3798907	['the OBSERVED ASSOCIATIONS between Vitamin E and childhood Respiratory disease are COMPLEX, and the nature and form of nutritional intervention NEED TO BE carefully CONSIDERED before inclusion in trials.']	[('INCOMPLETE_EVIDENCE', 4), ('SUPERFICIAL_RELATIONSHIP', 13), ('DIFFICULT_TASK', 82), ('FUTURE_WORK', 143), ('FUTURE_WORK', 164)]	5	[('CHEBI_27300', 'vitamin D', 34, 'vitamin E'), ('UBERON_0001004', 'respiratory system', 58, 'respiratory')]
PMC3798907	8/2013	S59-PMC3798907	['Vitamin E supplementation of cbmc\nthe addition of Vitamin E to 70 cbmc cultures REVEALED COMPLEX EFFECTS.']	[('INCOMPLETE_EVIDENCE', 80), ('DIFFICULT_TASK', 89), ('SUPERFICIAL_RELATIONSHIP', 97)]	3	[('CHEBI_28384', 'vitamin K', 0, 'Vitamin E'), ('PR_000017319', 'vacuolar protein sorting-associated protein 13A', 0, 'Vitamin'), ('CHEBI_27300', 'vitamin D', 50, 'vitamin E')]
PMC3798907	8/2013	S66-PMC3798907	['note that, EVEN where significant EFFECTS were seen, there was considerable Individual VARIATION in the EFFECTS of Vitamin E between different cbmc samples.']	[('ANOMALY_CURIOUS_FINDING', 11), ('SUPERFICIAL_RELATIONSHIP', 34), ('DIFFICULT_TASK', 87), ('SUPERFICIAL_RELATIONSHIP', 104)]	4	[('NCBITaxon_1', 'root', 76, 'individual'), ('CHEBI_27300', 'vitamin D', 115, 'vitamin E')]
PMC3798907	8/2013	S91-PMC3798907	['summary of supplementation results\nthe COMPLEX results of supplementation of cbmc and pbmc cultures with Vitamins E and c are summarised for responses to the two Allergens hdm and tg infigure 5and intable 1.']	[('DIFFICULT_TASK', 39)]	1	[('CHEBI_27300', 'vitamin D', 105, 'vitamins E'), ('CHEBI_33663', 'cyclic hydrocarbon', 162, 'allergens')]
PMC3798907	8/2013	S107-PMC3798907	['this is an IMPORTANT differential result because, together with the between-subject variation and the COMPLEX EFFECTS on Cytokine Production, it INDICATES that the observed in vivo epidemiological ASSOCIATION between maternal Vitamin E intake during Pregnancy and cbmc responses and childhood asthma/wheeze cannot be EXPLAINED by a direct and CONSISTENT EFFECT on overall th-cell responsiveness, as originally HYPOTHESISED [22].']	[('IMPORTANT_CONSIDERATION', 11), ('DIFFICULT_TASK', 102), ('SUPERFICIAL_RELATIONSHIP', 110), ('INCOMPLETE_EVIDENCE', 145), ('SUPERFICIAL_RELATIONSHIP', 197), ('PROBABLE_UNDERSTANDING', 317), ('INCOMPLETE_EVIDENCE', 343), ('SUPERFICIAL_RELATIONSHIP', 354), ('INCOMPLETE_EVIDENCE', 410)]	9	[('GO_0001814', 'negative regulation of antibody-dependent cellular cytotoxicity', 121, 'cytokine production'), ('CHEBI_27300', 'vitamin D', 226, 'vitamin E'), ('GO_0007565', 'female pregnancy', 250, 'pregnancy')]
PMC3798907	8/2013	S143-PMC3798907	['the mechanisms by which Vitamins E and C MEDIATED their COMPLEX EFFECTS on cbmc responses in THE CURRENT STUDY are UNCLEAR.']	[('SUPERFICIAL_RELATIONSHIP', 41), ('DIFFICULT_TASK', 56), ('SUPERFICIAL_RELATIONSHIP', 64), ('QUESTION_ANSWERED_BY_THIS_WORK', 93), ('FULL_UNKNOWN', 115)]	5	[('CHEBI_27300', 'vitamin D', 24, 'vitamins E'), ('CHEBI_18245', 'carboxylato group', 39, 'C'), ('PR_000004900', 'complement C3', 39, 'C')]
PMC3798907	8/2013	S153-PMC3798907	['this DISPARITY, in conjunction with RECENT Antenatal intervention DATA [21] EMPHASISES the COMPLEX nature of ASSOCIATIONS between Nutrients and disease and the NEED carefully to CONSIDER the nature of any Vitamin E based Antenatal intervention intended to reduce the LIKELIHOOD of childhood asthma.']	[('ANOMALY_CURIOUS_FINDING', 5), ('IMPORTANT_CONSIDERATION', 5), ('INCOMPLETE_EVIDENCE', 36), ('FUTURE_WORK', 66), ('IMPORTANT_CONSIDERATION', 76), ('DIFFICULT_TASK', 91), ('SUPERFICIAL_RELATIONSHIP', 109), ('FUTURE_WORK', 160), ('FUTURE_WORK', 178), ('PROBABLE_UNDERSTANDING', 267)]	10	[('GO_0007567', 'parturition', 43, 'antenatal'), ('CHEBI_33284', 'nutrient', 130, 'nutrients'), ('CHEBI_27300', 'vitamin D', 205, 'vitamin E'), ('GO_0007567', 'parturition', 221, 'antenatal')]
PMC3814422	10/2013	S53-PMC3814422	['this variable incorporates the seasonal INFLUENCE on 25(Oh)D. to remove this seasonal INFLUENCE in an ATTEMPT to obtain a MARKER of habitual Vitamin D concentrations for each mother, we used the residuals from the sine–cosine regression model.']	[('SUPERFICIAL_RELATIONSHIP', 40), ('SUPERFICIAL_RELATIONSHIP', 86), ('DIFFICULT_TASK', 102), ('SUPERFICIAL_RELATIONSHIP', 122)]	4	[('CHEBI_71657', 'versiconol acetate', 53, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 53, '25(OH)D'), ('CHEBI_27300', 'vitamin D', 141, 'vitamin D'), ('PR_000006444', 'diacylglycerol kinase delta', 149, 'D')]
PMC3814422	10/2013	S130-PMC3814422	['ALTHOUGH we COULD NOT directly investigate the ASSOCIATION of maternal 25(Oh)D with Early Life Respiratory infections, the LACK OF ASSOCIATION with transient early wheezing phenotype ARGUES AGAINST a PROTECTIVE EFFECT of Prenatal Vitamin D on Respiratory Viral infections in early childhood.']	[('ANOMALY_CURIOUS_FINDING', 0), ('DIFFICULT_TASK', 12), ('ANOMALY_CURIOUS_FINDING', 18), ('SUPERFICIAL_RELATIONSHIP', 47), ('INCOMPLETE_EVIDENCE', 123), ('SUPERFICIAL_RELATIONSHIP', 131), ('INCOMPLETE_EVIDENCE', 183), ('SUPERFICIAL_RELATIONSHIP', 200), ('SUPERFICIAL_RELATIONSHIP', 211)]	9	[('CHEBI_71657', 'versiconol acetate', 71, '25(OH)D'), ('PR_000008838', 'serine protease HTRA1', 71, '25(OH ... D'), ('UBERON_0001847', 'lobule of pinna', 84, 'early life'), ('UBERON_0001004', 'respiratory system', 95, 'respiratory'), ('GO_0007565', 'female pregnancy', 221, 'prenatal'), ('CHEBI_27300', 'vitamin D', 230, 'vitamin D'), ('UBERON_0001004', 'respiratory system', 243, 'respiratory'), ('NCBITaxon_1', 'root', 255, 'viral')]
PMC3814422	10/2013	S133-PMC3814422	['HOWEVER, given that Vitamin D intake is a POOR PROXY for total Vitamin D status11, APPARENT ASSOCIATIONS with dietary Vitamin D MAY HAVE BEEN CONFOUNDED by OTHER dietary or non-dietary factors which had not been controlled for in those Birth cohort studies.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('IMPORTANT_CONSIDERATION', 42), ('PROBLEM_COMPLICATION', 42), ('SUPERFICIAL_RELATIONSHIP', 47), ('ANOMALY_CURIOUS_FINDING', 83), ('INCOMPLETE_EVIDENCE', 83), ('SUPERFICIAL_RELATIONSHIP', 92), ('INCOMPLETE_EVIDENCE', 128), ('INCOMPLETE_EVIDENCE', 132), ('DIFFICULT_TASK', 142), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 156)]	11	[('CHEBI_27300', 'vitamin D', 20, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 63, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 118, 'vitamin D'), ('GO_0007567', 'parturition', 236, 'birth')]
PMC4074693	3/2014	S57-PMC4074693	['the types of dietary supplement commonly used by these students were Vitamin C, multivitamins, Vitamin A, Vitamin B12 and Vitamin B Complex.']	[('DIFFICULT_TASK', 132)]	1	[('CHEBI_27300', 'vitamin D', 69, 'vitamin C'), ('CHEBI_27300', 'vitamin D', 95, 'vitamin A'), ('CHEBI_33279', 'vitamin D5', 106, 'vitamin B12'), ('CHEBI_27300', 'vitamin D', 122, 'vitamin B'), ('CHEBI_34652', 'compactin diol lactone', 132, 'complex')]
PMC4074693	3/2014	S79-PMC4074693	['the types of dietary supplement commonly used by these students were Vitamin C, multivitamins, Vitamin A, Vitamin B12 and Vitamin B Complex.']	[('DIFFICULT_TASK', 132)]	1	[('CHEBI_27300', 'vitamin D', 69, 'vitamin C'), ('CHEBI_27300', 'vitamin D', 95, 'vitamin A'), ('CHEBI_33279', 'vitamin D5', 106, 'vitamin B12'), ('CHEBI_27300', 'vitamin D', 122, 'vitamin B'), ('CHEBI_34652', 'compactin diol lactone', 132, 'complex')]
PMC4034700	5/2014	S6-PMC4034700	['ALTHOUGH clinical trials on the use of antioxidant Vitamins in Pregnancy proved largely UNSUCCESSFUL, the scope for their use STILL exists GIVEN the beneficial cardioprotective EFFECTS of antioxidant-rich mediterranean diet, periconceptual Vitamin use and the synergistic EFFECT of Vitamin C andl-Arginine.']	[('ANOMALY_CURIOUS_FINDING', 0), ('DIFFICULT_TASK', 88), ('IMPORTANT_CONSIDERATION', 126), ('PROBABLE_UNDERSTANDING', 139), ('SUPERFICIAL_RELATIONSHIP', 177), ('SUPERFICIAL_RELATIONSHIP', 272)]	6	[('CHEBI_33277', 'gamma-tocotrienol', 51, 'vitamins'), ('GO_0007565', 'female pregnancy', 63, 'pregnancy'), ('CHEBI_33229', 'vitamin (role)', 240, 'vitamin'), ('CHEBI_27300', 'vitamin D', 282, 'vitamin C'), ('CHEBI_15511', 'trans-feruloyl-CoA', 296, '-arginine')]
PMC4034700	5/2014	S258-PMC4034700	['ALTHOUGH clinical trials on the use of antioxidant Vitamins in Pregnancy proved largely UNSUCCESSFUL, the scope for their use STILL exists GIVEN the beneficial cardioprotective EFFECTS of antioxidant-rich mediterranean diet, periconceptual Vitamin use and the synergistic EFFECT of Vitamin C andl-Arginine.']	[('ANOMALY_CURIOUS_FINDING', 0), ('DIFFICULT_TASK', 88), ('IMPORTANT_CONSIDERATION', 126), ('PROBABLE_UNDERSTANDING', 139), ('SUPERFICIAL_RELATIONSHIP', 177), ('SUPERFICIAL_RELATIONSHIP', 272)]	6	[('CHEBI_33277', 'gamma-tocotrienol', 51, 'vitamins'), ('GO_0007565', 'female pregnancy', 63, 'pregnancy'), ('CHEBI_33229', 'vitamin (role)', 240, 'vitamin'), ('CHEBI_27300', 'vitamin D', 282, 'vitamin C'), ('CHEBI_15511', 'trans-feruloyl-CoA', 296, '-arginine')]
PMC4071151	6/2014	S64-PMC4071151	['RISK factors MAY include preoperative malnutrition (e.g., Vitamin D, iron), decreased Food Intake (dumping syndrome, reduced hunger and increased satiety, Food intolerances), inadequate Nutrient supplementation (POOR compliance with multivitamin/multimineral regimen, insufficient amounts of Vitamins and/or Minerals in supplements) and/or nutritional support (lack of follow-up, INSUFFICIENT monitoring, DIFFICULTY in recognizing symptoms of deficiency), Nutrient malabsorption (reduced absorptive Gastro-Intestinal area) [18,19].']	[('SUPERFICIAL_RELATIONSHIP', 0), ('INCOMPLETE_EVIDENCE', 13), ('IMPORTANT_CONSIDERATION', 212), ('PROBLEM_COMPLICATION', 380), ('DIFFICULT_TASK', 405)]	5	[('CHEBI_27300', 'vitamin D', 58, 'vitamin D'), ('CHEBI_33290', 'food', 86, 'food'), ('GO_0007631', 'feeding behavior', 86, 'food intake'), ('CHEBI_33290', 'food', 155, 'food'), ('CHEBI_33284', 'nutrient', 186, 'nutrient'), ('CHEBI_33277', 'gamma-tocotrienol', 292, 'vitamins'), ('CHEBI_46751', 'quinolizidine', 308, 'minerals'), ('CHEBI_33284', 'nutrient', 456, 'nutrient'), ('UBERON_0005409', 'alimentary part of gastrointestinal system', 499, 'gastro-intestinal')]
PMC4113768	7/2014	S706-PMC4113768	['due to Renal dysfunction and altered Vitamin D Metabolism, the Serum Matrix and Metabolite composition of this patient cohort differ from the healthy, which represents a CHALLENGE in the accurate determination of their Vitamin D status.']	[('DIFFICULT_TASK', 170)]	1	[('UBERON_0002113', 'kidney', 7, 'renal'), ('CHEBI_28384', 'vitamin K', 37, 'Vitamin D'), ('GO_0046443', 'FAD metabolic process', 37, 'Vitamin D metabolism'), ('UBERON_0001977', 'blood serum', 63, 'serum'), ('GO_0031012', 'extracellular matrix', 69, 'matrix'), ('CHEBI_39382', 'flufenoxuron', 80, 'metabolite'), ('CHEBI_27300', 'vitamin D', 219, 'vitamin D')]
PMC4113768	7/2014	S825-PMC4113768	['there is wide VARIATION in the content and availability of Vitamin D supplements, and DESPITE nice guidelines on Vitamin D supplementation implementation REMAINS UNCERTAIN.']	[('DIFFICULT_TASK', 14), ('ANOMALY_CURIOUS_FINDING', 86), ('INCOMPLETE_EVIDENCE', 154), ('FULL_UNKNOWN', 162)]	4	[('CHEBI_27300', 'vitamin D', 59, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 113, 'vitamin D')]
PMC4113768	7/2014	S1203-PMC4113768	['conclusions: pth is the MOST LIKELY MARKER to be outside the reference range (raised) IF the patient is Vitamin D deficient BUT the literature SUGGESTS the RELATIONSHIP between 25Ohd and pth MAY BE COMPLICATED by Glomerular filtration rate.']	[('PROBABLE_UNDERSTANDING', 24), ('PROBABLE_UNDERSTANDING', 29), ('SUPERFICIAL_RELATIONSHIP', 36), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 86), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 124), ('INCOMPLETE_EVIDENCE', 143), ('SUPERFICIAL_RELATIONSHIP', 156), ('INCOMPLETE_EVIDENCE', 191), ('DIFFICULT_TASK', 198)]	9	[('CHEBI_27300', 'vitamin D', 104, 'vitamin D'), ('CHEBI_72652', "7,2'-dihydroxy-4'-methoxyisoflavan-4-ylium cation", 177, '25OHD'), ('UBERON_0000074', 'renal glomerulus', 213, 'glomerular')]
PMC4113768	7/2014	S1407-PMC4113768	['to COMPLICATE the picture, Genetic DIFFERENCES in the Vitamin D receptor (vdr) MAY also be of IMPORTANCE.']	[('DIFFICULT_TASK', 3), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 35), ('INCOMPLETE_EVIDENCE', 79), ('IMPORTANT_CONSIDERATION', 94)]	4	[('SO_0000704', 'gene', 27, 'genetic'), ('CHEBI_27300', 'vitamin D', 54, 'vitamin D')]
PMC4113768	7/2014	S1445-PMC4113768	['suboptimal Vitamin D status APPEARS TO increase an Individual’s RISK of developing cvd, ALTHOUGH the OPTIMAL level REQUIRED is UNCLEAR and the results of intervention studies REMAIN HETEROGENEOUS and INCONCLUSIVE.']	[('ANOMALY_CURIOUS_FINDING', 28), ('IMPORTANT_CONSIDERATION', 64), ('ANOMALY_CURIOUS_FINDING', 88), ('IMPORTANT_CONSIDERATION', 101), ('IMPORTANT_CONSIDERATION', 115), ('FULL_UNKNOWN', 127), ('INCOMPLETE_EVIDENCE', 175), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 182), ('DIFFICULT_TASK', 182), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 200)]	10	[('CHEBI_27300', 'vitamin D', 11, 'vitamin D'), ('NCBITaxon_1', 'root', 51, 'individual')]
PMC4113768	7/2014	S3323-PMC4113768	['HOWEVER, cold temperature is also a risk FACTOR for seasonal diseases and outcome, making it DIFFICULT to separate the EFFECTS of solar uvb/Vitamin D from those of temperature.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('SUPERFICIAL_RELATIONSHIP', 41), ('DIFFICULT_TASK', 93), ('SUPERFICIAL_RELATIONSHIP', 119)]	4	[('CHEBI_27300', 'vitamin D', 140, 'vitamin D')]
PMC4142706	7/2014	S72-PMC4142706	['this FINDING made it IMPOSSIBLE to carry out this test SINCE Vitamin C was present in cell extracts and masked the results (azqueta et al., 2009,2013b).']	[('INCOMPLETE_EVIDENCE', 5), ('DIFFICULT_TASK', 21), ('PROBLEM_COMPLICATION', 55)]	3	[('CHEBI_27300', 'vitamin D', 61, 'vitamin C')]
PMC4645901	8/2014	S83-PMC4645901	['a relatively SMALL data set MEANT it was NOT POSSIBLE to draw convincing CONCLUSIONS between dose of vitamin supplementation during Pregnancy and Vitamin D levels in babies.']	[('INCOMPLETE_EVIDENCE', 13), ('PROBABLE_UNDERSTANDING', 28), ('DIFFICULT_TASK', 41), ('PROBABLE_UNDERSTANDING', 73)]	4	[('GO_0007565', 'female pregnancy', 132, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 146, 'vitamin D')]
PMC4169453	9/2014	S197-PMC4169453	['taking into account the maternal REQUIREMENT, 1200 iu/d of Vitamin D MAY PROTECT against Vitamin D deficiency, but SEEMS TOO low TO fully replenish Vitamin D insufficiency (20 ng/ml<25(Oh)D <30 ng/ml).']	[('IMPORTANT_CONSIDERATION', 33), ('INCOMPLETE_EVIDENCE', 69), ('SUPERFICIAL_RELATIONSHIP', 73), ('ANOMALY_CURIOUS_FINDING', 115), ('DIFFICULT_TASK', 121)]	5	[('CHEBI_27300', 'vitamin D', 59, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 89, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 148, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 182, '25(OH)D'), ('PR_000009880', 'Lon protease, mitochondrial', 182, '25 ... OH ... D')]
PMC4169453	9/2014	S241-PMC4169453	['Vitamin D3 supplementation at a dose of 1200 iu/d is more EFFECTIVE at improving Vitamin D status of nursing women, but STILL SEEMS TOO low TO fully replenish Vitamin D deficiency/insufficiency.']	[('SUPERFICIAL_RELATIONSHIP', 58), ('ANOMALY_CURIOUS_FINDING', 120), ('IMPORTANT_CONSIDERATION', 120), ('ANOMALY_CURIOUS_FINDING', 126), ('DIFFICULT_TASK', 132)]	5	[('CHEBI_33237', 'vitamin D4', 0, 'Vitamin D3'), ('PR_000017319', 'vacuolar protein sorting-associated protein 13A', 0, 'Vitamin D3'), ('CHEBI_27300', 'vitamin D', 81, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 159, 'vitamin D')]
PMC4380518	9/2014	S7-PMC4380518	['introduction\nPerinatal health outcomes VARY dramatically by race in the united states.1african american women develop Preeclampsia more OFTEN than their white counterparts2and are more LIKELY to develop preterm labor.3the result is that black infants are 60% more LIKELY BE preterm and four times more LIKELY to die due to prematurity than white infants.1BECAUSE of less efficient Vitamin D Synthesis in the skin of darker Pigmented Individuals, african americans are at higher RISK than white americans of Vitamin D deficiency.4,5black women are also more LIKELY than white women to be overweight or obese6which is of CONCERN BECAUSE obesity is another RISK FACTOR for Vitamin D deficiency5,7and poor Perinatal outcomes.8in OBSERVATIONAL studies, 25-Hydroxyvitamin D (25[Oh]D) levels HAVE BEEN SHOWN to be ASSOCIATED with higher risk of several adverse Perinatal outcomes including Gestational diabetes9,10, preeclampsia,11preterm Birth12And small-for-Gestational age status.13,14,15,16,17BECAUSE of the PAUCITY of Vitamin D trial data with respect to Perinatal outcomes, WHETHER DIFFERENCES in Vitamin D status during Pregnancy explains or partially explains Perinatal DISPARITIES is PLAUSIBLE18but REMAINS UNKNOWN.']	[('DIFFICULT_TASK', 39), ('PROBABLE_UNDERSTANDING', 136), ('PROBABLE_UNDERSTANDING', 185), ('PROBABLE_UNDERSTANDING', 264), ('PROBABLE_UNDERSTANDING', 302), ('PROBABLE_UNDERSTANDING', 355), ('IMPORTANT_CONSIDERATION', 478), ('PROBABLE_UNDERSTANDING', 557), ('PROBLEM_COMPLICATION', 619), ('PROBABLE_UNDERSTANDING', 627), ('SUPERFICIAL_RELATIONSHIP', 654), ('INCOMPLETE_EVIDENCE', 725), ('INCOMPLETE_EVIDENCE', 785), ('SUPERFICIAL_RELATIONSHIP', 807), ('PROBABLE_UNDERSTANDING', 990), ('INCOMPLETE_EVIDENCE', 1005), ('EXPLICIT_QUESTION', 1073), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 1081), ('IMPORTANT_CONSIDERATION', 1171), ('INCOMPLETE_EVIDENCE', 1186), ('FULL_UNKNOWN', 1201)]	21	[('GO_0036268', 'swimming', 13, 'Perinatal'), ('UBERON_0012101', 'perinatal stage', 13, 'Perinatal'), ('GO_0007128', 'meiotic prophase I', 118, 'preeclampsia'), ('CHEBI_27300', 'vitamin D', 381, 'vitamin D'), ('GO_0042368', 'vitamin D biosynthetic process', 381, 'vitamin D synthesis'), ('CHEBI_26130', 'biological pigment', 423, 'pigmented'), ('NCBITaxon_1', 'root', 433, 'individuals'), ('CHEBI_27300', 'vitamin D', 507, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 670, 'vitamin D'), ('GO_0036268', 'swimming', 702, 'perinatal'), ('UBERON_0012101', 'perinatal stage', 702, 'perinatal'), ('CHEBI_62218', '23,24-dihydrocucurbitacin D', 748, '25-hydroxyvitamin D'), ('CHEBI_15643', '(6R)-6-(L-erythro-1,2-dihydroxypropyl)-7,8-dihydro-6H-pterin', 769, '25[OH]D'), ('GO_0036268', 'swimming', 854, 'perinatal'), ('UBERON_0012101', 'perinatal stage', 854, 'perinatal'), ('GO_0007565', 'female pregnancy', 883, 'gestational'), ('GO_0007594', 'puparial adhesion', 932, 'birth12and'), ('GO_0007565', 'female pregnancy', 953, 'gestational'), ('CHEBI_27300', 'vitamin D', 1016, 'vitamin D'), ('GO_0036268', 'swimming', 1053, 'perinatal'), ('UBERON_0012101', 'perinatal stage', 1053, 'perinatal'), ('CHEBI_27300', 'vitamin D', 1096, 'vitamin D'), ('GO_0007565', 'female pregnancy', 1120, 'pregnancy'), ('GO_0036268', 'swimming', 1161, 'perinatal'), ('UBERON_0012101', 'perinatal stage', 1161, 'perinatal')]
PMC4380518	9/2014	S8-PMC4380518	['furthermore, WHILE multivitamin intake HAS BEEN SHOWN to VARY by race,19it REMAINS UNKNOWN WHETHER multivitamin intake improves Vitamin D status among the HIGHEST RISK groups (african americans and overweight/obese) during Pregnancy.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 13), ('INCOMPLETE_EVIDENCE', 39), ('DIFFICULT_TASK', 57), ('FULL_UNKNOWN', 75), ('EXPLICIT_QUESTION', 91), ('IMPORTANT_CONSIDERATION', 155)]	6	[('CHEBI_27300', 'vitamin D', 128, 'vitamin D'), ('GO_0007565', 'female pregnancy', 223, 'pregnancy')]
PMC4380518	9/2014	S47-PMC4380518	['discussion\nour data SUGGEST that WHILE Prenatal pnv use is ASSOCIATED with lower odds of Vitamin D deficiency, the ASSOCIATION is NOT UNIFORM.']	[('INCOMPLETE_EVIDENCE', 20), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 33), ('SUPERFICIAL_RELATIONSHIP', 59), ('SUPERFICIAL_RELATIONSHIP', 115), ('DIFFICULT_TASK', 130)]	5	[('GO_0007565', 'female pregnancy', 39, 'prenatal'), ('CHEBI_27300', 'vitamin D', 89, 'vitamin D')]
PMC4380518	9/2014	S58-PMC4380518	['we had NO INFORMATION as to the duration of use or the Vitamin D dose in the pnv which typically is 400–600 iu per tablet, BUT can VARY.']	[('FULL_UNKNOWN', 7), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 123), ('DIFFICULT_TASK', 131)]	3	[('CHEBI_27300', 'vitamin D', 55, 'vitamin D')]
PMC4329404	10/2014	S148-PMC4329404	['it is CONSISTENT with FINDINGS from epidemiological studies which have FAILED TO SHOW reliable EFFECTS of Vitamin D deficiency or insufficiency on Lung function in children with asthma (6–8,11) ALTHOUGH ASSOCIATIONS are REPORTED in Adults (33).']	[('INCOMPLETE_EVIDENCE', 6), ('INCOMPLETE_EVIDENCE', 22), ('DIFFICULT_TASK', 71), ('QUESTION_ANSWERED_BY_THIS_WORK', 78), ('INCOMPLETE_EVIDENCE', 81), ('SUPERFICIAL_RELATIONSHIP', 95), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 194), ('ANOMALY_CURIOUS_FINDING', 194), ('SUPERFICIAL_RELATIONSHIP', 203), ('INCOMPLETE_EVIDENCE', 220)]	10	[('CHEBI_27300', 'vitamin D', 106, 'vitamin D'), ('UBERON_0002048', 'lung', 147, 'lung'), ('UBERON_0007023', 'adult organism', 232, 'adults')]
PMC4329745	10/2014	S95-PMC4329745	['THIS STUDY was performed on Vitamin D status specially on women .we did have some LIMITATIONS in our work; detailed diet habits of the participants as well as rates of sun exposure were NOT CONSIDERED in the method BECAUSE of practical DIFFICULTIES.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 0), ('INCOMPLETE_EVIDENCE', 82), ('INCOMPLETE_EVIDENCE', 186), ('PROBLEM_COMPLICATION', 215), ('DIFFICULT_TASK', 236)]	5	[('CHEBI_27300', 'vitamin D', 28, 'vitamin D')]
PMC4251419	12/2014	S9-PMC4251419	['clues from epidemiology\nindications that Vitamin D MAY BE ASSOCIATED with disorders of Human Immune function OFTEN originate from OBSERVATIONS of geographic VARIATION in disease occurrence.']	[('INCOMPLETE_EVIDENCE', 51), ('SUPERFICIAL_RELATIONSHIP', 58), ('PROBABLE_UNDERSTANDING', 109), ('INCOMPLETE_EVIDENCE', 130), ('DIFFICULT_TASK', 157)]	5	[('CHEBI_27300', 'vitamin D', 41, 'vitamin D'), ('NCBITaxon_9606', 'Homo sapiens', 87, 'human'), ('UBERON_0002405', 'immune system', 93, 'immune')]
PMC4251419	12/2014	S23-PMC4251419	['HOWEVER, for AT LEAST some of the Immune-RELATED diseases, it is DIFFICULT to determine WHETHER low sun exposure OR Vitamin D cause, OR are caused by, the disease.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('PROBABLE_UNDERSTANDING', 13), ('SUPERFICIAL_RELATIONSHIP', 41), ('DIFFICULT_TASK', 65), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 88)]	5	[('UBERON_0002405', 'immune system', 34, 'immune'), ('CHEBI_27300', 'vitamin D', 116, 'vitamin D')]
PMC4251419	12/2014	S72-PMC4251419	['it is CHALLENGING to DIFFERENTIATE between Vitamin D-DEPENDENT and INDEPENDENT pathways in the EFFECT of sun exposure on disease risk.']	[('DIFFICULT_TASK', 6), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 21), ('SUPERFICIAL_RELATIONSHIP', 53), ('SUPERFICIAL_RELATIONSHIP', 67), ('SUPERFICIAL_RELATIONSHIP', 95)]	5	[('CHEBI_27300', 'vitamin D', 43, 'vitamin D')]
PMC4251419	12/2014	S139-PMC4251419	['Genetic variation in the physiological response to Vitamin D supplementation\na high degree of Individual VARIABILITY in the 25(Oh)D response to Vitamin D supplementation has been DESCRIBED that is the result of demographic, environmental and Genetic FACTORS [79].']	[('DIFFICULT_TASK', 105), ('INCOMPLETE_EVIDENCE', 179), ('SUPERFICIAL_RELATIONSHIP', 250)]	3	[('SO_0000704', 'gene', 0, 'Genetic'), ('CHEBI_27300', 'vitamin D', 51, 'vitamin D'), ('NCBITaxon_1', 'root', 94, 'individual'), ('CHEBI_71657', 'versiconol acetate', 124, '25(OH)D'), ('CHEBI_27300', 'vitamin D', 144, 'vitamin D'), ('SO_0000704', 'gene', 242, 'genetic')]
PMC4256222	12/2014	S110-PMC4256222	['[6]were UNABLE TO detect any RELEVANT ASSOCIATION between maternal Vitamin D status and bmc and bmd shortly after Birth, ALTHOUGH they did indeed find a positive CORRELATION between maternal Vitamin D status and fetal Femur volume measured by three-dimensional ultrasound.']	[('DIFFICULT_TASK', 8), ('IMPORTANT_CONSIDERATION', 29), ('SUPERFICIAL_RELATIONSHIP', 38), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 121), ('ANOMALY_CURIOUS_FINDING', 121), ('SUPERFICIAL_RELATIONSHIP', 162)]	6	[('CHEBI_27300', 'vitamin D', 67, 'vitamin D'), ('GO_0007567', 'parturition', 114, 'birth'), ('CHEBI_27300', 'vitamin D', 191, 'vitamin D'), ('UBERON_0000981', 'femur', 218, 'femur')]
PMC4256222	12/2014	S135-PMC4256222	['weight and height MAY BE RELATED both to maternal Vitamin D status and offspring bone mass, and our results MAY BE CONFOUNDED when those data are missing.']	[('INCOMPLETE_EVIDENCE', 18), ('SUPERFICIAL_RELATIONSHIP', 25), ('INCOMPLETE_EVIDENCE', 108), ('DIFFICULT_TASK', 115)]	4	[('CHEBI_27300', 'vitamin D', 50, 'vitamin D')]
PMC4303849	1/2015	S29-PMC4303849	['this Complex recognizes Vitamin D response elements (vdre) in the Promoter regions of vd target Genes and recruits co-activators or co-repressors in order to induce or repress Gene transcription [6].']	[('DIFFICULT_TASK', 5)]	1	[('GO_0032991', 'protein-containing complex', 5, 'complex'), ('CHEBI_27300', 'vitamin D', 24, 'vitamin D'), ('SO_0000167', 'promoter', 66, 'promoter'), ('SO_0000704', 'gene', 96, 'genes'), ('SO_0000704', 'gene', 176, 'gene')]
PMC4383226	2/2015	S147-PMC4383226	['WHILE the PROTECTIVE ASSOCIATION between Vitamin A and malaria REMAINED, the low prevalence of maternal hiv in our study population (and HENCE LOW statistical power) makes it DIFFICULT to RULE OUT POTENTIAL Vitamin A–hiv INTERACTIONS.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ANOMALY_CURIOUS_FINDING', 0), ('SUPERFICIAL_RELATIONSHIP', 10), ('SUPERFICIAL_RELATIONSHIP', 21), ('INCOMPLETE_EVIDENCE', 63), ('PROBABLE_UNDERSTANDING', 137), ('PROBLEM_COMPLICATION', 143), ('DIFFICULT_TASK', 175), ('INCOMPLETE_EVIDENCE', 188), ('INCOMPLETE_EVIDENCE', 197), ('SUPERFICIAL_RELATIONSHIP', 221)]	11	[('CHEBI_27300', 'vitamin D', 41, 'vitamin A'), ('CHEBI_27300', 'vitamin D', 207, 'vitamin A')]
PMC4340999	3/2015	S112-PMC4340999	['ALTHOUGH THE CURRENT STUDY is UNABLE TO precisely determine the REASON for mob variation in Adult measures of ll, general adiposity, and central adiposity, the study improves our current understanding of a POTENTIAL ASSOCIATION of Prenatal low exposure to Vitamin D during late second and early third trimesters with short ll and adiposity in later Life.']	[('ANOMALY_CURIOUS_FINDING', 0), ('QUESTION_ANSWERED_BY_THIS_WORK', 9), ('DIFFICULT_TASK', 30), ('PROBABLE_UNDERSTANDING', 64), ('INCOMPLETE_EVIDENCE', 206), ('SUPERFICIAL_RELATIONSHIP', 216)]	6	[('UBERON_0007023', 'adult organism', 92, 'adult'), ('GO_0007565', 'female pregnancy', 231, 'prenatal'), ('CHEBI_27300', 'vitamin D', 256, 'vitamin D'), ('UBERON_0000104', 'life cycle', 349, 'life')]
PMC4377870	3/2015	S82-PMC4377870	['[60] reported decreased ahr to Methacholine and Inflammatory Cell infiltration of Perivascular and Peribronchiolar spaces when Vitamin C was supplemented during Allergen CHALLENGE.']	[('DIFFICULT_TASK', 170)]	1	[('CHEBI_6805', 'methacycline', 31, 'methacholine'), ('CL_0009002', 'inflammatory cell', 48, 'inflammatory cell'), ('GO_0043204', 'perikaryon', 82, 'perivascular'), ('UBERON_0014930', 'perivascular space', 82, 'perivascular'), ('GO_0043204', 'perikaryon', 99, 'peribronchiolar'), ('UBERON_0001297', 'serosa of uterus', 99, 'peribronchiolar'), ('CHEBI_27300', 'vitamin D', 127, 'vitamin C'), ('CHEBI_50904', 'allergen', 161, 'allergen')]
PMC4377870	3/2015	S134-PMC4377870	['THOUGH like Vitamin C, it MAY BE DIFFICULT to disentangle the EFFECTS of Flavonoids from OTHER Nutrients in Flavonoid-rich foods.']	[('ANOMALY_CURIOUS_FINDING', 0), ('INCOMPLETE_EVIDENCE', 26), ('DIFFICULT_TASK', 33), ('SUPERFICIAL_RELATIONSHIP', 62), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 89)]	5	[('CHEBI_27300', 'vitamin D', 12, 'vitamin C'), ('PR_000004900', 'complement C3', 20, 'C'), ('CHEBI_72544', 'flavonoids', 73, 'flavonoids'), ('CHEBI_33284', 'nutrient', 95, 'nutrients'), ('CHEBI_47916', 'flavonoid', 108, 'flavonoid')]
PMC4377870	3/2015	S139-PMC4377870	['WHILE Vitamin D has beneficial EFFECTS INDEPENDENT of uv exposure [109], it can be DIFFICULT to separate this POTENTIAL CONFOUNDER from direct EFFECTS of Vitamin D on Lung health [110].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('SUPERFICIAL_RELATIONSHIP', 31), ('SUPERFICIAL_RELATIONSHIP', 39), ('DIFFICULT_TASK', 83), ('INCOMPLETE_EVIDENCE', 110), ('PROBLEM_COMPLICATION', 120), ('SUPERFICIAL_RELATIONSHIP', 143)]	7	[('CHEBI_27300', 'vitamin D', 6, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 154, 'vitamin D'), ('UBERON_0002048', 'lung', 167, 'lung')]
PMC4405493	4/2015	S15-PMC4405493	['the etiology for this increase is LIKELY MULTIFACTORIAL, but due IN PART to low dietary intake of Vitamin D and limited exposure to sunlight.']	[('PROBABLE_UNDERSTANDING', 34), ('DIFFICULT_TASK', 41), ('INCOMPLETE_EVIDENCE', 65)]	3	[('CHEBI_27300', 'vitamin D', 98, 'vitamin D')]
PMC4405493	4/2015	S20-PMC4405493	['RECENT observational and randomized control trials have ATTEMPTED TO investigate THIS ISSUE, but there REMAINS LIMITED GUIDANCE on the management of Vitamin D deficiency during Pregnancy.']	[('INCOMPLETE_EVIDENCE', 0), ('DIFFICULT_TASK', 56), ('INCOMPLETE_EVIDENCE', 56), ('QUESTION_ANSWERED_BY_THIS_WORK', 66), ('QUESTION_ANSWERED_BY_THIS_WORK', 81), ('PROBLEM_COMPLICATION', 86), ('INCOMPLETE_EVIDENCE', 103), ('INCOMPLETE_EVIDENCE', 111), ('FUTURE_WORK', 119)]	9	[('CHEBI_27300', 'vitamin D', 149, 'vitamin D'), ('GO_0007565', 'female pregnancy', 177, 'pregnancy')]
PMC4405493	4/2015	S77-PMC4405493	['mean Gestational age of recruitment and Vitamin D Plasma measurement was 62.2 ± 29.7 days (8.9 ± 4.2 weeks).a Pregnancy was considered COMPLICATED if the patient was diagnosed with any of the following adverse Pregnancy outcomes: Preeclampsia, Gestational diabetes, spontaneous Preterm Delivery, Intrauterine growth restriction, or spontaneous Abortion (table 1).']	[('DIFFICULT_TASK', 135)]	1	[('GO_0007565', 'female pregnancy', 5, 'gestational'), ('CHEBI_27300', 'vitamin D', 40, 'vitamin D'), ('UBERON_0001969', 'blood plasma', 50, 'plasma'), ('GO_0007565', 'female pregnancy', 110, 'pregnancy'), ('GO_0007565', 'female pregnancy', 210, 'pregnancy'), ('GO_0007128', 'meiotic prophase I', 230, 'preeclampsia'), ('GO_0007565', 'female pregnancy', 244, 'gestational'), ('GO_0007565', 'female pregnancy', 278, 'preterm'), ('GO_0007567', 'parturition', 286, 'delivery'), ('UBERON_0022293', 'reproductive gland secretion', 296, 'intrauterine'), ('GO_0007569', 'cell aging', 344, 'abortion')]
PMC4405493	4/2015	S117-PMC4405493	['this study was NOT POWERED to detect ASSOCIATIONS between Vitamin D status and these individual Pregnancy complications.fig 1compares our study population with RECENTLY PUBLISHED cohort studies and randomized controlled trials (reviewed in christesen [2012] and wei [2013]) [13,39].10.1371/journal.pone.0123763.g001\n\ncaption (fig): fig 1\ncomparison of study parameters in recent Vitamin D OBSERVATIONAL and intervention studies.']	[('DIFFICULT_TASK', 15), ('SUPERFICIAL_RELATIONSHIP', 37), ('INCOMPLETE_EVIDENCE', 160), ('INCOMPLETE_EVIDENCE', 389)]	4	[('CHEBI_27300', 'vitamin D', 58, 'vitamin D'), ('GO_0007565', 'female pregnancy', 96, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 379, 'vitamin D')]
PMC4405493	4/2015	S120-PMC4405493	['the etiology of the decline of Vitamin D status in women is LIKELY MULTIFACTORIAL, but is due IN PART to increasing bmi and increased sun protection, coupled with decreased dietary intake of Vitamin D, such as milk and other dairy products.']	[('PROBABLE_UNDERSTANDING', 60), ('DIFFICULT_TASK', 67), ('INCOMPLETE_EVIDENCE', 94)]	3	[('CHEBI_27300', 'vitamin D', 31, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 191, 'vitamin D')]
PMC4405493	4/2015	S175-PMC4405493	['this study was NOT POWERED to detect ASSOCIATIONS between Vitamin D status and these individual complications of Pregnancy.']	[('DIFFICULT_TASK', 15), ('SUPERFICIAL_RELATIONSHIP', 37)]	2	[('CHEBI_27300', 'vitamin D', 58, 'vitamin D'), ('GO_0007565', 'female pregnancy', 113, 'pregnancy')]
PMC4417995	4/2015	S12-PMC4417995	['the function of Vitamin D, traditionally ASSOCIATED with calcium and Phosphate Homeostasis, IS THOUGHT TO be highly COMPLEX, and its POTENTIAL ROLES in Cardiovascular, neoplastic, and Microbial infections and Autoimmune diseases HAVE BEEN investigated in RECENT STUDIES [5].']	[('SUPERFICIAL_RELATIONSHIP', 41), ('INCOMPLETE_EVIDENCE', 92), ('DIFFICULT_TASK', 116), ('INCOMPLETE_EVIDENCE', 133), ('SUPERFICIAL_RELATIONSHIP', 143), ('INCOMPLETE_EVIDENCE', 229), ('INCOMPLETE_EVIDENCE', 255)]	7	[('CHEBI_27300', 'vitamin D', 16, 'vitamin D'), ('GO_0051320', 'S phase', 69, 'phosphate'), ('GO_0042592', 'homeostatic process', 79, 'homeostasis'), ('UBERON_0004535', 'cardiovascular system', 152, 'cardiovascular'), ('NCBITaxon_10088', 'Mus <genus>', 184, 'microbial'), ('UBERON_0001442', 'skeleton of manus', 209, 'autoimmune')]
PMC4417995	4/2015	S83-PMC4417995	['this indirectly CHALLENGES the HYPOTHESIS that the increased prevalence of atopic disease CAN be a CONSEQUENCE of Vitamin D insufficiency secondary to reduced solar/uvb exposure.']	[('DIFFICULT_TASK', 16), ('INCOMPLETE_EVIDENCE', 31), ('INCOMPLETE_EVIDENCE', 90), ('PROBABLE_UNDERSTANDING', 99)]	4	[('CHEBI_27300', 'vitamin D', 114, 'vitamin D')]
PMC4417995	4/2015	S186-PMC4417995	['similarly, to devise a STRATEGY for using Vitamin D in the therapy of ad SEEMS at present to be NOT FEASIBLE for DIFFERENT reasons: many CONFOUNDING and unidentified VARIABLES appear in EXISTING STUDIES, and they are OFTEN LIMITED by SMALL numbers of participants, their short durations, and the use of a fixed dose without optimizing for adequate Serum levels.']	[('FUTURE_WORK', 23), ('ANOMALY_CURIOUS_FINDING', 73), ('DIFFICULT_TASK', 96), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 113), ('PROBLEM_COMPLICATION', 137), ('SUPERFICIAL_RELATIONSHIP', 166), ('INCOMPLETE_EVIDENCE', 186), ('PROBABLE_UNDERSTANDING', 217), ('INCOMPLETE_EVIDENCE', 223), ('INCOMPLETE_EVIDENCE', 234)]	10	[('CHEBI_27300', 'vitamin D', 42, 'vitamin D'), ('UBERON_0001977', 'blood serum', 348, 'serum')]
PMC4427001	4/2015	S21-PMC4427001	['the COMPLEXITY of Vitamin D action is FURTHER increased by vdr Gene polymorphism.']	[('DIFFICULT_TASK', 4), ('INCOMPLETE_EVIDENCE', 38)]	2	[('CHEBI_27300', 'vitamin D', 18, 'vitamin D'), ('SO_0000704', 'gene', 63, 'gene')]
PMC4448820	5/2015	S239-PMC4448820	['in vivo data for Vitamin A– and Vitamin D–DEPENDENT induction of Tregs in Humans are EMERGING but are EXTREMELY DIFFICULT to establish methodologically BECAUSE of the LIKELY need to obtain biopsied materials (144–146).']	[('SUPERFICIAL_RELATIONSHIP', 42), ('INCOMPLETE_EVIDENCE', 85), ('IMPORTANT_CONSIDERATION', 102), ('DIFFICULT_TASK', 112), ('PROBLEM_COMPLICATION', 152), ('PROBABLE_UNDERSTANDING', 167)]	6	[('CHEBI_27300', 'vitamin D', 17, 'vitamin A'), ('CHEBI_27300', 'vitamin D', 32, 'vitamin D'), ('CL_0000909', 'CD8-positive, alpha-beta memory T cell', 65, 'Tregs'), ('NCBITaxon_9606', 'Homo sapiens', 74, 'humans')]
PMC4448820	5/2015	S299-PMC4448820	['the molecular actions of zinc APPEAR TO BE more COMPLEX than those of Vitamins A and D. in Humans, the zinc-containing proteome contains <3000 members (193).']	[('ANOMALY_CURIOUS_FINDING', 30), ('DIFFICULT_TASK', 48)]	2	[('CHEBI_27300', 'vitamin D', 70, 'vitamins A'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 85, 'D'), ('NCBITaxon_9606', 'Homo sapiens', 91, 'humans')]
PMC4488777	5/2015	S176-PMC4488777	['COMPLEX evaluation of Vitamin D activity mechanism on fertility REQUIRES FURTHER STUDIES.']	[('DIFFICULT_TASK', 0), ('IMPORTANT_CONSIDERATION', 64), ('FUTURE_WORK', 73)]	3	[('CHEBI_27300', 'vitamin D', 22, 'vitamin D')]
PMC4466139	6/2015	S93-PMC4466139	['THESE STUDIES EVEN IF LIMITED to specific populations (caucasians [28], arab an asian [29], rural populations of south china [30]) SHOW a COMPLEX picture of Genetic FACTORS determining the level of 25Ohd and consequent risks of deficiency of Vitamin D. DESPITE this, the environmental COMPONENT is STILL preponderant ALTHOUGH LIMITED to 57–71% in determining the level of 25Ohd.']	[('INCOMPLETE_EVIDENCE', 0), ('ANOMALY_CURIOUS_FINDING', 14), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 19), ('INCOMPLETE_EVIDENCE', 22), ('INCOMPLETE_EVIDENCE', 131), ('DIFFICULT_TASK', 138), ('SUPERFICIAL_RELATIONSHIP', 165), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 253), ('ANOMALY_CURIOUS_FINDING', 253), ('SUPERFICIAL_RELATIONSHIP', 285), ('IMPORTANT_CONSIDERATION', 298), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 317), ('INCOMPLETE_EVIDENCE', 326)]	13	[('SO_0000704', 'gene', 157, 'genetic'), ('CHEBI_72652', "7,2'-dihydroxy-4'-methoxyisoflavan-4-ylium cation", 198, '25OHD'), ('CHEBI_27300', 'vitamin D', 242, 'vitamin D'), ('CHEBI_72652', "7,2'-dihydroxy-4'-methoxyisoflavan-4-ylium cation", 372, '25OHD')]
PMC4516377	6/2015	S13-PMC4516377	['the deficiency of Micronutrients, such as Calcium and Vitamin D, is common in many countries, REGARDLESS OF the nutritional status; HOWEVER, its magnitude is greater in children with excess weight.2,5-7in this context, CONCERNS about the ASSOCIATION between Calcium intake and Serum Vitamin D and Metabolic diseases in children has gained prominence in the scientific world for at least 30 years,8and SEVERAL STUDIES HAVE ATTEMPTED to clarify the several QUESTIONS about the subject,6,9,10as the combination of low Serum 25-Hydroxyvitamin D (25 [Oh] D) and INADEQUATE Calcium Intake HAS BEEN ASSOCIATED with Cardiovascular risk factors such as hypertension, obesity, Metabolic syndrome (ms) and type 2 diabetes mellitus.2,4,5,8that is, the combined deficiency of both Nutrients DESERVE special CONSIDERATION in children.4\nHOWEVER, the RECOMMENDATIONS of Calcium and Vitamin D intake have NOT been PROPOSED for the PREVENTION of noncommunicable chronic diseases, AS the STUDIES are STILL SCARCE, INCONSISTENT and SOMETIMES of poor quality.11ALTHOUGH Vitamin D insufficiency and low Calcium intake are commonly REPORTED, LITTLE IS KNOWN about the EFFECT of these Micronutrients in the prevention and treatment of diseases such as obesity.']	[('INCOMPLETE_EVIDENCE', 94), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 132), ('PROBLEM_COMPLICATION', 219), ('SUPERFICIAL_RELATIONSHIP', 238), ('INCOMPLETE_EVIDENCE', 401), ('IMPORTANT_CONSIDERATION', 417), ('DIFFICULT_TASK', 422), ('INCOMPLETE_EVIDENCE', 422), ('EXPLICIT_QUESTION', 455), ('IMPORTANT_CONSIDERATION', 557), ('INCOMPLETE_EVIDENCE', 583), ('SUPERFICIAL_RELATIONSHIP', 592), ('IMPORTANT_CONSIDERATION', 778), ('FUTURE_WORK', 794), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 822), ('FUTURE_WORK', 835), ('ANOMALY_CURIOUS_FINDING', 888), ('INCOMPLETE_EVIDENCE', 897), ('SUPERFICIAL_RELATIONSHIP', 914), ('PROBABLE_UNDERSTANDING', 962), ('INCOMPLETE_EVIDENCE', 969), ('IMPORTANT_CONSIDERATION', 981), ('INCOMPLETE_EVIDENCE', 987), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 995), ('INCOMPLETE_EVIDENCE', 1012), ('ANOMALY_CURIOUS_FINDING', 1038), ('INCOMPLETE_EVIDENCE', 1109), ('FULL_UNKNOWN', 1119), ('SUPERFICIAL_RELATIONSHIP', 1145)]	29	[('CHEBI_33839', 'macromolecule', 18, 'micronutrients'), ('CHEBI_22313', 'alkaline earth metal atom', 42, 'calcium'), ('CHEBI_27300', 'vitamin D', 54, 'vitamin D'), ('CHEBI_22313', 'alkaline earth metal atom', 258, 'calcium'), ('UBERON_0001977', 'blood serum', 277, 'serum'), ('CHEBI_27300', 'vitamin D', 283, 'vitamin D'), ('GO_0008152', 'metabolic process', 297, 'metabolic'), ('UBERON_0001977', 'blood serum', 515, 'serum'), ('CHEBI_62218', '23,24-dihydrocucurbitacin D', 521, '25-hydroxyvitamin D'), ('CHEBI_15643', '(6R)-6-(L-erythro-1,2-dihydroxypropyl)-7,8-dihydro-6H-pterin', 542, '25 [OH] D'), ('CHEBI_22313', 'alkaline earth metal atom', 568, 'calcium'), ('GO_0007631', 'feeding behavior', 576, 'intake'), ('UBERON_0004535', 'cardiovascular system', 608, 'cardiovascular'), ('GO_0008152', 'metabolic process', 667, 'metabolic'), ('CHEBI_33284', 'nutrient', 768, 'nutrients'), ('CHEBI_22313', 'alkaline earth metal atom', 854, 'calcium'), ('CHEBI_27300', 'vitamin D', 866, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 1049, 'vitamin D'), ('CHEBI_22313', 'alkaline earth metal atom', 1081, 'calcium'), ('CHEBI_33839', 'macromolecule', 1161, 'micronutrients')]
PMC4516377	6/2015	S82-PMC4516377	['final CONSIDERATIONS\nthe ASSOCIATION between Calcium and Vitamin D with obesity is COMPLEX and much REMAINS TO BE ELUCIDATED.']	[('IMPORTANT_CONSIDERATION', 6), ('SUPERFICIAL_RELATIONSHIP', 25), ('DIFFICULT_TASK', 83), ('FULL_UNKNOWN', 100)]	4	[('CHEBI_22313', 'alkaline earth metal atom', 45, 'calcium'), ('CHEBI_27300', 'vitamin D', 57, 'vitamin D')]
PMC4586450	10/2015	S288-PMC4586450	['it PROVED IMPOSSIBLE to incorporate enough Vitamin D–containing foods to cover the RECOMMENDATIONS, implying that Vitamin D–deficient diets are LIKELY to be the norm.32\nin the mid-2000s, there was a great deal of CONTROVERSY about the nutritional content of school meals.']	[('PROBABLE_UNDERSTANDING', 3), ('DIFFICULT_TASK', 10), ('FUTURE_WORK', 83), ('PROBABLE_UNDERSTANDING', 144), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 213)]	5	[('CHEBI_27300', 'vitamin D', 43, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 114, 'vitamin D')]
PMC4586451	10/2015	S174-PMC4586451	['women reporting the most difficulty affording Food had lower intakes of energy and of most Nutrients, particularly Vitamin C, zinc, and iron, compared with those with no DIFFICULTY.']	[('DIFFICULT_TASK', 170)]	1	[('CHEBI_33290', 'food', 46, 'food'), ('CHEBI_33284', 'nutrient', 91, 'nutrients'), ('CHEBI_27300', 'vitamin D', 115, 'vitamin C')]
PMC4598849	10/2015	S15-PMC4598849	['the CONFLICTING findings MAY BE DUE TO VARIATIONS of study designs including the Gestational weeks of Vitamin D testing, the cut-point of Vitamin D, ethnicity of the study population, Genetic variation and outcome variables.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 4), ('INCOMPLETE_EVIDENCE', 25), ('PROBLEM_COMPLICATION', 32), ('DIFFICULT_TASK', 39)]	4	[('GO_0007565', 'female pregnancy', 81, 'gestational'), ('CHEBI_27300', 'vitamin D', 102, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 138, 'vitamin D'), ('SO_0000704', 'gene', 184, 'genetic')]
PMC4598849	10/2015	S76-PMC4598849	['HOWEVER, we were UNABLE TO assess the EFFECT of Vitamin D levels during early Pregnancy on fetal growth as these data are unavailable.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('DIFFICULT_TASK', 17), ('SUPERFICIAL_RELATIONSHIP', 38)]	3	[('CHEBI_27300', 'vitamin D', 48, 'vitamin D'), ('GO_0007565', 'female pregnancy', 78, 'pregnancy')]
PMC4632418	10/2015	S105-PMC4632418	['our sensitivity analyses SUGGESTED two studies [15,36] conducted in women with Vitamin D sufficiency PROBABLY CONTRIBUTED to the HETEROGENEITY.']	[('INCOMPLETE_EVIDENCE', 25), ('PROBABLE_UNDERSTANDING', 101), ('SUPERFICIAL_RELATIONSHIP', 110), ('DIFFICULT_TASK', 129)]	4	[('CHEBI_27300', 'vitamin D', 79, 'vitamin D')]
PMC4632418	10/2015	S119-PMC4632418	['besides, EARLIER STUDIES have IDENTIFIED a NUMBER OF FACTORS that INFLUENCE Serum levels of 25(Oh)D, including obesity, fat malabsorption syndrome which is UNABLE TO absorb the fat-soluble Vitamin D, medications enhancing the Catabolism of 25(Oh)D and 1,25(Oh)2D3, and so on [5].']	[('INCOMPLETE_EVIDENCE', 9), ('INCOMPLETE_EVIDENCE', 30), ('INCOMPLETE_EVIDENCE', 43), ('SUPERFICIAL_RELATIONSHIP', 53), ('SUPERFICIAL_RELATIONSHIP', 66), ('DIFFICULT_TASK', 156)]	6	[('UBERON_0001977', 'blood serum', 76, 'serum'), ('CHEBI_71657', 'versiconol acetate', 92, '25(OH)D'), ('CHEBI_27300', 'vitamin D', 189, 'vitamin D'), ('GO_0009056', 'catabolic process', 226, 'catabolism'), ('CHEBI_71657', 'versiconol acetate', 240, '25(OH)D'), ('CHEBI_73394', 'Ala-Ser', 254, '25(OH)2D3')]
PMC4934634	11/2015	S142-PMC4934634	['it SHOULD BE NOTED that OTHER STUDIES have FAILED TO CONFIRM OBSERVATIONS that lower 25(Oh)D status is ASSOCIATED with the occurrence of Preeclampsia, and it is STILL UNCLEAR WHETHER suboptimal Vitamin D status is a cause, OR an EFFECT, of preeclampsia [55,56].']	[('IMPORTANT_CONSIDERATION', 3), ('ANOMALY_CURIOUS_FINDING', 10), ('ANOMALY_CURIOUS_FINDING', 13), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 24), ('INCOMPLETE_EVIDENCE', 24), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 43), ('ANOMALY_CURIOUS_FINDING', 43), ('DIFFICULT_TASK', 43), ('INCOMPLETE_EVIDENCE', 53), ('INCOMPLETE_EVIDENCE', 61), ('SUPERFICIAL_RELATIONSHIP', 103), ('FULL_UNKNOWN', 161), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 175), ('SUPERFICIAL_RELATIONSHIP', 229)]	14	[('CHEBI_71657', 'versiconol acetate', 85, '25(OH)D'), ('GO_0007128', 'meiotic prophase I', 137, 'preeclampsia'), ('CHEBI_27300', 'vitamin D', 194, 'vitamin D')]
PMC4277121	12/2015	S186-PMC4277121	['in an ATTEMPT to prevent the developmental consequences of elevated oxidative stress, Pregnant ts65dn female Mice and their offspring were treated with a Vitamin E-enriched diet (0.002%, or tenfold lower than the amounts used in lockrow et al94).94offspring were continued on the enriched diet and tested on the mwm at 10 weeks of age.']	[('DIFFICULT_TASK', 6)]	1	[('GO_0007565', 'female pregnancy', 86, 'pregnant'), ('NCBITaxon_10088', 'Mus <genus>', 109, 'mice'), ('CHEBI_27300', 'vitamin D', 154, 'vitamin E')]
PMC4684854	12/2015	S66-PMC4684854	['many of the RECENT publications CHALLENGING the efficacy of Gestational Vitamin D sufficiency HAVE BEEN meta-analyses which ATTEMPT to synthesize diverse data from numerous observational and supplementation studies which do NOT NECESSARILY incorporate individual differences in these central DETERMINANTS.']	[('INCOMPLETE_EVIDENCE', 12), ('DIFFICULT_TASK', 32), ('INCOMPLETE_EVIDENCE', 94), ('DIFFICULT_TASK', 124), ('INCOMPLETE_EVIDENCE', 224), ('SUPERFICIAL_RELATIONSHIP', 292)]	6	[('GO_0007565', 'female pregnancy', 60, 'gestational'), ('CHEBI_27300', 'vitamin D', 72, 'vitamin D')]
PMC4684854	12/2015	S68-PMC4684854	['(i) there is wide HETEROGENEITY of studied populations with VARIATIONS in Vitamin D supplement dosing, geophysical location, social and dietary conditions, and OTHER FACTORS in studied groups [45].']	[('DIFFICULT_TASK', 18), ('DIFFICULT_TASK', 60), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 160), ('SUPERFICIAL_RELATIONSHIP', 166)]	4	[('CHEBI_27300', 'vitamin D', 74, 'vitamin D')]
PMC4684854	12/2015	S119-PMC4684854	['economic burden of Gestational Vitamin D deficiency\nthe economic IMPACT of Vitamin D deficiency as it RELATES to maternal-fetal health is DIFFICULT to objectively quantify AS INSUFFICIENT evidence has ACCUMULATED THUS FAR on the totality of short- and long-term sequelae of Vitamin D insufficiency.']	[('SUPERFICIAL_RELATIONSHIP', 65), ('SUPERFICIAL_RELATIONSHIP', 102), ('DIFFICULT_TASK', 138), ('PROBABLE_UNDERSTANDING', 172), ('INCOMPLETE_EVIDENCE', 175), ('PROBLEM_COMPLICATION', 175), ('INCOMPLETE_EVIDENCE', 201), ('INCOMPLETE_EVIDENCE', 213)]	8	[('GO_0007565', 'female pregnancy', 19, 'Gestational'), ('CHEBI_28384', 'vitamin K', 31, 'Vitamin D'), ('CHEBI_27300', 'vitamin D', 75, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 274, 'vitamin D')]
PMC4689556	12/2015	S13-PMC4689556	['conclusions\nwe FOUND NO EVIDENCE that Prenatal Vitamin D supplementation from 27 weeks Gestation to Delivery, at doses which FAILED to completely correct maternal Vitamin D deficiency, INFLUENCE overall healthcare utilisation in children in the first 3 years.']	[('INCOMPLETE_EVIDENCE', 15), ('INCOMPLETE_EVIDENCE', 21), ('DIFFICULT_TASK', 125), ('SUPERFICIAL_RELATIONSHIP', 185)]	4	[('GO_0007565', 'female pregnancy', 38, 'prenatal'), ('CHEBI_27300', 'vitamin D', 47, 'vitamin D'), ('GO_0007565', 'female pregnancy', 87, 'gestation'), ('GO_0007567', 'parturition', 100, 'delivery'), ('CHEBI_27300', 'vitamin D', 163, 'vitamin D')]
PMC4689556	12/2015	S153-PMC4689556	['first the EFFECT (or lack OF effect) of the specific timing and dose of Vitamin D used in our study CANNOT BE generalised to OTHER dosing and timing schedules.']	[('SUPERFICIAL_RELATIONSHIP', 10), ('ANOMALY_CURIOUS_FINDING', 26), ('DIFFICULT_TASK', 100), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 125)]	4	[('CHEBI_27300', 'vitamin D', 72, 'vitamin D')]
PMC4689556	12/2015	S171-PMC4689556	['a further LIMITATION of the study is its SMALL size and wide confidence intervals, SO that a small EFFECT of Prenatal Vitamin D on child healthcare utilization in the first 3 years CANNOT BE confidently EXCLUDED.']	[('INCOMPLETE_EVIDENCE', 10), ('INCOMPLETE_EVIDENCE', 41), ('PROBABLE_UNDERSTANDING', 83), ('SUPERFICIAL_RELATIONSHIP', 99), ('DIFFICULT_TASK', 181), ('INCOMPLETE_EVIDENCE', 203)]	6	[('GO_0007565', 'female pregnancy', 109, 'prenatal'), ('CHEBI_27300', 'vitamin D', 118, 'vitamin D')]
PMC4690051	12/2015	S171-PMC4690051	['the design also COULD NOT control for POTENTIAL CONFOUNDING by differences in sunscreen use, sun exposure (e.g., air pollution or outdoor lifestyles), culture, skin cover by clothing, or post-Natal Vitamin D intake via diet.']	[('DIFFICULT_TASK', 16), ('INCOMPLETE_EVIDENCE', 38), ('PROBLEM_COMPLICATION', 48)]	3	[('GO_0007567', 'parturition', 192, 'natal'), ('CHEBI_27300', 'vitamin D', 198, 'vitamin D')]
PMC4691762	12/2015	S113-PMC4691762	['restricting the trial to infants with Vitamin D deficiency would REQUIRE a smaller trial, HOWEVER it would be UNETHICAL to randomise these infants to placebo thereby not treating with Vitamin D. the use of Vitamin D supplements in the placebo group is ANOTHER POTENTIAL ISSUE HOWEVER we are collecting sufficient data regarding Feeding practices, Supplement use and sun exposure to account for this.']	[('FUTURE_WORK', 65), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 90), ('DIFFICULT_TASK', 110), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 252), ('INCOMPLETE_EVIDENCE', 260), ('PROBLEM_COMPLICATION', 270), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 276)]	7	[('CHEBI_27300', 'vitamin D', 38, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 184, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 206, 'vitamin D'), ('GO_0007631', 'feeding behavior', 328, 'feeding'), ('CHEBI_16158', 'steroid sulfate', 347, 'supplement')]
PMC4770602	1/2016	S22-PMC4770602	['[14151617] lack of adequate sunlight exposure NEEDED to synthesize Vitamin D3 in the skin, and Oral intakes that are TOO low TO meet the increased demands of Pregnancy are REASONS of epidemic deficiency of Vitamin D during Pregnancy.']	[('IMPORTANT_CONSIDERATION', 46), ('DIFFICULT_TASK', 117), ('PROBABLE_UNDERSTANDING', 172)]	3	[('CHEBI_33279', 'vitamin D5', 67, 'vitamin D3'), ('PR_000017299', 'VIP peptides', 67, 'vitamin D3'), ('UBERON_0000165', 'mouth', 95, 'oral'), ('GO_0007565', 'female pregnancy', 158, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 206, 'vitamin D'), ('GO_0007565', 'female pregnancy', 223, 'pregnancy')]
PMC4785305	3/2016	S20-PMC4785305	['results derived from Nutrient rct, specifically Vitamin D supplementation, SUFFER from several CONFOUNDING FACTORS RELATED to the baseline status, intake of OTHER Nutrients, such as calcium and proteins, and sun exposure, which are DIFFICULT to quantify accurately.']	[('IMPORTANT_CONSIDERATION', 75), ('PROBLEM_COMPLICATION', 95), ('SUPERFICIAL_RELATIONSHIP', 115), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 157), ('DIFFICULT_TASK', 232)]	5	[('CHEBI_33284', 'nutrient', 21, 'nutrient'), ('CHEBI_27300', 'vitamin D', 48, 'vitamin D'), ('CHEBI_33284', 'nutrient', 163, 'nutrients')]
PMC4785305	3/2016	S23-PMC4785305	['maternal Vitamin D status during Pregnancy\nvitamin D deficiency during Pregnancy is PREVALENT worldwide, ESPECIALLY in developing countries.8in a systematic review of 18 studies conducted in western countries during the first Trimester, white caucasian Pregnant women were found to have a mean 25(Oh)D level between 29 and 73\u2005nmol/l.9mean 25(Oh)D levels were lower in non-caucasian Pregnant women, ranging between 15.2 and 43\u2005nmol/l.9in addition to ethnicity, higher latitude was a significant predisposing FACTOR for hypovitaminosis d.9similarly, in non-western countries, more than half of the Pregnant women who were beyond their first trimester had 25(Oh)D levels below 75\u2005nmol/l; these include countries such as india,10kuwait,11pakistan12and turkey.13even lower levels (<25\u2005nmol/l) HAVE BEEN REPORTED at Delivery in saudi arabia, iran and the united arab emirates.14furthermore, immigrant women were at PARTICULAR RISK.1516an OBSERVATIONAL study from the netherlands SHOWED significantly lower 25(Oh)D levels during the first Trimester in immigrant Pregnant women (turkish, moroccan and others), compared to western participants.17\n\nASSOCIATION between maternal Vitamin D status and maternal adverse outcomes\nVitamin D insufficiency during Pregnancy is ASSOCIATED with adverse maternal outcomes such as increased risk of Gestational diabetes mellitus (gdm), preeclampsia, caesarean-section Delivery and bacterial vaginosis.18in a recent meta-analysis of observational studies, the risk of gdm was FOUND TO BE increased by 40–84% in Pregnant women with low 25(Oh)D levels, defined as <50\u2005nmol/l or <75\u2005nmol/l, DEPENDING ON the studies.19–21while Preeclampsia risk was significantly increased in Vitamin D insufficient women,22c-section rates were INCONSISTENTLY AFFECTED by Vitamin D status.23HOWEVER, THESE FINDINGS REMAIN LIMITED by the inherent BIASES of OBSERVATIONAL studies, INCONSISTENT adjustment for CONFOUNDERS, in addition to the wide HETEROGENEITY in Vitamin D assays and Vitamin D cut-offs definition.']	[('IMPORTANT_CONSIDERATION', 84), ('IMPORTANT_CONSIDERATION', 105), ('SUPERFICIAL_RELATIONSHIP', 507), ('INCOMPLETE_EVIDENCE', 788), ('IMPORTANT_CONSIDERATION', 909), ('INCOMPLETE_EVIDENCE', 932), ('INCOMPLETE_EVIDENCE', 973), ('SUPERFICIAL_RELATIONSHIP', 1139), ('SUPERFICIAL_RELATIONSHIP', 1259), ('ANOMALY_CURIOUS_FINDING', 1503), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 1615), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 1752), ('SUPERFICIAL_RELATIONSHIP', 1767), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 1796), ('INCOMPLETE_EVIDENCE', 1807), ('INCOMPLETE_EVIDENCE', 1822), ('INCOMPLETE_EVIDENCE', 1829), ('PROBLEM_COMPLICATION', 1853), ('INCOMPLETE_EVIDENCE', 1863), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 1886), ('PROBLEM_COMPLICATION', 1914), ('DIFFICULT_TASK', 1951)]	22	[('CHEBI_27300', 'vitamin D', 9, 'vitamin D'), ('GO_0007565', 'female pregnancy', 33, 'pregnancy'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 51, 'D'), ('GO_0007565', 'female pregnancy', 71, 'pregnancy'), ('GO_0009294', 'DNA mediated transformation', 226, 'trimester'), ('GO_0007565', 'female pregnancy', 253, 'pregnant'), ('CHEBI_71657', 'versiconol acetate', 294, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 294, '25(OH)D'), ('CHEBI_71657', 'versiconol acetate', 339, '25(OH)D'), ('PR_000006444', 'diacylglycerol kinase delta', 345, 'D'), ('GO_0007565', 'female pregnancy', 382, 'pregnant'), ('GO_0007565', 'female pregnancy', 596, 'pregnant'), ('CHEBI_71657', 'versiconol acetate', 653, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 653, '25(OH)D'), ('GO_0007567', 'parturition', 810, 'delivery'), ('CHEBI_71657', 'versiconol acetate', 1000, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 1000, '25(OH)D'), ('GO_0009294', 'DNA mediated transformation', 1032, 'trimester'), ('GO_0007565', 'female pregnancy', 1055, 'pregnant'), ('CHEBI_27300', 'vitamin D', 1168, 'vitamin D'), ('CHEBI_28384', 'vitamin K', 1215, 'Vitamin D'), ('GO_0007565', 'female pregnancy', 1246, 'pregnancy'), ('GO_0007565', 'female pregnancy', 1327, 'gestational'), ('GO_0007567', 'parturition', 1396, 'delivery'), ('GO_0007565', 'female pregnancy', 1538, 'pregnant'), ('CHEBI_71657', 'versiconol acetate', 1562, '25(OH)D'), ('GO_0007128', 'meiotic prophase I', 1651, 'preeclampsia'), ('CHEBI_27300', 'vitamin D', 1700, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 1779, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 1968, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 1989, 'vitamin D')]
PMC4785305	3/2016	S24-PMC4785305	["ASSOCIATION between maternal Vitamin D level and neonatal adverse outcomes\nlow maternal 25(Oh)D levels were RECENTLY LINKED to fetal programming, and were found TO be ASSOCIATED with adverse events in neonates, resulting in small for Gestational age (sga) at Birth,1923and also later on during childhood, leading to reduced muscle and bone mass in offspring at 4 and 9\u2005years.2425this MAY BE EXPLAINED by the fact that maternal Vitamin D is ESSENTIAL for fetal Musculoskeletal integrity, as it Regulates neonatal bone accrual, POSSIBLY through specific proteins that are responsible for Placental Calcium Transport.26RECENTLY, data from the southampton women's survey (sws) SHOWED that maternal 25(Oh)D level is significantly CORRELATED with Placental Amino Acid transporters Expression, that mediate the Transport Of various Nutrients to the fetus.27furthermore, maternal Vitamin D MAY INFLUENCE the fetal muscle motor Unit size, and CONSEQUENTLY muscle mass and strength after Birth.25it is NOTEWORTHY that fetal bone development is one of the PREDICTORS of peak bone mass, Adult bone Mineral content and Hip geometry, THUS CORRELATING with fracture risk later in Life.2628\n\nVitamin d replacement guidelines during Pregnancy\nthe guidelines regarding Vitamin D replacement or supplementation during Pregnancy VARY substantially."]	[('SUPERFICIAL_RELATIONSHIP', 0), ('INCOMPLETE_EVIDENCE', 108), ('SUPERFICIAL_RELATIONSHIP', 117), ('QUESTION_ANSWERED_BY_THIS_WORK', 161), ('SUPERFICIAL_RELATIONSHIP', 167), ('INCOMPLETE_EVIDENCE', 384), ('ANOMALY_CURIOUS_FINDING', 388), ('PROBABLE_UNDERSTANDING', 391), ('IMPORTANT_CONSIDERATION', 440), ('INCOMPLETE_EVIDENCE', 526), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 614), ('INCOMPLETE_EVIDENCE', 673), ('SUPERFICIAL_RELATIONSHIP', 725), ('INCOMPLETE_EVIDENCE', 882), ('SUPERFICIAL_RELATIONSHIP', 886), ('PROBABLE_UNDERSTANDING', 934), ('ANOMALY_CURIOUS_FINDING', 992), ('SUPERFICIAL_RELATIONSHIP', 1045), ('PROBABLE_UNDERSTANDING', 1120), ('SUPERFICIAL_RELATIONSHIP', 1125), ('DIFFICULT_TASK', 1309)]	21	[('CHEBI_27300', 'vitamin D', 29, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 88, '25(OH)D'), ('GO_0007565', 'female pregnancy', 234, 'gestational'), ('GO_0007567', 'parturition', 259, 'birth'), ('CHEBI_27300', 'vitamin D', 427, 'vitamin D'), ('UBERON_0002204', 'musculoskeletal system', 460, 'musculoskeletal'), ('GO_0065007', 'biological regulation', 493, 'regulates'), ('UBERON_0001987', 'placenta', 586, 'placental'), ('GO_0006816', 'calcium ion transport', 596, 'calcium transport'), ('CHEBI_71657', 'versiconol acetate', 694, '25(OH)D'), ('UBERON_0001987', 'placenta', 741, 'placental'), ('CHEBI_82880', 'N-acyltetradecaphytosphingosine', 751, 'amino acid'), ('GO_0010467', 'gene expression', 775, 'expression'), ('GO_0006415', 'translational termination', 804, 'transport of ... nutrients'), ('CHEBI_33284', 'nutrient', 825, 'nutrients'), ('CHEBI_27300', 'vitamin D', 872, 'vitamin D'), ('UBERON_0002105', 'vestibulo-auditory system', 919, 'unit'), ('GO_0007567', 'parturition', 978, 'birth'), ('UBERON_0007023', 'adult organism', 1075, 'adult'), ('CHEBI_46662', 'mineral', 1086, 'mineral'), ('UBERON_0001464', 'hip', 1106, 'hip'), ('UBERON_0000104', 'life cycle', 1165, 'life'), ('CHEBI_33229', 'vitamin (role)', 1176, 'Vitamin'), ('GO_0007565', 'female pregnancy', 1216, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 1251, 'vitamin D'), ('GO_0007565', 'female pregnancy', 1299, 'pregnancy')]
PMC4785305	3/2016	S86-PMC4785305	['Vitamin D supplementation ≤200\u2005iu daily.ii\nexclusion criteria:\n25(Oh)D level <25\u2005nmol/l, AS it would be UNETHICAL to randomise Pregnant women to the low dose of Vitamin D, and 25(Oh)D level >75\u2005nmol/l (30\u2005ng/ml), as Vitamin D supplementation with routine Prenatal multivitamins would be sufficient.']	[('PROBABLE_UNDERSTANDING', 89), ('DIFFICULT_TASK', 104)]	2	[('CHEBI_28384', 'vitamin K', 0, 'Vitamin D'), ('CHEBI_71657', 'versiconol acetate', 63, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 63, '25(OH)D'), ('GO_0007565', 'female pregnancy', 127, 'pregnant'), ('CHEBI_27300', 'vitamin D', 161, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 176, '25(OH)D'), ('PR_000006444', 'diacylglycerol kinase delta', 182, 'D'), ('CHEBI_27300', 'vitamin D', 216, 'vitamin D'), ('GO_0007565', 'female pregnancy', 255, 'prenatal')]
PMC4785305	3/2016	S174-PMC4785305	['FINDINGS from our trial, and SIMILAR TO results derived from Nutrient rcts, are PRONE to the CONFOUNDING effect of several FACTORS.52indeed, the baseline 25(Oh)D level, the dietary Intake of Vitamin D and OTHER Nutrients, such as Calcium and proteins, sun exposure and others, REMAIN IMPORTANT PREDICTORS AFFECTING the response to Vitamin D supplementation, but are very DIFFICULT to quantify accurately.']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 29), ('PROBABLE_UNDERSTANDING', 80), ('PROBLEM_COMPLICATION', 93), ('SUPERFICIAL_RELATIONSHIP', 123), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 205), ('INCOMPLETE_EVIDENCE', 277), ('IMPORTANT_CONSIDERATION', 284), ('SUPERFICIAL_RELATIONSHIP', 294), ('SUPERFICIAL_RELATIONSHIP', 305), ('DIFFICULT_TASK', 371)]	11	[('CHEBI_33284', 'nutrient', 61, 'nutrient'), ('CHEBI_72805', '2-alkyl-sn-glycero-3-phosphocholine', 157, 'OH)D'), ('GO_0007631', 'feeding behavior', 181, 'intake'), ('CHEBI_27300', 'vitamin D', 191, 'vitamin D'), ('CHEBI_33284', 'nutrient', 211, 'nutrients'), ('CHEBI_22313', 'alkaline earth metal atom', 230, 'calcium'), ('CHEBI_27300', 'vitamin D', 331, 'vitamin D')]
PMC4811441	3/2016	S31-PMC4811441	['case-control STUDIES OFTEN have INSUFFICIENT or no matching, GENERATING CONCERNS about CONFOUNDING AS VARIATIONS in Vitamin D status ASSOCIATED with season, skin pigmentation and lifestyle factors are known [15].']	[('INCOMPLETE_EVIDENCE', 13), ('PROBABLE_UNDERSTANDING', 21), ('PROBLEM_COMPLICATION', 32), ('PROBABLE_UNDERSTANDING', 61), ('PROBLEM_COMPLICATION', 72), ('PROBLEM_COMPLICATION', 87), ('PROBABLE_UNDERSTANDING', 99), ('DIFFICULT_TASK', 102), ('SUPERFICIAL_RELATIONSHIP', 133)]	9	[('CHEBI_27300', 'vitamin D', 116, 'vitamin D')]
PMC4896250	4/2016	S6132-PMC4896250	['SINCE THESE studies were very HETEROGENEOUS and the retrospective or the observational cohort studies, large randomized controlled TRIALS ARE NEEDED to determine WHETHER Vitamin D supplementation MAY BE beneficial in the PREVENTION of ar.']	[('PROBLEM_COMPLICATION', 0), ('INCOMPLETE_EVIDENCE', 6), ('DIFFICULT_TASK', 30), ('FUTURE_WORK', 131), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 162), ('INCOMPLETE_EVIDENCE', 196), ('SUPERFICIAL_RELATIONSHIP', 221)]	7	[('CHEBI_27300', 'vitamin D', 170, 'vitamin D')]
PMC4998950	4/2016	S38-PMC4998950	['indeed, diagnosed maternal Vitamin D deficiency CO-OCCURRED with such FACTORS including parental psychiatric histories10(including depression, a PROXY also for in utero exposure to Antidepressants, shown to, RATHER than the underlying disorder, increase the risk of asd),11immigration status3and disadvantageous social position.8hence, residual CONFOUNDING CANNOT BE ruled out.']	[('SUPERFICIAL_RELATIONSHIP', 48), ('IMPORTANT_CONSIDERATION', 50), ('SUPERFICIAL_RELATIONSHIP', 51), ('SUPERFICIAL_RELATIONSHIP', 70), ('SUPERFICIAL_RELATIONSHIP', 145), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 208), ('PROBLEM_COMPLICATION', 345), ('DIFFICULT_TASK', 357)]	8	[('CHEBI_27300', 'vitamin D', 27, 'vitamin D'), ('CHEBI_35475', 'non-steroidal anti-inflammatory drug', 181, 'antidepressants')]
PMC4889866	5/2016	S118-PMC4889866	['these INCONSISTENT OBSERVATIONS POINT to the COMPLICATED ROLE of Vitamin D in the Immune modulation and disease process.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 6), ('INCOMPLETE_EVIDENCE', 19), ('INCOMPLETE_EVIDENCE', 32), ('DIFFICULT_TASK', 45), ('SUPERFICIAL_RELATIONSHIP', 57)]	5	[('CHEBI_27300', 'vitamin D', 65, 'vitamin D'), ('UBERON_0002405', 'immune system', 82, 'immune')]
PMC4897157	5/2016	S148-PMC4897157	['third, we COULD NOT directly examine the RELATIONSHIP between Vitamin D status and allergic disease prevalence BECAUSE Serum Vitamin D levels were NOT RECORDED.']	[('DIFFICULT_TASK', 10), ('SUPERFICIAL_RELATIONSHIP', 41), ('PROBLEM_COMPLICATION', 111), ('ANOMALY_CURIOUS_FINDING', 147), ('FULL_UNKNOWN', 147)]	5	[('CHEBI_27300', 'vitamin D', 62, 'vitamin D'), ('UBERON_0001977', 'blood serum', 119, 'serum'), ('CHEBI_27300', 'vitamin D', 125, 'vitamin D')]
PMC4910255	6/2016	S283-PMC4910255	['the mechanisms of action are LIKELY to be MULTIFACTORIAL and follow-up REPORTS SUGGEST OTHER mechanisms such as the EFFECT of Vitamin A on Regulation of fetal Lung growth, branching and alveolarisation [67,68].']	[('PROBABLE_UNDERSTANDING', 29), ('DIFFICULT_TASK', 42), ('INCOMPLETE_EVIDENCE', 71), ('INCOMPLETE_EVIDENCE', 79), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 87), ('SUPERFICIAL_RELATIONSHIP', 116)]	6	[('CHEBI_27300', 'vitamin D', 126, 'vitamin A'), ('GO_0065007', 'biological regulation', 139, 'regulation'), ('UBERON_0002048', 'lung', 159, 'lung')]
PMC4930210	7/2016	S22-PMC4930210	['THIS REVIEW HIGHLIGHTED the extremely HETEROGENEOUS evidence in regards to definition of Serum Vitamin D concentration THRESHOLD and the LACK OF high-quality interventional studies [10].']	[('QUESTION_ANSWERED_BY_THIS_WORK', 0), ('INCOMPLETE_EVIDENCE', 12), ('DIFFICULT_TASK', 38), ('PROBABLE_UNDERSTANDING', 119), ('INCOMPLETE_EVIDENCE', 137), ('ANOMALY_CURIOUS_FINDING', 142)]	6	[('UBERON_0001977', 'blood serum', 89, 'serum'), ('CHEBI_27300', 'vitamin D', 95, 'vitamin D')]
PMC4930210	7/2016	S164-PMC4930210	['THUS, it APPEARS that ALTHOUGH winter uvr exposure MAY BE insufficient, VARIATIONS in summer sun exposure will alter fall 25(Oh)D concentration and THUS indirectly INFLUENCE winter Vitamin D levels.']	[('PROBABLE_UNDERSTANDING', 0), ('ANOMALY_CURIOUS_FINDING', 9), ('ANOMALY_CURIOUS_FINDING', 22), ('INCOMPLETE_EVIDENCE', 51), ('DIFFICULT_TASK', 72), ('PROBABLE_UNDERSTANDING', 148), ('SUPERFICIAL_RELATIONSHIP', 164)]	7	[('CHEBI_71657', 'versiconol acetate', 122, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 122, '25(OH)D'), ('CHEBI_27300', 'vitamin D', 181, 'vitamin D')]
PMC4969253	8/2016	S90-PMC4969253	['circulating levels of Vitamin A (Retinol), Retinyl Esters, or ra do NOT NECESSARILY REFLECT the Retinoid status of target cells, SINCE activation of ra signaling depends on a COMPLEX interplay of the components of this pathway, including the presence of ra-synthesizing enzymes, ra receptors (rar, rxr), co-activators/co-repressors, and ra-Metabolizing enzymes.']	[('INCOMPLETE_EVIDENCE', 68), ('SUPERFICIAL_RELATIONSHIP', 84), ('PROBABLE_UNDERSTANDING', 129), ('PROBLEM_COMPLICATION', 129), ('DIFFICULT_TASK', 175)]	5	[('CHEBI_27300', 'vitamin D', 22, 'vitamin A'), ('CHEBI_26536', 'retinoic acid', 33, 'retinol'), ('CHEBI_26523', 'reactive oxygen species', 43, 'retinyl esters'), ('CHEBI_26537', 'retinoid', 96, 'retinoid'), ('GO_0008152', 'metabolic process', 340, 'metabolizing')]
PMC4971719	8/2016	S152-PMC4971719	['the LACK OF association OBSERVED between Vitamin D level in early or late Pregnancy and the 6–8 week Postpartum bdi score MAY BE EXPLAINED by the COMPLEXITY of the pathogenesis of Postpartum depression symptoms, OR it MAY represent a TRUE negative FINDING.']	[('INCOMPLETE_EVIDENCE', 4), ('INCOMPLETE_EVIDENCE', 24), ('INCOMPLETE_EVIDENCE', 122), ('ANOMALY_CURIOUS_FINDING', 126), ('PROBABLE_UNDERSTANDING', 129), ('DIFFICULT_TASK', 146), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 212), ('INCOMPLETE_EVIDENCE', 218), ('PROBABLE_UNDERSTANDING', 234), ('INCOMPLETE_EVIDENCE', 248)]	10	[('CHEBI_27300', 'vitamin D', 41, 'vitamin D'), ('GO_0007565', 'female pregnancy', 74, 'pregnancy'), ('GO_0007565', 'female pregnancy', 101, 'postpartum'), ('GO_0007565', 'female pregnancy', 180, 'postpartum')]
PMC4979151	8/2016	S146-PMC4979151	['down-regulation of Genes in the Tcr Complex, T Cell co-stimulatory Molecules and Major Histocompatibility Complexes (T Cell Adaptive Immunity) in the vitd group SUGGESTS suppression of T Cell Signaling Pathway by Vitamin D. induction of Cd2, Cd40Lg and Il-12Rb2 Expression that are IMPORTANT in T and Nk Cell function and inflammatory responses, and down-regulation of receptors for these ligands SUGGEST balanced responses to in vivo vitd3supplementation that would be expected to mitigate MAJOR downstream effects.']	[('DIFFICULT_TASK', 36), ('INCOMPLETE_EVIDENCE', 161), ('IMPORTANT_CONSIDERATION', 282), ('INCOMPLETE_EVIDENCE', 397), ('IMPORTANT_CONSIDERATION', 491)]	5	[('SO_0000704', 'gene', 19, 'genes'), ('GO_0042101', 'T cell receptor complex', 32, 'TCR complex'), ('CL_0000084', 'T cell', 45, 'T cell'), ('CHEBI_36357', 'polyatomic entity', 67, 'molecules'), ('GO_0042611', 'MHC protein complex', 81, 'major histocompatibility complexes'), ('CL_0000084', 'T cell', 117, 'T cell'), ('GO_0002456', 'T cell mediated immunity', 117, 'T cell adaptive immunity'), ('CL_0000084', 'T cell', 185, 'T cell'), ('GO_0002770', 'T cell inhibitory signaling pathway', 185, 'T cell signaling pathway'), ('CHEBI_27300', 'vitamin D', 213, 'vitamin D'), ('PR_000001204', 'C-C chemokine receptor type 8', 237, 'CD2'), ('PR_000001309', 'CD70 molecule', 242, 'CD40LG'), ('PR_000008990', 'interleukin-1 family member 9', 253, 'IL-12RB2'), ('GO_0010467', 'gene expression', 262, 'expression'), ('CL_0000909', 'CD8-positive, alpha-beta memory T cell', 295, 'T ...'), ('CL_0000623', 'natural killer cell', 301, 'NK cell'), ('GO_0005634', 'nucleus', 301, 'NK')]
PMC4989298	8/2016	S237-PMC4989298	['NUMEROUS STUDIES have also evaluated the Intake of Vitamins (vit a, e, c) and Minerals (Mg, zn, Ca, p) [please NOTE that except for this chapter the data on Vitamin D is treated in a special section], BUT these often include methodological ERRORS, starting with the DIFFICULTY of FINDING a correct quantification of dietary Intakes of various Foods.']	[('INCOMPLETE_EVIDENCE', 0), ('IMPORTANT_CONSIDERATION', 111), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 201), ('PROBLEM_COMPLICATION', 240), ('DIFFICULT_TASK', 266), ('INCOMPLETE_EVIDENCE', 280)]	6	[('GO_0007631', 'feeding behavior', 41, 'intake'), ('CHEBI_33277', 'gamma-tocotrienol', 51, 'vitamins'), ('CHEBI_46751', 'quinolizidine', 78, 'minerals'), ('CHEBI_34829', 'Medrysone', 88, 'Mg'), ('CHEBI_32588', 'potassium chloride', 96, 'Ca'), ('CHEBI_27300', 'vitamin D', 157, 'vitamin D'), ('GO_0007631', 'feeding behavior', 324, 'intakes'), ('CHEBI_33290', 'food', 343, 'foods')]
PMC4990268	8/2016	S315-PMC4990268	['meta-analyses do not SUPPORT this intervention as a Maternal survival strategy[101,108] HOWEVER the most RECENT such analysis NOTED significant heterogeneity in trial outcomes (i2 = 52%, p = 0.04) MOST LIKELY due TO VARIATIONS in underlying population levels of Vitamin A deficiency between studies[101].']	[('INCOMPLETE_EVIDENCE', 21), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 88), ('INCOMPLETE_EVIDENCE', 105), ('ANOMALY_CURIOUS_FINDING', 126), ('PROBABLE_UNDERSTANDING', 197), ('QUESTION_ANSWERED_BY_THIS_WORK', 213), ('DIFFICULT_TASK', 216)]	7	[('GO_0007618', 'mating', 52, 'maternal'), ('CHEBI_27300', 'vitamin D', 262, 'vitamin A')]
PMC4990268	8/2016	S1184-PMC4990268	['BUT current RECOMMENDED dose imposes IMPORTANT logistical DIFFICULTIES.antenatal vitamin aroutine supplementation not indicated BUT in Vitamin A deficient populations screening for night blindness and treating such cases with Vitamin A CAN be RECOMMENDED.Postnatal vitamin abenefit expected in Vitamin A deficient populations (e.g.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('FUTURE_WORK', 12), ('IMPORTANT_CONSIDERATION', 37), ('DIFFICULT_TASK', 58), ('PROBLEM_COMPLICATION', 58), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 128), ('INCOMPLETE_EVIDENCE', 236), ('FUTURE_WORK', 243)]	8	[('CHEBI_27300', 'vitamin D', 135, 'vitamin A'), ('CHEBI_27300', 'vitamin D', 226, 'vitamin A'), ('GO_0007567', 'parturition', 255, 'Postnatal'), ('CHEBI_27300', 'vitamin D', 294, 'vitamin A')]
PMC5024513	9/2016	S157-PMC5024513	['it was NOT POSSIBLE to conduct analysis of Vitamin D status by ethnicity or exposure to sunlight, however, which are FACTORS KNOWN to have a significant IMPACT on Vitamin D status [51–53].']	[('DIFFICULT_TASK', 7), ('SUPERFICIAL_RELATIONSHIP', 117), ('INCOMPLETE_EVIDENCE', 125), ('SUPERFICIAL_RELATIONSHIP', 153)]	4	[('CHEBI_27300', 'vitamin D', 43, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 163, 'vitamin D')]
PMC5030591	9/2016	S80-PMC5030591	["caption (table-wrap): table 4\n\nthemes and elements relating to specific Conception and Pregnancy information for women with rheumatoid arthritis and their familiessaying : information that should be discussed by health professionals doing : actions that SHOULD BE undertaken by health professionals review of current Medications in relation to safety during Conception and Pregnancy (100%) prior to Conception and Pregnancy, review current Medication(s) and discuss:\nmedications vary with respect to their SAFETY during Pregnancy and RISKS related to Fertility, Ovulation, Conception and Miscarriage\nSOME Medicines used in ra care MAY have EFFECTS on Fertility, Conception and Pregnancy process, for example, regular Nsaids MAY impair fertility and ASSOCIATED RISKS with fetus\nit is IMPORTANT to time Conceptionprovide GUIDANCE as to WHERE to obtain reliable information about SAFETY of Medicines in Pregnancywhere current Medication(s) is (are) contraindicated for Conception/Pregnancy the following SHOULD BE discussed with the patient:\nthere are SAFE Medication options pre, during (including Delivery) and Postpregnancy (including Breast feeding)\ntiming is IMPORTANT in RELATION to ceasing or switching of current Medications and allowing for washout periods prior to Conception\nthere is a need for close supervision/monitoring by a rheumatologist when discontinuing current Medications prior to Pregnancy, including CONSIDERING POTENTIAL NEED for disease stabilisation on new treatment prior to Conception and Pregnancydiscuss IMPACT of ra pathology on Pregnancy and Pregnancy on ra (100%) there are DIFFERENT SCENARIOS regarding ra disease activity during Pregnancy (eg, POSSIBLE remission/low disease activity)discuss: ra-related pain management options during Pregnancyconception MAY take longer compared with women who do not have rathere is a need to balance disease Control with maternal and fetal health and safetyra MAY AFFECT Pregnancy and Pregnancy MAY AFFECT ra, and there are POSSIBLE adverse outcomes where risks are identified (eg, Prematurity)there are significant risks ASSOCIATED with active or uncontrolled ra for the mother and baby, ESPECIALLY irreversible Joint damage and functional impairmentpregnancy MAY change a patient’s health outlook in the futurethe size of the baby MAY BE smaller than women without ra and MAY also be Delivered pre-term discuss IMPORTANT elements of Preconception care RELEVANT to patient (97.1%) it is IMPORTANT to achieve optimal disease control prior to considering Pregnancy—Planning Conception is preferable after patients achieve and maintain low disease activityencourage and facilitate early discussions with all health practitioners involved in care about family planning to allow for adequate preparationthere is a CRITICAL need for a planned Pregnancy RATHER than an unplanned Pregnancyreview Prenatal nutrition, including need for dietary/vitamin supplements (ie, Folic Acid, calcium, Vitamin D, Iodine, iron)history of previous Attempts To Conceive/Pregnancies or Pregnancy-related complications (eg, Miscarriage) and other relevant patient history (such as smoking/Illicit Drug use history, family history of hereditary issues) MAY AFFECT Pregnancyundertake RELEVANT health checks such as immunisation status (eg, rubella, varicella, pertussis), Sexually Transmitted disease screening, pap test, screening for other Autoimmune disorders that MAY IMPACT on Pregnancyweight management and appropriate exercise are very IMPORTANTCONSIDER the NEED for review of diabetes or impaired Glucose tolerance if RISK factors are present (eg, on Steroid medication or overweight/obese)it is IMPORTANT to manage comorbid conditions, such as diabetes and hypertensionsome women MAY NEED to avoid Conception during a flarera disease activity MAY or MAY not improve with Pregnancy and there is a LIKELIHOOD of Postpartum flares importance of maintaining optimistic outlook and providing positive messages (97.1%) Pregnancy and Breast feeding success rates are near normal in women with mild to moderate ra nowadays (where appropriate for the patient's clinical status)ra is not a BARRIER to Pregnancystrategies to address anxiety, stress and depression (if relevant) are IMPORTANT, such as mindfulness meditation need for close monitoring of a patient prior to and during Pregnancy, where indicated (94.1%) it is IMPORTANCE to have a healthcare team with expertise in Autoimmune disorders for SOME women with radetermine THE NEED for high-level obstetric care during a Pregnancy (where indicated), including the need for Anaesthetic inputsome women REQUIRE closer monitoring of their Pregnancy and this is USUALLY proportional to disease activity, comorbidities and maternal historyassess the REQUIREMENTS for any extra treatment or monitoring prior to, or during, Pregnancyit is IMPORTANT to develop a Pregnancy plan, which includes different options for management of ra and support for different scenariosvaginal Delivery MAY NOT always BE POSSIBLE, depending on condition of the patient's Hips."]	[('FUTURE_WORK', 254), ('IMPORTANT_CONSIDERATION', 506), ('IMPORTANT_CONSIDERATION', 534), ('INCOMPLETE_EVIDENCE', 600), ('INCOMPLETE_EVIDENCE', 631), ('SUPERFICIAL_RELATIONSHIP', 640), ('INCOMPLETE_EVIDENCE', 724), ('SUPERFICIAL_RELATIONSHIP', 749), ('IMPORTANT_CONSIDERATION', 760), ('IMPORTANT_CONSIDERATION', 783), ('FUTURE_WORK', 819), ('EXPLICIT_QUESTION', 834), ('IMPORTANT_CONSIDERATION', 877), ('FUTURE_WORK', 1001), ('IMPORTANT_CONSIDERATION', 1049), ('IMPORTANT_CONSIDERATION', 1161), ('SUPERFICIAL_RELATIONSHIP', 1174), ('FUTURE_WORK', 1421), ('IMPORTANT_CONSIDERATION', 1421), ('INCOMPLETE_EVIDENCE', 1433), ('SUPERFICIAL_RELATIONSHIP', 1532), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 1605), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 1615), ('INCOMPLETE_EVIDENCE', 1677), ('INCOMPLETE_EVIDENCE', 1788), ('INCOMPLETE_EVIDENCE', 1929), ('SUPERFICIAL_RELATIONSHIP', 1933), ('INCOMPLETE_EVIDENCE', 1964), ('SUPERFICIAL_RELATIONSHIP', 1968), ('INCOMPLETE_EVIDENCE', 1993), ('SUPERFICIAL_RELATIONSHIP', 2091), ('IMPORTANT_CONSIDERATION', 2158), ('INCOMPLETE_EVIDENCE', 2230), ('INCOMPLETE_EVIDENCE', 2302), ('INCOMPLETE_EVIDENCE', 2343), ('IMPORTANT_CONSIDERATION', 2382), ('SUPERFICIAL_RELATIONSHIP', 2423), ('IMPORTANT_CONSIDERATION', 2457), ('IMPORTANT_CONSIDERATION', 2779), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 2817), ('INCOMPLETE_EVIDENCE', 3196), ('SUPERFICIAL_RELATIONSHIP', 3200), ('IMPORTANT_CONSIDERATION', 3226), ('INCOMPLETE_EVIDENCE', 3410), ('SUPERFICIAL_RELATIONSHIP', 3414), ('IMPORTANT_CONSIDERATION', 3485), ('INCOMPLETE_EVIDENCE', 3507), ('SUPERFICIAL_RELATIONSHIP', 3568), ('IMPORTANT_CONSIDERATION', 3646), ('INCOMPLETE_EVIDENCE', 3731), ('FUTURE_WORK', 3735), ('IMPORTANT_CONSIDERATION', 3735), ('INCOMPLETE_EVIDENCE', 3794), ('INCOMPLETE_EVIDENCE', 3801), ('PROBABLE_UNDERSTANDING', 3847), ('DIFFICULT_TASK', 4131), ('IMPORTANT_CONSIDERATION', 4222), ('IMPORTANT_CONSIDERATION', 4364), ('INCOMPLETE_EVIDENCE', 4444), ('INCOMPLETE_EVIDENCE', 4472), ('IMPORTANT_CONSIDERATION', 4600), ('INCOMPLETE_EVIDENCE', 4657), ('IMPORTANT_CONSIDERATION', 4744), ('IMPORTANT_CONSIDERATION', 4831), ('INCOMPLETE_EVIDENCE', 4976), ('DIFFICULT_TASK', 4980)]	66	[('GO_0007631', 'feeding behavior', 72, 'conception ...'), ('GO_0007565', 'female pregnancy', 87, 'pregnancy'), ('CHEBI_25441', 'mycothiols', 317, 'medications'), ('GO_0007620', 'copulation', 358, 'conception'), ('GO_0007565', 'female pregnancy', 373, 'pregnancy'), ('GO_0007620', 'copulation', 399, 'conception'), ('GO_0007565', 'female pregnancy', 414, 'pregnancy'), ('CHEBI_60211', 'compound Z', 440, 'medication'), ('GO_0007565', 'female pregnancy', 520, 'pregnancy'), ('GO_0009566', 'fertilization', 551, 'fertility'), ('GO_0030728', 'ovulation', 562, 'ovulation'), ('GO_0007620', 'copulation', 573, 'conception'), ('GO_0046660', 'female sex differentiation', 588, 'miscarriage'), ('CHEBI_25179', 'melanins', 605, 'medicines'), ('GO_0009566', 'fertilization', 651, 'fertility'), ('GO_0007620', 'copulation', 662, 'conception'), ('GO_0007565', 'female pregnancy', 677, 'pregnancy'), ('CHEBI_16039', 'ITP', 717, 'NSAIDs'), ('GO_0070268', 'cornification', 801, 'conceptionProvide'), ('CHEBI_25179', 'melanins', 887, 'medicines'), ('GO_0000712', 'resolution of meiotic recombination intermediates', 900, 'pregnancyWhere'), ('CHEBI_60211', 'compound Z', 923, 'medication'), ('GO_0007620', 'copulation', 966, 'conception'), ('GO_0007565', 'female pregnancy', 977, 'pregnancy'), ('CHEBI_60211', 'compound Z', 1054, 'medication'), ('GO_0007567', 'parturition', 1096, 'delivery'), ('GO_0007565', 'female pregnancy', 1110, 'postpregnancy'), ('UBERON_0000310', 'breast', 1135, 'breast'), ('CHEBI_25441', 'mycothiols', 1218, 'medications'), ('GO_0007620', 'copulation', 1272, 'conception'), ('CHEBI_25441', 'mycothiols', 1379, 'medications'), ('GO_0007565', 'female pregnancy', 1400, 'pregnancy'), ('GO_0007620', 'copulation', 1500, 'conception'), ('GO_0006915', 'apoptotic process', 1515, 'pregnancyDiscuss'), ('GO_0007565', 'female pregnancy', 1558, 'pregnancy'), ('GO_0007565', 'female pregnancy', 1572, 'pregnancy'), ('GO_0007565', 'female pregnancy', 1662, 'pregnancy'), ('GO_0007602', 'phototransduction', 1768, 'pregnancyConception'), ('GO_0065007', 'biological regulation', 1877, 'control'), ('GO_0007565', 'female pregnancy', 1940, 'pregnancy'), ('GO_0007565', 'female pregnancy', 1954, 'pregnancy'), ('GO_0007565', 'female pregnancy', 2051, 'prematurity'), ('UBERON_0004905', 'articulation', 2182, 'joint'), ('GO_0007567', 'parturition', 2355, 'delivered'), ('GO_0007565', 'female pregnancy', 2404, 'preconception'), ('GO_0007565', 'female pregnancy', 2523, 'pregnancy'), ('GO_0006260', 'DNA replication', 2533, 'planning'), ('GO_0007620', 'copulation', 2542, 'conception'), ('GO_0007565', 'female pregnancy', 2807, 'pregnancy'), ('GO_0006412', 'translation', 2842, 'pregnancyReview'), ('GO_0007565', 'female pregnancy', 2858, 'prenatal'), ('CHEBI_30751', 'formic acid', 2930, 'folic acid'), ('CHEBI_27300', 'vitamin D', 2951, 'vitamin D'), ('CHEBI_24859', 'iodine atom', 2962, 'iodine'), ('GO_0000380', 'alternative mRNA splicing, via spliceosome', 2995, 'attempts to conceive'), ('GO_0007565', 'female pregnancy', 3016, 'pregnancies'), ('GO_0007565', 'female pregnancy', 3031, 'pregnancy'), ('GO_0046660', 'female sex differentiation', 3068, 'miscarriage'), ('CHEBI_35704', 'N(2)-acetyl-L-lysine', 3133, 'illicit drug'), ('GO_0051610', 'serotonin uptake', 3207, 'pregnancyUndertake'), ('GO_0019095', 'pole plasm mitochondrial rRNA localization', 3314, 'sexually transmitted'), ('UBERON_0001442', 'skeleton of manus', 3384, 'autoimmune'), ('GO_0006412', 'translation', 3424, 'pregnancyWeight'), ('CHEBI_17234', 'glucose', 3547, 'glucose'), ('CHEBI_35341', 'steroid', 3601, 'steroid'), ('GO_0007620', 'copulation', 3749, 'conception'), ('GO_0007565', 'female pregnancy', 3822, 'pregnancy'), ('GO_0007565', 'female pregnancy', 3861, 'postpartum'), ('GO_0007565', 'female pregnancy', 3964, 'Pregnancy'), ('UBERON_0000310', 'breast', 3978, 'breast'), ('GO_0006915', 'apoptotic process', 4142, 'pregnancyStrategies'), ('GO_0007565', 'female pregnancy', 4323, 'pregnancy'), ('UBERON_0001442', 'skeleton of manus', 4419, 'autoimmune'), ('GO_0007565', 'female pregnancy', 4520, 'pregnancy'), ('CHEBI_38867', 'anaesthetic', 4572, 'anaesthetic'), ('GO_0007565', 'female pregnancy', 4635, 'pregnancy'), ('GO_0007565', 'female pregnancy', 4816, 'pregnancyIt'), ('GO_0007565', 'female pregnancy', 4854, 'pregnancy'), ('GO_0007567', 'parturition', 4967, 'delivery'), ('UBERON_0000988', 'pons', 5044, 'hips')]
PMC5051327	9/2016	S77-PMC5051327	['further, Vitamin D non-deficient women MAY have a healthier lifestyle for which we COULD NOT control.']	[('INCOMPLETE_EVIDENCE', 39), ('DIFFICULT_TASK', 83)]	2	[('CHEBI_27300', 'vitamin D', 9, 'vitamin D')]
PMC5028238	10/2016	S201-PMC5028238	["COMMENT on Vitamin D3's in-direct inhibition of Dhcr7\nOF NOTE, Vitamin D (Cholecalciferol) decreases the Dhcr7 activity through an indirect mechanism.54there HAS BEEN SOME SPECULATION on the POSSIBILITY of Teratogenic AFFECTS resulting from high doses of Vitamin D when taken as a Prenatal supplement.89HOWEVER, a RECENT REVIEW of Vitamin D supplementation among Pregnant women FOUND that Vitamin D supplementation MAY reduce the RISK of pre-eclampsia, low Birth weight, Preterm Birth90,91and adverse Kidney outcomes in offspring.92BECAUSE the mechanism of Vitamin D3's inhibition of Dhcr7 is indirect (UNLIKE our studied Pharmacological Dhcr7 Inhibitors) it is LIKELY to be MEDIATED through a COMPLEX pathway with many INTERACTING feedback loops."]	[('INCOMPLETE_EVIDENCE', 0), ('ANOMALY_CURIOUS_FINDING', 54), ('INCOMPLETE_EVIDENCE', 158), ('INCOMPLETE_EVIDENCE', 167), ('INCOMPLETE_EVIDENCE', 172), ('INCOMPLETE_EVIDENCE', 191), ('SUPERFICIAL_RELATIONSHIP', 218), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 301), ('INCOMPLETE_EVIDENCE', 314), ('INCOMPLETE_EVIDENCE', 378), ('INCOMPLETE_EVIDENCE', 415), ('IMPORTANT_CONSIDERATION', 430), ('PROBABLE_UNDERSTANDING', 530), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 603), ('PROBABLE_UNDERSTANDING', 662), ('SUPERFICIAL_RELATIONSHIP', 675), ('DIFFICULT_TASK', 694), ('SUPERFICIAL_RELATIONSHIP', 720)]	18	[('CHEBI_33279', 'vitamin D5', 11, 'vitamin D3'), ('PR_000017299', 'VIP peptides', 11, 'vitamin D3'), ('PR_000006474', 'ATP-dependent RNA helicase A', 48, 'DHCR7'), ('CHEBI_27300', 'vitamin D', 63, 'vitamin D'), ('CHEBI_52550', 'theopalauamide', 74, 'cholecalciferol'), ('PR_000006474', 'ATP-dependent RNA helicase A', 105, 'DHCR7'), ('CHEBI_50905', 'teratogenic agent', 206, 'teratogenic'), ('GO_0031649', 'heat generation', 206, 'teratogenic'), ('CHEBI_27300', 'vitamin D', 255, 'vitamin D'), ('GO_0007565', 'female pregnancy', 281, 'prenatal'), ('CHEBI_27300', 'vitamin D', 331, 'vitamin D'), ('GO_0007565', 'female pregnancy', 363, 'pregnant'), ('CHEBI_27300', 'vitamin D', 389, 'vitamin D'), ('GO_0007567', 'parturition', 457, 'birth'), ('GO_0007565', 'female pregnancy', 471, 'preterm'), ('GO_0042633', 'hair cycle', 479, 'birth90'), ('UBERON_0002113', 'kidney', 501, 'kidney'), ('CHEBI_33279', 'vitamin D5', 557, 'vitamin D3'), ('PR_000017299', 'VIP peptides', 557, 'vitamin D3'), ('PR_000006474', 'ATP-dependent RNA helicase A', 584, 'DHCR7'), ('CHEBI_52217', 'pharmaceutical', 622, 'pharmacological'), ('PR_000006474', 'ATP-dependent RNA helicase A', 638, 'DHCR7'), ('CHEBI_35222', 'inhibitor', 644, 'inhibitors')]
PMC5045784	10/2016	S13-PMC5045784	['introduction\nbronchopulmonary dysplasia (bpd) is the MOST PREVALENT long-term morbidity among surviving EXTREMELY preterm infants and has a MULTIFACTORIAL etiology.1bpd is ASSOCIATED with later risk of reactive Airways disease, such as asthma,2post neonatal mortality and adverse Neurodevelopmental outcomes.1bpd AFFECTS ~20% of preterm infants, and up to 60% of extremely preterm infants who are Born before 26 completed weeks of Gestation.2an ESTIMATED 10\u2009000 to 15\u2009000 infants are affected in the united states each year and this has substantial medical and socioeconomic IMPLICATIONS.2,3\nACCUMULATING epidemiologic EVIDENCE SUGGESTS that Vitamin D deficiency or insufficiency is ASSOCIATED with Respiratory disease in children.']	[('IMPORTANT_CONSIDERATION', 53), ('IMPORTANT_CONSIDERATION', 104), ('DIFFICULT_TASK', 140), ('SUPERFICIAL_RELATIONSHIP', 172), ('SUPERFICIAL_RELATIONSHIP', 313), ('INCOMPLETE_EVIDENCE', 445), ('IMPORTANT_CONSIDERATION', 575), ('INCOMPLETE_EVIDENCE', 592), ('INCOMPLETE_EVIDENCE', 628), ('SUPERFICIAL_RELATIONSHIP', 683)]	10	[('UBERON_0001005', 'respiratory airway', 211, 'airways'), ('GO_0007399', 'nervous system development', 280, 'neurodevelopmental'), ('GO_0007567', 'parturition', 397, 'born'), ('GO_0007565', 'female pregnancy', 431, 'gestation'), ('CHEBI_27300', 'vitamin D', 642, 'vitamin D'), ('UBERON_0001004', 'respiratory system', 699, 'respiratory')]
PMC5095257	11/2016	S86-PMC5095257	['verifying Vitamin D deficiency and aad risk by ascertaining 25 (Oh)D status in infancy, HOWEVER, will be difficult given the RARITY of the condition and the fact that diagnosis is USUALLY made in Individuals in their third to fifth decade.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 88), ('DIFFICULT_TASK', 125), ('INCOMPLETE_EVIDENCE', 180)]	3	[('CHEBI_27300', 'vitamin D', 10, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 60, '25 (OH)D'), ('NCBITaxon_1', 'root', 196, 'individuals')]
PMC5146866	12/2016	S12-PMC5146866	['assessing Vitamin D status using cb is a CHALLENGE AS the OPTIMAL level of Vitamin D in children is STILL the subject of discussion [7].']	[('DIFFICULT_TASK', 41), ('PROBABLE_UNDERSTANDING', 51), ('IMPORTANT_CONSIDERATION', 58), ('IMPORTANT_CONSIDERATION', 100)]	4	[('CHEBI_27300', 'vitamin D', 10, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 75, 'vitamin D')]
PMC5146866	12/2016	S23-PMC5146866	['DIFFERENCES in the classification [8–10] used to assess the infants’ Vitamin D status and strong DEPENDENCE of their Vitamin D pool on maternal Vitamin D levels [18] MAY BE RESPONSIBLE for the wide VARIABILITY in the REPORTED rates of Vitamin D deficiency/insufficiency in infants at Birth.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('SUPERFICIAL_RELATIONSHIP', 97), ('INCOMPLETE_EVIDENCE', 166), ('PROBABLE_UNDERSTANDING', 173), ('DIFFICULT_TASK', 198), ('INCOMPLETE_EVIDENCE', 217)]	6	[('CHEBI_27300', 'vitamin D', 69, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 117, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 144, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 235, 'vitamin D'), ('GO_0007567', 'parturition', 284, 'birth')]
PMC5155676	12/2016	S133-PMC5155676	['ALTHOUGH this Genetic information CAN enable a more COMPREHENSIVE understanding of the biochemical response to Vitamin D supplementation, the current inability to undertake genotyping on a widespread population basis means this additional information WOULD NOT ALLOW for alterations to current clinical PRACTICE regarding Vitamin D supplementation in Pregnancy.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ANOMALY_CURIOUS_FINDING', 0), ('INCOMPLETE_EVIDENCE', 34), ('PROBABLE_UNDERSTANDING', 52), ('DIFFICULT_TASK', 251), ('INCOMPLETE_EVIDENCE', 303)]	6	[('SO_0000704', 'gene', 14, 'genetic'), ('CHEBI_27300', 'vitamin D', 111, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 322, 'vitamin D'), ('GO_0007565', 'female pregnancy', 351, 'pregnancy')]
PMC5340372	3/2017	S93-PMC5340372	['ALTHOUGH a circulating level of 25(Oh)D less than 20 ng/ml is DEFINED AS Vitamin D deficiency [27,28], the mean levels MAY VARY among DIFFERENT populations [29].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('PROBABLE_UNDERSTANDING', 62), ('PROBABLE_UNDERSTANDING', 70), ('INCOMPLETE_EVIDENCE', 119), ('DIFFICULT_TASK', 123), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 134)]	6	[('CHEBI_71657', 'versiconol acetate', 32, '25(OH)D'), ('PR_000006444', 'diacylglycerol kinase delta', 38, 'D'), ('CHEBI_27300', 'vitamin D', 73, 'vitamin D')]
PMC5340372	3/2017	S107-PMC5340372	['THEREFORE, drawing CONCLUSIONS about the EFFECTS of Perinatal and Postnatal Vitamin D status from these results can be DIFFICULT.']	[('PROBABLE_UNDERSTANDING', 0), ('PROBABLE_UNDERSTANDING', 19), ('SUPERFICIAL_RELATIONSHIP', 41), ('DIFFICULT_TASK', 119)]	4	[('GO_0036268', 'swimming', 52, 'perinatal'), ('UBERON_0012101', 'perinatal stage', 52, 'perinatal'), ('GO_0007567', 'parturition', 66, 'postnatal'), ('CHEBI_27300', 'vitamin D', 76, 'vitamin D')]
PMC5340372	3/2017	S144-PMC5340372	['ALTHOUGH poor Lung function performance and an INCREASED RISK of Respiratory Tract infection were RELATED to relatively low cord Serum Vitamin D levels, FURTHER extrapolating the EFFECTS of Vitamin d on the Respiratory function of the general infant population MIGHT STILL BE DIFFICULT.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('IMPORTANT_CONSIDERATION', 47), ('SUPERFICIAL_RELATIONSHIP', 98), ('FUTURE_WORK', 153), ('SUPERFICIAL_RELATIONSHIP', 179), ('INCOMPLETE_EVIDENCE', 261), ('FUTURE_WORK', 267), ('DIFFICULT_TASK', 276)]	8	[('UBERON_0002048', 'lung', 14, 'lung'), ('UBERON_0000065', 'respiratory tract', 65, 'respiratory tract'), ('UBERON_0001977', 'blood serum', 129, 'serum'), ('CHEBI_27300', 'vitamin D', 135, 'vitamin D'), ('CHEBI_33229', 'vitamin (role)', 190, 'vitamin'), ('UBERON_0001004', 'respiratory system', 207, 'respiratory')]
PMC5405075	4/2017	S19-PMC5405075	['it SHOULD BE NOTICED that high Maternal Intake of 25(Oh)D or exceeding Vitamin D Serum levels during Pregnancy is not COMPLICATED from either hypercalcemia or hypercalciuria (16).']	[('IMPORTANT_CONSIDERATION', 3), ('ANOMALY_CURIOUS_FINDING', 13), ('DIFFICULT_TASK', 118)]	3	[('GO_0007618', 'mating', 31, 'maternal'), ('GO_0007631', 'feeding behavior', 40, 'intake'), ('CHEBI_71657', 'versiconol acetate', 50, '25(OH)D'), ('CHEBI_27300', 'vitamin D', 71, 'vitamin D'), ('UBERON_0001977', 'blood serum', 81, 'serum'), ('GO_0007565', 'female pregnancy', 101, 'pregnancy')]
PMC5405075	4/2017	S56-PMC5405075	['still, the ASSOCIATION of Vitamin D with asthma, AMBIGUOUSLY emerged from observational studies, COULD NOT be confirmed and established AS a causative FACTOR.']	[('SUPERFICIAL_RELATIONSHIP', 11), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 49), ('DIFFICULT_TASK', 97), ('PROBABLE_UNDERSTANDING', 136), ('SUPERFICIAL_RELATIONSHIP', 151)]	5	[('CHEBI_27300', 'vitamin D', 26, 'vitamin D')]
PMC5405075	4/2017	S84-PMC5405075	['THEREFORE, it remains to be answered IF a real cause-effect RELATIONSHIP exists OR Vitamin D exerts a PROTECTIVE ROLE via OTHER UNDERLYING mechanisms of this MULTIFACTORIAL disease, such as Lung function or protection against Viral infections.']	[('PROBABLE_UNDERSTANDING', 0), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 37), ('SUPERFICIAL_RELATIONSHIP', 60), ('SUPERFICIAL_RELATIONSHIP', 102), ('SUPERFICIAL_RELATIONSHIP', 113), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 122), ('SUPERFICIAL_RELATIONSHIP', 128), ('DIFFICULT_TASK', 158)]	8	[('CHEBI_27300', 'vitamin D', 83, 'vitamin D'), ('UBERON_0002048', 'lung', 190, 'lung'), ('NCBITaxon_1', 'root', 226, 'viral')]
PMC5405075	4/2017	S92-PMC5405075	['IRREFUTABLY, both entities of asthma and Vitamin D deficiency are MULTIFACTORIAL.']	[('ANOMALY_CURIOUS_FINDING', 0), ('ANOMALY_CURIOUS_FINDING', 0), ('DIFFICULT_TASK', 66)]	3	[('CHEBI_27300', 'vitamin D', 41, 'vitamin D')]
PMC5405075	4/2017	S93-PMC5405075	['a plethora of environmental and Genetic/epigenetic FACTORS CONTRIBUTE in a COMPLEX manner to a PARTLY understood pathogenesis, WHILE the shifted Vitamin D Metabolism during Pregnancy is also NOT FULLY ELUCIDATED.']	[('SUPERFICIAL_RELATIONSHIP', 51), ('SUPERFICIAL_RELATIONSHIP', 59), ('DIFFICULT_TASK', 75), ('INCOMPLETE_EVIDENCE', 95), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 127), ('INCOMPLETE_EVIDENCE', 191)]	6	[('SO_0000704', 'gene', 32, 'genetic'), ('CHEBI_27300', 'vitamin D', 145, 'vitamin D'), ('GO_0042359', 'vitamin D metabolic process', 145, 'vitamin D metabolism'), ('GO_0007565', 'female pregnancy', 173, 'pregnancy')]
PMC5418719	5/2017	S101-PMC5418719	['preterm infants with radiologic evidence of rickets or high alkaline phosphatase (>800\xa0iu/l) are GENERALLY given the upper intake total of 800\xa0iu/day of Vitamin D. DESPITE Vitamin D supplementation, it is DIFFICULT to maintain the RECOMMENDED daily Vitamin D intake from dietary in preterm infants, and there are FEW EVIDENCE-based data to support Vitamin D supplementation to meet a desired Serum 25(Oh)D ACCORDING to Vitamin D status at Birth in preterm infants.']	[('PROBABLE_UNDERSTANDING', 97), ('ANOMALY_CURIOUS_FINDING', 164), ('DIFFICULT_TASK', 205), ('FUTURE_WORK', 231), ('INCOMPLETE_EVIDENCE', 313), ('SUPERFICIAL_RELATIONSHIP', 406)]	6	[('CHEBI_27300', 'vitamin D', 153, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 172, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 249, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 348, 'vitamin D'), ('UBERON_0001977', 'blood serum', 392, 'serum'), ('CHEBI_71657', 'versiconol acetate', 398, '25(OH)D'), ('PR_000012046', 'oxysterol-binding protein-related protein 11', 401, 'OH ... D'), ('CHEBI_27300', 'vitamin D', 419, 'vitamin D'), ('GO_0007567', 'parturition', 439, 'birth')]
PMC5513133	7/2017	S145-PMC5513133	['ALTHOUGH these STUDIES FIND an inverse ASSOCIATION between Vitamin D levels and pe, this ASSOCIATION MAY BE CONFOUNDED by the Gestational age at Serum collection.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ANOMALY_CURIOUS_FINDING', 0), ('INCOMPLETE_EVIDENCE', 15), ('INCOMPLETE_EVIDENCE', 23), ('SUPERFICIAL_RELATIONSHIP', 39), ('SUPERFICIAL_RELATIONSHIP', 89), ('INCOMPLETE_EVIDENCE', 101), ('DIFFICULT_TASK', 108)]	8	[('CHEBI_27300', 'vitamin D', 59, 'vitamin D'), ('GO_0007565', 'female pregnancy', 126, 'gestational'), ('UBERON_0001977', 'blood serum', 145, 'serum')]
PMC5513133	7/2017	S186-PMC5513133	['SUGGESTED that EARLIER STUDIES have measured total 25(Oh)D AS a Vitamin D/Vitamin D binding protein (vdp) Complex, and not the free vitamin.']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 15), ('PROBABLE_UNDERSTANDING', 59), ('DIFFICULT_TASK', 106)]	4	[('CHEBI_71657', 'versiconol acetate', 51, '25(OH)D'), ('CHEBI_27300', 'vitamin D', 64, 'vitamin D'), ('CHEBI_28384', 'vitamin K', 74, 'Vitamin D'), ('PR_000017319', 'vacuolar protein sorting-associated protein 13A', 74, 'Vitamin D'), ('GO_0032991', 'protein-containing complex', 106, 'complex')]
PMC5513133	7/2017	S221-PMC5513133	['maternal dietary intake of Vitamin D from Foods or supplements MAY also VARY.']	[('INCOMPLETE_EVIDENCE', 63), ('DIFFICULT_TASK', 72)]	2	[('CHEBI_27300', 'vitamin D', 27, 'vitamin D'), ('CHEBI_33290', 'food', 42, 'foods')]
PMC5513133	7/2017	S223-PMC5513133	['the use of cod Liver oil as a Food supplement in some diets presents a CHALLENGE in determining an isolated EFFECT of Vitamin D supplementation.']	[('DIFFICULT_TASK', 71), ('SUPERFICIAL_RELATIONSHIP', 108)]	2	[('UBERON_0002107', 'liver', 15, 'liver'), ('CHEBI_33290', 'food', 30, 'food'), ('CHEBI_27300', 'vitamin D', 118, 'vitamin D')]
PMC5513133	7/2017	S231-PMC5513133	['the ROLE of Fish Oils in pe REMAINS UNCERTAIN and SIMILARLY poses a CHALLENGE in determining an isolated EFFECT of Vitamin D supplementation, UNLESS studies are designed such that they CONSIDER this.']	[('SUPERFICIAL_RELATIONSHIP', 4), ('INCOMPLETE_EVIDENCE', 28), ('FULL_UNKNOWN', 36), ('SUPERFICIAL_RELATIONSHIP', 50), ('DIFFICULT_TASK', 68), ('SUPERFICIAL_RELATIONSHIP', 105), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 142), ('FUTURE_WORK', 142), ('INCOMPLETE_EVIDENCE', 185)]	9	[('CHEBI_39279', 'halomethane', 12, 'fish oils'), ('CHEBI_27300', 'vitamin D', 115, 'vitamin D')]
PMC5513133	7/2017	S237-PMC5513133	['additionally, investigators SHOULD ATTEMPT to assess Preconception and early Pregnancy dietary intake, sun exposure or baseline Vitamin D status.']	[('FUTURE_WORK', 28), ('DIFFICULT_TASK', 35)]	2	[('GO_0007565', 'female pregnancy', 53, 'preconception'), ('GO_0007565', 'female pregnancy', 77, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 128, 'vitamin D')]
PMC5524288	7/2017	S18-PMC5524288	['Serum 25(Oh)D concentration captures the EFFECT of multiple Vitamin D input sources (Supplement, sun, and Food) and makes provision for inter-individual VARIABILITY in dose response [11].']	[('SUPERFICIAL_RELATIONSHIP', 41), ('DIFFICULT_TASK', 153)]	2	[('UBERON_0001977', 'blood serum', 0, 'Serum'), ('CHEBI_71657', 'versiconol acetate', 6, '25(OH)D'), ('PR_000008838', 'serine protease HTRA1', 6, '25(OH ... D'), ('CHEBI_27300', 'vitamin D', 60, 'vitamin D'), ('CHEBI_16158', 'steroid sulfate', 85, 'supplement'), ('CHEBI_33290', 'food', 106, 'food')]
PMC5524288	7/2017	S126-PMC5524288	['additionally, using Serum 25(Oh)D concentration is a BETTER INDICATOR of Vitamin D status and statistically more powerful than using reported Intake BECAUSE it ACCOUNTS FOR all Vitamin D input sources (sun exposure, Food, and Supplements) and makes provision for inter-Individual VARIABILITY in Vitamin D dose response.']	[('PROBABLE_UNDERSTANDING', 53), ('SUPERFICIAL_RELATIONSHIP', 60), ('PROBABLE_UNDERSTANDING', 149), ('INCOMPLETE_EVIDENCE', 160), ('DIFFICULT_TASK', 280)]	5	[('UBERON_0001977', 'blood serum', 20, 'serum'), ('CHEBI_71657', 'versiconol acetate', 26, '25(OH)D'), ('PR_000011040', 'nuclear receptor coactivator 1', 28, '(OH'), ('PR_000006444', 'diacylglycerol kinase delta', 32, 'D'), ('CHEBI_27300', 'vitamin D', 73, 'vitamin D'), ('GO_0007631', 'feeding behavior', 142, 'intake'), ('CHEBI_27300', 'vitamin D', 177, 'vitamin D'), ('CHEBI_33290', 'food', 216, 'food'), ('CHEBI_33341', 'titanium atom', 226, 'supplements'), ('NCBITaxon_1', 'root', 269, 'individual'), ('CHEBI_27300', 'vitamin D', 295, 'vitamin D')]
PMC5524288	7/2017	S127-PMC5524288	['a LIMITATION of THIS STUDY was that nearly two-thirds of the women (63%) had ONLY one 25(Oh)D test during Pregnancy, which PROHIBITED assessment by Trimester and a more thorough analysis of Vitamin D BENEFIT among those with low initial levels.']	[('INCOMPLETE_EVIDENCE', 2), ('QUESTION_ANSWERED_BY_THIS_WORK', 16), ('INCOMPLETE_EVIDENCE', 77), ('DIFFICULT_TASK', 123), ('IMPORTANT_CONSIDERATION', 200)]	5	[('CHEBI_71657', 'versiconol acetate', 86, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 86, '25(OH)D'), ('GO_0007565', 'female pregnancy', 106, 'pregnancy'), ('GO_0009294', 'DNA mediated transformation', 148, 'trimester'), ('CHEBI_27300', 'vitamin D', 190, 'vitamin D')]
PMC5537904	7/2017	S150-PMC5537904	['IT IS POSSIBLE that the differential ASSOCIATIONS between 25(Oh)D and Birthweight according to maternal bmi we OBSERVED are DUE TO VARIATIONS in overall energy intake or OTHER nutritional factors that are concomitant with increased Vitamin D intake and THUS increased 25(Oh)D levels.']	[('INCOMPLETE_EVIDENCE', 0), ('SUPERFICIAL_RELATIONSHIP', 37), ('INCOMPLETE_EVIDENCE', 111), ('PROBLEM_COMPLICATION', 124), ('DIFFICULT_TASK', 131), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 170), ('PROBABLE_UNDERSTANDING', 253)]	7	[('CHEBI_71657', 'versiconol acetate', 58, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 58, '25(OH)D'), ('GO_0007596', 'blood coagulation', 70, 'birthweight'), ('CHEBI_27300', 'vitamin D', 232, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 268, '25(OH)D')]
PMC5537904	7/2017	S171-PMC5537904	['IT IS POSSIBLE that VARIATIONS in absorption and specific sources of Vitamin D (D2Versus D3) ACCOUNT FOR our differing ESTIMATE, and THUS should be INTERPRETED with caution.']	[('INCOMPLETE_EVIDENCE', 0), ('DIFFICULT_TASK', 20), ('PROBABLE_UNDERSTANDING', 93), ('INCOMPLETE_EVIDENCE', 119), ('PROBABLE_UNDERSTANDING', 133), ('FULL_UNKNOWN', 148)]	6	[('CHEBI_27300', 'vitamin D', 69, 'vitamin D'), ('PR_000006770', 'cytoplasmic dynein 1 heavy chain 1', 80, 'D2versus D3')]
PMC5664622	9/2017	S15-PMC5664622	['AS dietary sources of Vitamin D have FAILED to meet the RECOMMENDED levels for years [12,13], Vitamin D concentration is in fact enhanced by supplementation and exposure to sunlight [2,5].']	[('PROBABLE_UNDERSTANDING', 0), ('DIFFICULT_TASK', 37), ('FUTURE_WORK', 56)]	3	[('CHEBI_27300', 'vitamin D', 22, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 94, 'vitamin D')]
PMC5664622	9/2017	S102-PMC5664622	['THUS, it SEEMS IMPOSSIBLE for it to ever become a significant source of Vitamin D, especially in light of exaggerated media REPORTS on chemical Pollutants absorbed by the fish.']	[('PROBABLE_UNDERSTANDING', 0), ('ANOMALY_CURIOUS_FINDING', 9), ('DIFFICULT_TASK', 15), ('INCOMPLETE_EVIDENCE', 124)]	4	[('CHEBI_27300', 'vitamin D', 72, 'vitamin D'), ('CHEBI_26199', 'polyprenol', 144, 'pollutants')]
PMC5706533	11/2017	S76-PMC5706533	['there was substantial clinical and methodological heterogeneity between trials (table 1), including wide VARIATION in baseline maternal Vitamin D status (fig 3; table b in Appendix 5).']	[('DIFFICULT_TASK', 105)]	1	[('CHEBI_27300', 'vitamin D', 136, 'vitamin D'), ('UBERON_0001154', 'vermiform appendix', 172, 'appendix')]
PMC5706533	11/2017	S146-PMC5706533	['although data COULD BE statistically pooled for several outcomes, irreconcilable heterogeneity between trials (such as variable baseline Vitamin D status) rendered most inferences DIFFICULT to interpret or apply.']	[('INCOMPLETE_EVIDENCE', 14), ('DIFFICULT_TASK', 180)]	2	[('CHEBI_27300', 'vitamin D', 137, 'vitamin D')]
PMC5706533	11/2017	S159-PMC5706533	['the INTERPRETATION of Micronutrient intervention trials, HOWEVER, is COMPLEX BECAUSE all Individuals have some Vitamin D intake or Endogenous production.35the EFFECT of a given dose depends on the difference between the intervention and control doses (or the difference in mean 25(Oh)D in the intervention versus control group at/near delivery) as well as baseline Vitamin D status.']	[('INCOMPLETE_EVIDENCE', 4), ('PROBABLE_UNDERSTANDING', 4), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 57), ('DIFFICULT_TASK', 69), ('PROBABLE_UNDERSTANDING', 77), ('SUPERFICIAL_RELATIONSHIP', 159)]	6	[('CHEBI_33962', 'mu4-sulfido-quadro-tetracopper(6+)', 22, 'micronutrient'), ('NCBITaxon_1', 'root', 89, 'individuals'), ('CHEBI_27300', 'vitamin D', 111, 'vitamin D'), ('GO_0009790', 'embryo development', 131, 'endogenous'), ('CHEBI_71657', 'versiconol acetate', 278, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 278, '25(OH)D'), ('CHEBI_27300', 'vitamin D', 365, 'vitamin D')]
PMC5707701	11/2017	S177-PMC5707701	['HOWEVER, our results INDICATED that neither Vitamin A nor E intakes from one 24-h dietary Recall was associated with Vitamin A and E in Human milk, which MAY BE DUE TO the inherent Intake variability of one single 24-h dietary Recall questionnaire, which DID NOT ALLOW for estimations of an Individual’s usual diet, and THEREFORE, it is LIKELY to under- OR overestimate some Nutrient intakes.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 21), ('INCOMPLETE_EVIDENCE', 154), ('PROBLEM_COMPLICATION', 161), ('DIFFICULT_TASK', 255), ('ANOMALY_CURIOUS_FINDING', 259), ('PROBABLE_UNDERSTANDING', 320), ('PROBABLE_UNDERSTANDING', 337), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 354)]	9	[('CHEBI_27300', 'vitamin D', 44, 'vitamin A'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 58, 'E'), ('GO_0060033', 'anatomical structure regression', 90, 'recall'), ('CHEBI_27300', 'vitamin D', 117, 'vitamin A'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 131, 'E'), ('NCBITaxon_9606', 'Homo sapiens', 136, 'human'), ('GO_0007631', 'feeding behavior', 181, 'intake'), ('GO_0060033', 'anatomical structure regression', 227, 'recall'), ('NCBITaxon_1', 'root', 291, 'individual'), ('CHEBI_33284', 'nutrient', 375, 'nutrient')]
PMC5707701	11/2017	S184-PMC5707701	['thirdly, SINCE our design was a cross-sectional study, we COULD NOT collect DIRECT EVIDENCE about changes in Vitamins A and E with Lactation stages.']	[('PROBLEM_COMPLICATION', 9), ('DIFFICULT_TASK', 58), ('ANOMALY_CURIOUS_FINDING', 64), ('INCOMPLETE_EVIDENCE', 76), ('INCOMPLETE_EVIDENCE', 83)]	5	[('CHEBI_27300', 'vitamin D', 109, 'vitamins A'), ('PR_000004480', 'V-type proton ATPase catalytic subunit A', 109, 'vitamins A'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 124, 'E'), ('GO_0007595', 'lactation', 131, 'lactation')]
PMC5707701	11/2017	S187-PMC5707701	['indeed, our results SHOWED that all of these milks, except for colostrum, did not meet an infant’s nutritional REQUIREMENT of Vitamin E. HOWEVER, we COULD NOT ESTIMATE the POSSIBLE supply of Vitamin A to the infant in the present study, DUE TO the LACKING detection of Retinol in Human milk.']	[('INCOMPLETE_EVIDENCE', 20), ('IMPORTANT_CONSIDERATION', 111), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 137), ('DIFFICULT_TASK', 149), ('INCOMPLETE_EVIDENCE', 155), ('INCOMPLETE_EVIDENCE', 172), ('PROBLEM_COMPLICATION', 237), ('FULL_UNKNOWN', 248)]	8	[('CHEBI_27300', 'vitamin D', 126, 'vitamin E'), ('CHEBI_27300', 'vitamin D', 191, 'vitamin A'), ('CHEBI_26536', 'retinoic acid', 269, 'retinol'), ('NCBITaxon_9606', 'Homo sapiens', 280, 'human')]
PMC5732505	12/2017	S148-PMC5732505	['furthermore, SOME of these FACTORS are RELATED to or CO-EXIST with POOR Vitamin D status [24,25], which further increases the CHALLENGE when dissecting INDEPENDENT EFFECT.']	[('INCOMPLETE_EVIDENCE', 13), ('SUPERFICIAL_RELATIONSHIP', 27), ('SUPERFICIAL_RELATIONSHIP', 39), ('SUPERFICIAL_RELATIONSHIP', 53), ('IMPORTANT_CONSIDERATION', 67), ('DIFFICULT_TASK', 126), ('SUPERFICIAL_RELATIONSHIP', 152), ('SUPERFICIAL_RELATIONSHIP', 164)]	8	[('CHEBI_27300', 'vitamin D', 72, 'vitamin D')]
PMC5732505	12/2017	S166-PMC5732505	['a CHALLENGE in PREVIOUS STUDIES on Vitamin D status and gdm HAS BEEN the LACK OF RELEVANT adjustments, for example adjustments for bmi and smoking status [6].']	[('DIFFICULT_TASK', 2), ('INCOMPLETE_EVIDENCE', 15), ('INCOMPLETE_EVIDENCE', 60), ('PROBLEM_COMPLICATION', 73), ('IMPORTANT_CONSIDERATION', 81)]	5	[('CHEBI_27300', 'vitamin D', 35, 'vitamin D')]
PMC5732505	12/2017	S168-PMC5732505	['the threshold for DEFINING Vitamin D deficiency and the diagnostic criteria for gdm VARY between STUDIES, which MIGHT AFFECT the results and COMPLICATE the comparison of STUDIES.']	[('INCOMPLETE_EVIDENCE', 18), ('DIFFICULT_TASK', 84), ('INCOMPLETE_EVIDENCE', 97), ('INCOMPLETE_EVIDENCE', 112), ('SUPERFICIAL_RELATIONSHIP', 118), ('DIFFICULT_TASK', 141), ('INCOMPLETE_EVIDENCE', 170)]	7	[('CHEBI_27300', 'vitamin D', 27, 'vitamin D')]
PMC5941617	5/2018	S49-PMC5941617	['the measurement of 25(Oh)D is DIFFICULT DUE TO its lipophilic nature, the binding to Vitamin D binding protein, the DIFFERENT circulating forms that also include epimers and isobars, and the standardization.']	[('DIFFICULT_TASK', 30), ('PROBLEM_COMPLICATION', 40), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 116)]	3	[('CHEBI_71657', 'versiconol acetate', 19, '25(OH)D'), ('CHEBI_27300', 'vitamin D', 85, 'vitamin D')]
PMC5941617	5/2018	S91-PMC5941617	['in italy children are UNABLE TO synthesize Vitamin D in the skin during late fall, winter months and early spring, EVEN if sufficiently exposed to sunlight [50].']	[('DIFFICULT_TASK', 22), ('ANOMALY_CURIOUS_FINDING', 115)]	2	[('CHEBI_27300', 'vitamin D', 43, 'vitamin D')]
PMC5941617	5/2018	S129-PMC5941617	['we RECOMMEND against using Vitamin D Metabolites and their analogs (Calcifediol, Alfacalcidol, Calcitriol, and Dihydrotachysterol) for the routine Vitamin D supplementation, as the administration of these Compounds increases the RISK of hypercalcemia and is NOT ABLE to maintain and/or restore Vitamin D stores [118,119].']	[('FUTURE_WORK', 3), ('IMPORTANT_CONSIDERATION', 229), ('DIFFICULT_TASK', 258)]	3	[('CHEBI_27300', 'vitamin D', 27, 'vitamin D'), ('CHEBI_25212', 'metabolite', 37, 'metabolites'), ('CHEBI_22975', 'cadinane sesquiterpenoid', 68, 'calcifediol'), ('CHEBI_31186', 'alfacalcidol', 81, 'alfacalcidol'), ('CHEBI_17823', 'calcitriol', 95, 'calcitriol'), ('CHEBI_4657', 'disopyramide', 111, 'dihydrotachysterol'), ('CHEBI_27300', 'vitamin D', 147, 'vitamin D'), ('CHEBI_36357', 'polyatomic entity', 205, 'compounds'), ('CHEBI_27300', 'vitamin D', 294, 'vitamin D')]
PMC5941617	5/2018	S160-PMC5941617	['VARIOUS STUDIES evaluated DIFFERENT regimens of Vitamin D supplementation, BUT comparison of results is COMPLEX DUE TO HETEROGENEITY in Vitamin D administration (dose, interval, and length of supplementation) and population enrolled (age, gender, ethnicity, body mass index, latitude of the country of residence, season of enrolment, and basal Vitamin D status).']	[('INCOMPLETE_EVIDENCE', 0), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 26), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 75), ('PROBLEM_COMPLICATION', 75), ('DIFFICULT_TASK', 104), ('PROBLEM_COMPLICATION', 112), ('DIFFICULT_TASK', 119)]	7	[('CHEBI_27300', 'vitamin D', 48, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 136, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 344, 'vitamin D')]
PMC5941617	5/2018	S174-PMC5941617	['following the publication of sacn review of the EVIDENCE on Vitamin D and health [25], public health england advised that uk children aged 1 to 4\xa0years should receive Vitamin D supplementation at 400\xa0iu/day, and older children and adolescents SHOULD take a daily supplement containing 400\xa0iu of Vitamin D in autumn and winter to PROTECT bone and muscle health because it is DIFFICULT to meet this intake from dietary sources.']	[('INCOMPLETE_EVIDENCE', 48), ('FUTURE_WORK', 243), ('SUPERFICIAL_RELATIONSHIP', 329), ('DIFFICULT_TASK', 374)]	4	[('CHEBI_27300', 'vitamin D', 60, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 167, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 295, 'vitamin D')]
PMC5941617	5/2018	S192-PMC5941617	['caption (table-wrap): table 7\n\nrisk factors for Vitamin D deficiency between 1 and 18\xa0years of age• non-caucasian ethnicity with dark skin pigmentation• reduced sunlight exposure (due to lifestyle factors, chronic illness or hospitalization, COMPLEX disability, institutionalization, covering clothing for religious or cultural reasons) and/or constant use of sunscreens• international adoption• obesity• inadequate diets (i.e.']	[('DIFFICULT_TASK', 242)]	1	[('CHEBI_27300', 'vitamin D', 48, 'vitamin D')]
PMC5941617	5/2018	S197-PMC5941617	['indeed, Serum 25(Oh)D evaluation SHOULD BE reserved to subjects AT RISK for Vitamin D deficiency, BUT INDICATIONS for 25(Oh)D measurement significantly VARY among different societies (table\xa08) [9,11,13,15,20–23,27,30].']	[('FUTURE_WORK', 33), ('IMPORTANT_CONSIDERATION', 64), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 98), ('INCOMPLETE_EVIDENCE', 102), ('DIFFICULT_TASK', 152)]	5	[('UBERON_0001977', 'blood serum', 8, 'serum'), ('CHEBI_71657', 'versiconol acetate', 14, '25(OH)D'), ('CHEBI_27300', 'vitamin D', 76, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 118, '25(OH)D')]
PMC5941617	5/2018	S257-PMC5941617	['results of these studies are HETEROGENEOUS, because SOME DEMONSTRATED that Vitamin D status was significantly RELATED to bone mass [41,42,54,206–208] WHILE others DID NOT FIND any association [44,209–211].']	[('DIFFICULT_TASK', 29), ('INCOMPLETE_EVIDENCE', 52), ('INCOMPLETE_EVIDENCE', 57), ('SUPERFICIAL_RELATIONSHIP', 110), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 150), ('INCOMPLETE_EVIDENCE', 163)]	6	[('CHEBI_27300', 'vitamin D', 75, 'vitamin D')]
PMC5941617	5/2018	S284-PMC5941617	['Extraskeletal actions of Vitamin D\n\nrespiratory infections\nVitamin D has COMPLEX immunoregolatory properties, exerted by Modulating both Innate and Adaptive Immunity and Regulating the inflammatory Response.']	[('DIFFICULT_TASK', 73)]	1	[('UBERON_0001431', 'distal carpal bone 2', 0, 'Extraskeletal'), ('CHEBI_27300', 'vitamin D', 25, 'vitamin D'), ('CHEBI_28384', 'vitamin K', 59, 'Vitamin D'), ('GO_0065007', 'biological regulation', 121, 'modulating'), ('GO_0007631', 'feeding behavior', 137, 'innate ...'), ('GO_0051866', 'general adaptation syndrome', 148, 'adaptive immunity'), ('GO_0065007', 'biological regulation', 170, 'regulating'), ('GO_0060033', 'anatomical structure regression', 198, 'response')]
PMC5941617	5/2018	S344-PMC5941617	['moreover, a large meta-analysis FAILED TO demonstrate that Vitamin D supplementation MAY BE beneficial in children with tubercular infection [300].']	[('ANOMALY_CURIOUS_FINDING', 32), ('DIFFICULT_TASK', 32), ('INCOMPLETE_EVIDENCE', 85)]	3	[('CHEBI_27300', 'vitamin D', 59, 'vitamin D')]
PMC5941617	5/2018	S405-PMC5941617	['furthermore, the use of Vitamin D supplementation for primary PREVENTION of allergic diseases REMAINS an attractive AREA OF STUDY, BUT CURRENT KNOWLEDGE and EVIDENCE DOES NOT ALLOW to RECOMMEND it in routine use.']	[('SUPERFICIAL_RELATIONSHIP', 62), ('INCOMPLETE_EVIDENCE', 94), ('FUTURE_WORK', 116), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 131), ('INCOMPLETE_EVIDENCE', 135), ('INCOMPLETE_EVIDENCE', 157), ('DIFFICULT_TASK', 166), ('FUTURE_WORK', 184)]	8	[('CHEBI_27300', 'vitamin D', 24, 'vitamin D')]
PMC5941617	5/2018	S431-PMC5941617	['ALTHOUGH SOME SUGGESTIVE and encouraging data on epidemiological observational studies and pilot clinical studies of intervention, the LACK OF EVIDENCE deriving by rcts DOES NOT ALLOW to ENCOURAGE treatment with Cholecalciferol or other Vitamin D Metabolites in patients with t1dm or subjects at higher RISK.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ANOMALY_CURIOUS_FINDING', 0), ('INCOMPLETE_EVIDENCE', 9), ('INCOMPLETE_EVIDENCE', 14), ('INCOMPLETE_EVIDENCE', 135), ('DIFFICULT_TASK', 169), ('FUTURE_WORK', 187), ('IMPORTANT_CONSIDERATION', 303)]	8	[('CHEBI_52550', 'theopalauamide', 212, 'cholecalciferol'), ('CHEBI_27300', 'vitamin D', 237, 'vitamin D'), ('CHEBI_25212', 'metabolite', 247, 'metabolites')]
PMC5941617	5/2018	S436-PMC5941617	['the etiology of Vitamin D deficiency in patients with ibd is MULTIFACTORIAL and not entirely known.']	[('DIFFICULT_TASK', 61)]	1	[('CHEBI_27300', 'vitamin D', 16, 'vitamin D')]
PMC5941617	5/2018	S626-PMC5941617	['the administration of these Compounds increases the RISK of hypercalcemia and is NOT ABLE to maintain and/or restore Vitamin D stores.']	[('IMPORTANT_CONSIDERATION', 52), ('DIFFICULT_TASK', 81)]	2	[('CHEBI_36357', 'polyatomic entity', 28, 'compounds'), ('CHEBI_27300', 'vitamin D', 117, 'vitamin D')]
PMC5941617	5/2018	S645-PMC5941617	['the administration of these Compounds increases the RISK of hypercalcemia and is NOT ABLE to maintain and/or restore Vitamin D stores.']	[('IMPORTANT_CONSIDERATION', 52), ('DIFFICULT_TASK', 81)]	2	[('CHEBI_36357', 'polyatomic entity', 28, 'compounds'), ('CHEBI_27300', 'vitamin D', 117, 'vitamin D')]
PMC5956785	5/2018	S265-PMC5956785	['these variables CAN make it DIFFICULT to interpret the RELATIONSHIP between Vitamin D and disease activity in RELATION to both inflammation status and risk of relapse.']	[('INCOMPLETE_EVIDENCE', 16), ('DIFFICULT_TASK', 28), ('SUPERFICIAL_RELATIONSHIP', 55), ('SUPERFICIAL_RELATIONSHIP', 110)]	4	[('CHEBI_27300', 'vitamin D', 76, 'vitamin D')]
PMC5956785	5/2018	S271-PMC5956785	['this review was UNABLE TO explore the RELATIONSHIP between Vitamin D status and ethnicity, Vitamin D receptor Genes or OTHER Genes that INFLUENCE Vitamin D Metabolism.']	[('DIFFICULT_TASK', 16), ('SUPERFICIAL_RELATIONSHIP', 38), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 119), ('SUPERFICIAL_RELATIONSHIP', 136)]	4	[('CHEBI_27300', 'vitamin D', 59, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 91, 'vitamin D'), ('SO_0000704', 'gene', 110, 'genes'), ('SO_0000704', 'gene', 125, 'genes'), ('CHEBI_27300', 'vitamin D', 146, 'vitamin D'), ('GO_0042359', 'vitamin D metabolic process', 146, 'vitamin D metabolism')]
PMC6011374	6/2018	S15-PMC6011374	['this MAY BE explained, IN PART, by INADEQUATE control of RELATED risk factors and CONFOUNDERS in statistical analyses, VARIATIONS between assays that measure Vitamin D and significant HETEROGENEITY between studied populations [6].']	[('INCOMPLETE_EVIDENCE', 5), ('INCOMPLETE_EVIDENCE', 23), ('PROBLEM_COMPLICATION', 35), ('SUPERFICIAL_RELATIONSHIP', 57), ('PROBLEM_COMPLICATION', 82), ('DIFFICULT_TASK', 119), ('DIFFICULT_TASK', 184)]	7	[('CHEBI_27300', 'vitamin D', 158, 'vitamin D')]
PMC6011374	6/2018	S50-PMC6011374	['given that the month in which the Serum was sampled heavily INFLUENCES Vitamin D status, “standardised” Serum 25(Oh)D concentrations were calculated as previously described [34] in order to normalise against seasonal VARIATION.']	[('SUPERFICIAL_RELATIONSHIP', 60), ('DIFFICULT_TASK', 217)]	2	[('UBERON_0001977', 'blood serum', 34, 'serum'), ('CHEBI_27300', 'vitamin D', 71, 'vitamin D'), ('UBERON_0001977', 'blood serum', 104, 'serum'), ('CHEBI_71657', 'versiconol acetate', 110, '25(OH)D'), ('PR_000008838', 'serine protease HTRA1', 110, '25(OH ... D')]
PMC6011374	6/2018	S89-PMC6011374	['this was independent of diet and lifestyles factors including bmi and sei and highlights the DIFFICULTY in understanding the ROLE of Vitamin D in Pregnancy in Human cohort studies.']	[('DIFFICULT_TASK', 93), ('SUPERFICIAL_RELATIONSHIP', 125)]	2	[('CHEBI_27300', 'vitamin D', 133, 'vitamin D'), ('GO_0007565', 'female pregnancy', 146, 'pregnancy'), ('NCBITaxon_9606', 'Homo sapiens', 159, 'human')]
PMC6011374	6/2018	S121-PMC6011374	['HOWEVER, DIFFERENCES in Vitamin D status between the women recruited in adelaide and those recruited in auckland reflect obvious DIFFICULTIES in studying HOW Vitamin D MAY support healthy Pregnancies.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 9), ('DIFFICULT_TASK', 129), ('EXPLICIT_QUESTION', 154), ('INCOMPLETE_EVIDENCE', 168)]	5	[('CHEBI_27300', 'vitamin D', 24, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 158, 'vitamin D'), ('GO_0007565', 'female pregnancy', 188, 'pregnancies')]
